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Background: Periodontal disease is preventable but remains the most common oral disease worldwide,
with major health and economic implications. Stakeholders lack reliable evidence of the relative clinical
effectiveness and cost-effectiveness of different types of oral hygiene advice (OHA) and the optimal
frequency of periodontal instrumentation (PI).
Objectives: To test clinical effectiveness and assess the economic value of the following strategies:
personalised OHA versus routine OHA, 12-monthly PI (scale and polish) compared with 6-monthly PI, and
no PI compared with 6-monthly PI.
Design: Multicentre, pragmatic split-plot, randomised open trial with a cluster factorial design and blinded
outcome evaluation with 3 years’ follow-up and a within-trial cost–benefit analysis. NHS and participant
costs were combined with benefits [willingness to pay (WTP)] estimated from a discrete choice
experiment (DCE).
Setting: UK dental practices.
Participants: Adult dentate NHS patients, regular attenders, with Basic Periodontal Examination (BPE)
scores of 0, 1, 2 or 3.
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Intervention: Practices were randomised to provide routine or personalised OHA. Within each practice,
participants were randomised to the following groups: no PI, 12-monthly PI or 6-monthly PI
(current practice).
Main outcome measures: Clinical – gingival inflammation/bleeding on probing at the gingival margin
(3 years). Patient – oral hygiene self-efficacy (3 years). Economic – net benefits (mean WTP minus
mean costs).
Results: A total of 63 dental practices and 1877 participants were recruited. The mean number of teeth
and percentage of bleeding sites was 24 and 33%, respectively. Two-thirds of participants had BPE scores
of ≤ 2. Under intention-to-treat analysis, there was no evidence of a difference in gingival inflammation/
bleeding between the 6-monthly PI group and the no-PI group [difference 0.87%, 95% confidence interval
(CI) –1.6% to 3.3%; p = 0.481] or between the 6-monthly PI group and the 12-monthly PI group (difference
0.11%, 95% CI –2.3% to 2.5%; p = 0.929). There was also no evidence of a difference between
personalised and routine OHA (difference –2.5%, 95% CI –8.3% to 3.3%; p = 0.393). There was no
evidence of a difference in self-efficacy between the 6-monthly PI group and the no-PI group (difference
–0.028, 95% CI –0.119 to 0.063; p = 0.543) and no evidence of a clinically important difference between
the 6-monthly PI group and the 12-monthly PI group (difference –0.097, 95% CI –0.188 to –0.006;
p = 0.037). Compared with standard care, no PI with personalised OHA had the greatest cost savings: NHS
perspective –£15 (95% CI –£34 to £4) and participant perspective –£64 (95% CI –£112 to –£16). The DCE
shows that the general population value these services greatly. Personalised OHA with 6-monthly PI had the
greatest incremental net benefit [£48 (95% CI £22 to £74)]. Sensitivity analyses did not change conclusions.
Limitations: Being a pragmatic trial, we did not deny PIs to the no-PI group; there was clear separation in
the mean number of PIs between groups.
Conclusions: There was no additional benefit from scheduling 6-monthly or 12-monthly PIs over not
providing this treatment unless desired or recommended, and no difference between OHA delivery for
gingival inflammation/bleeding and patient-centred outcomes. However, participants valued, and were
willing to pay for, both interventions, with greater financial value placed on PI than on OHA.
Future work: Assess the clinical effectiveness and cost-effectiveness of providing multifaceted periodontal
care packages in primary dental care for those with periodontitis.
Trial registration: Current Controlled Trials ISRCTN56465715.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 38.
See the NIHR Journals Library website for further project information.
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Plain English summary
A lmost half of adults in the UK show signs of gum disease. It is a largely preventable disease, withtreatment usually taking the form of self-care, including tooth brushing and dentist cleaning, which is
often called ‘scale and polish’. In this study, we wanted to find out whether or not the advice patients are
given and the cleaning they receive from the dentist work and offer good value for money.
A total of 1877 adults who regularly attended 63 different NHS dental practices across Scotland and
north-east England were involved. The adults had early signs of gum disease and were randomly chosen to
be offered a scale and polish every 6 months, every 12 months or not at all. They received normal advice
or personalised advice depending on what dental practice they attended. The recruited adults completed
study surveys every year. They also had clinical measurements of their mouth taken by study staff at the
start of the study and 3 years later.
After 3 years, there was no evidence of differences in gum health, whether a scale and polish was carried
out every 6 or 12 months or only when either the patient requested it or the dentist recommended it for
clinical reasons. There was also no added benefit of providing personalised oral health advice. However,
patients value, and are willing to pay for, cleaning advice and scale and polish, but are willing to pay more
for scale and polish than for advice.
DOI: 10.3310/hta22380 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 38
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Ramsay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxi

Scientific summary
Background
Periodontal disease is an inflammatory disease that affects the soft and hard tissues supporting teeth.
This disease is largely preventable, yet it remains the major cause of poor oral health worldwide and is the
primary cause of tooth loss in older adults. Severe periodontitis is the sixth most prevalent human disease,
with a standardised prevalence of 11.2%.
The categorisation of periodontal disease is based on which of the tissues surrounding and supporting the
teeth are affected and is classified into two broad categories: (1) gingivitis and (2) periodontitis. Gingivitis is
a reversible condition characterised by inflammation and bleeding at the gingival margin. The gum becomes
swollen and red because of the inflammation and will bleed easily on probing. It is a prerequisite for
periodontitis and a risk indicator for caries progression. Periodontitis is the irreversible destruction and loss
of the supporting periodontal structures (periodontal ligament, cementum and alveolar bone). The result
can be unsightly gingival recession, sensitivity of the exposed root surface, root caries (decay), mobility and
drifting of teeth and, ultimately, tooth loss.
Individuals and dental care professionals have different roles to play in the prevention and management of
periodontal disease. Effective individual self-care (tooth brushing and interdental aids) for plaque control is
considered the foundation stone of successful periodontal prevention and therapy of disease. The current
annual public spend on oral care products in the UK alone is £950M. Dental care professionals’ role in
prevention and periodontal treatment involves providing patients with oral hygiene advice (OHA) (self-care)
and periodontal instrumentation (PI), often known as ‘scale and polish’. There is no agreed published
content of OHA but the overall aim is to encourage effective self-care. PI comprises removal of plaque and
plaque retentive factors [e.g. calculus (tartar) deposits] which, together with the removal of overhanging
restorations (poorly adapted dental fillings), facilitates adequate patient-performed oral self-care. In the UK,
almost all of this treatment is provided by general dental practitioners and dental hygienists/therapists in
primary care.
Despite evidence of an association between sustained, good oral hygiene and a low incidence of
periodontal disease and caries in adults, there is a lack of strong and reliable evidence to inform clinicians of
the relative clinical effectiveness (if any) of different types of OHA that can be delivered in a dental setting.
The evidence to inform clinicians of the effectiveness and optimal frequency of PI is mixed. A Cochrane
systematic review (Worthington HV, Clarkson JE, Bryan G, Beirne PV. Routine scale and polish for periodontal
health in adults. Cochrane Database Syst Rev 2013;11:CD004625) of routine PI for periodontal health in
adults found insufficient evidence to determine the effects of routine PI treatments, providing little guidance
for policy-makers, dental professionals or patients.
There was therefore an urgent need to assess the relative clinical effectiveness of OHA and PI in a robust,
sufficiently powered randomised controlled trial (RCT) in primary dental care.
The trial protocol was published in BMC Oral Health (Clarkson JE, Ramsay CR, Averley P, Bonetti D, Boyers D,
Campbell L, et al. IQuaD dental trial; improving the quality of dentistry: a multicentre randomised controlled
trial comparing oral hygiene advice and periodontal instrumentation for the prevention and management of
periodontal disease in dentate adults attending dental primary care. BMC Oral Health 2013;13:58).
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Objectives
The aim of this study was to compare the clinical effectiveness and cost-effectiveness of theory-based,
personalised OHA or PI at different time intervals (no PI, 12-monthly PI or 6-monthly PI), or their
combination (OHA and 6-monthly PI), with routine care for improving periodontal health in dentate adults
attending general dental practice.
The primary objectives were to test the clinical effectiveness and cost-effectiveness of the following dental
management strategies:
1. personalised OHA versus routine OHA
2. 6-monthly PI versus 12-monthly PI
3. 6-monthly PI versus no PI.
The secondary objectives were to:
1. test the clinical effectiveness and cost-effectiveness of a combination of personalised OHA with
different time intervals for PI
2. measure dentist/hygienist beliefs relating to giving OHA, PI and maintenance of periodontal health.
Methods
Design
Improving the Quality of Dentistry (IQuaD) was a 5-year multicentre, pragmatic split-plot, cluster
randomised, open trial with blinded outcome evaluation. The comparisons were made within a factorial
design using a combination of cluster and individual participant randomisation. As personalised OHA
was given by the dentist or hygienist, there was a theoretical risk of ‘contamination’ between patient
participants seen within the same dental practice. To minimise this potential risk, dental practices were
randomised to deliver routine or personalised OHA. All patient participants seen by the same dental
practice (a ‘cluster’) received either routine (current practice) or personalised OHA, depending on their
dental practice allocation. To test the effects of PI, each individual patient participant was randomised to
no PI, 12-monthly PI or 6-monthly PI (current practice).
Setting
The trial recruited dental practitioners from general dental practices in Scotland and north-east England
(Newcastle upon Tyne). Participating dentists represented a cross-section of practitioners operating in
a range of different circumstances (e.g. urban or rural, high- to low-income communities, employing a
dental hygienist or not).
Dentist participants
Inclusion criteria
l NHS provider for adult patients.
l Primary care provider.
l Willing to follow protocol.
Exclusion criteria
l Providing only private dental care.
l Unwilling to follow protocol.
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Patient participants
Inclusion criteria
Adult patients (aged ≥ 18 years) with gingivitis or moderate periodontitis [a Basic Periodontal Examination
(BPE) score of 0, 1, 2 or 3] who:
l were dentate
l had attended for a check-up at least twice in the previous 2 years
l received their dental care in part or in full as a NHS patient.
Exclusion criteria
l Patients with a BPE score of 4 (clinical probing depth of > 6 mm and/or furcation involvements or
attachment loss of ≥ 7mm) in any sextant on the basis that more extensive periodontal care was indicated.
l Patients with an uncontrolled chronic medical condition (e.g. diabetes mellitus, immunocompromised).
Interventions
Routine OHA was defined as the OHA currently being provided by the practices. There is no published
information describing ‘routine’ OHA, but anecdotal evidence suggests that this is often the provision
of minimal OHA (e.g. ‘you need to brush your teeth more frequently’) or no OHA.
The personalised OHA intervention was based on social cognitive theory and implementation intention
theory. The content of the OHA delivered was personalised according to the dentist’s/hygienist’s
assessment of the needs of the patient. At a minimum, the content included advice and instruction in
self-diagnosis (e.g. bleeding gums on brushing indicates the presence of reversible gingival inflammation)
and advice and instruction on tooth brushing and flossing (frequency and technique). On completion of
the OHA, the dentist agreed an action plan with the patient.
The definition of PI was as used in standard practice and could include the removal of plaque and calculus
from the crown and root surfaces using manual or ultrasonic scalers, with no adjunctive subgingival
therapy (e.g. local delivery antibiotics), and the appropriate management of plaque retention factors.
Experimental groups received a PI at 6- or 12-monthly intervals according to the individual participant-level
randomisation. Participants allocated to the no-PI groups attended their dentist at time intervals determined
by current practice. However, participants and dental practices were advised that every trial participant
should be invited to attend for a routine examination appointment at least every 12 months.
Main outcome measures
Primary outcomes
l Clinical: gingival inflammation/bleeding on probing at the gingival margin at the 3-year follow-up.
l Patient centred: oral hygiene self-efficacy at the 3-year follow-up.
l Economic: net benefits [mean willingness to pay (WTP) minus mean costs].
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Secondary outcomes
l Clinical: (1) calculus, (2) clinical probing depth, (3) additional PI and (4) referral. (All of which were
collected at the 3-year follow-up.)
l Patient centred: (1) dental quality of life, (2) oral health behaviour and (3) knowledge. (All of which
were collected during 3 years’ annual follow-up.)
l Economic: costs to the NHS and patients; WTP.
l Provider: beliefs relating to giving OHA and maintenance of periodontal health.
Note: the Periodontal Advisory Group considered that Clinical Attachment Loss and plaque cannot be
measured reliably and so neither was included as outcomes.
Clinical outcomes were measured at baseline by trained outcome assessors (OAs) who were blinded to
allocation. Gingival inflammation/bleeding scores, calculus, clinical probing depth and BPE scores were
measured by the OAs and recorded on the baseline clinical chart by the dental research nurse, who
was a member of the trial team. Patient-centred outcomes were measured at baseline and annually by
self-administered postal questionnaire.
Economic evaluation
A within-trial cost–benefit analysis assessed the costs and benefits (in monetary terms) of each policy
compared with standard care (routine OHA with 6-monthly PI). NHS and wider (NHS and participant)
perspectives were considered.
Routinely collected dental claims data were linked to trial data to determine the costs of NHS-provided
care (including participant co-charges). Additional participant costs, including private care, self-purchased
products, and time and travel costs, were sourced from participant annual questionnaires.
A discrete choice experiment (DCE), administered to a nationally representative online sample of the UK
general population, was used to estimate WTP. The design was pivoted and segmented to improve
realism. DCE data were analysed using mixed logit regression models. WTP tariffs from the DCE were
mapped to treatments received (PI and OHA), self-reported bleeding and aesthetics outcomes to
calculate benefits.
The discount rate was 3.5%. Multilevel hierarchical models accounted for clustering, correlation between
benefits and costs, and minimisation covariates. Results were presented as incremental net benefits,
using confidence ellipses to illustrate uncertainty. Deterministic sensitivity analyses tested the impact of
key assumptions on results. The fully approved protocol for the IQuaD trial can be accessed online via
www.journalslibrary.nihr.ac.uk/programmes/hta/090145/#/ (accessed October 2017).
Results
A total of 2341 patients were screened for trial entry and 1877 participants were recruited. Of the
screened patients, a total of 183 (8%) were found to be ineligible. The primary reason for ineligibility was
a BPE score of 4 or * (furcation involvement), affecting 160 patients. From those ineligible because of a
BPE score of 4 or *, 144 (90%) patients agreed to join a separate cohort group. There were 281 patients
potentially eligible for the study who were not recruited.
At baseline, the mean number of teeth per participant was 24. Two-thirds of participants had a BPE score
of ≤ 2. The mean proportion of sites affected by bleeding was 33% and 35% of teeth had calculus
present. The mean clinical probing depth was 1.8 mm. Between 10% and 12% of participants in each
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group had four or more pockets with a clinical probing depth of ≥ 4 mm. There were no important
imbalances across the randomised groups.
The pre-chosen clinical primary outcome was mean gingival inflammation/bleeding at 3 years’ follow-up;
71% of the participants attended the 3-year clinical follow-up appointment. Under intention-to-treat (ITT)
analysis, there was no evidence of a difference between those randomised to receive 6-monthly PI and
those randomised to receive no PI [difference 0.87%, 95% confidence interval (CI) –1.6% to 3.3%;
p = 0.481] (i.e. there was a < 1% difference in the average number of sites with gingival bleeding
between the randomised groups). Similarly, there was no evidence of a difference between 6-monthly PI
and 12-monthly PI (difference 0.11%, 95% CI –2.3% to 2.5%; p = 0.929). The 95% CIs were small
enough to exclude the prespecified clinically important difference of 7.5% in bleeding. There was also no
evidence of a difference between participants randomised to personalised OHA and those randomised to
routine OHA (difference –2.5%, 95% CI –8.3% to 3.3%; p = 0.393). The results were robust to other
adjusted/unadjusted models. The interaction between personalised OHA and 6-monthly PI was 1.7
(95% CI –3.8 to 7.3) (i.e. neither statistically nor clinically significant).
The pre-chosen patient-centred primary outcome was self-efficacy at the 3-year follow-up; 77% of the
participants completed a 3-year questionnaire. Under ITT analysis, there was no evidence of a difference
between those randomised to receive 6-monthly PI and those randomised to receive no PI (difference
–0.028, 95% CI –0.119 to 0.063; p = 0.543). Between those randomised to receive 6-monthly and
12-monthly PI, there was a statistically significant difference at the 5% level favouring the 6-monthly PI
(difference –0.097, 95% CI –0.188 to –0.006; p = 0.037); however, the size of the difference was not
clinically important.
There were no significant differences in NHS dental costs. No PI with personalised OHA was the least
costly policy (£62.42) [mean difference vs. standard care –£14.91 (95% CI –£15.70 to £28.16)], followed
by no PI and routine OHA (£72.23) [mean difference –£3.12 (95% CI –£18.18 to £11.93)]. From a wider
perspective, no PI with personalised OHA was significantly less costly [mean difference –£64.11 (95% CI
–£112.33 to –£15.88)], followed by no PI with routine OHA [mean difference –£39.80 (95% CI –£83.94
to £4.33)].
The DCE showed that the general population valued both PI and personalised OHA even when controlling
for bleeding and aesthetic outcomes. Therefore, 6-monthly PI with personalised OHA has the greatest
benefit [mean difference vs. standard care £61.67 (95% CI £40.19 to £83.14)]. A 12-monthly PI with
personalised OHA also had positive, but not significant, incremental benefits [mean difference £19.70
(95% CI –£1.64 to £41.04)]. This suggests that, in terms of WTP, a reduction in PI frequency can, in part,
be compensated for by introducing personalised OHA.
Six-monthly PI with personalised OHA had the largest incremental net benefit compared with standard
care from a NHS perspective [mean difference £48 (95% CI £22 to £74)] and a wider perspective [mean
difference £68 (95% CI £15 to £120)]. The overall health economic results were broadly consistent across
the UK countries and findings were robust to the sensitivity analyses undertaken.
Limitations
Being a pragmatic trial, we did not deny PIs to the no-PI group, although we did not collect detailed
information about the reasons for additional PIs. However, there was clear separation in the mean number
of PIs between groups. The economic evaluation was based on current NHS contracts that may change
over time. A lifetime decision model was not conducted; however, given the lack of difference in clinical
outcomes, extrapolation of trial results would be unlikely to change conclusions.
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Conclusions
The IQuaD trial, involving regular adult NHS dental attenders (with no or early signs of periodontitis), has
shown that, over a 3-year period, there is no additional benefit from scheduling 6-monthly or 12-monthly
PIs over not providing this treatment unless desired or recommended, and that there is no difference
between personalised or routine OHA (current practice) for the trial’s primary clinical (gingival inflammation/
bleeding) and patient-centred (self-reported) outcomes. However, patients value, and are willing to pay for,
both interventions, with greater financial value placed on PI than on OHA.
Recommendations for research
l Research is needed to assess the clinical effectiveness and cost-effectiveness of providing multifaceted
periodontal care packages (e.g. OHA, oral care-products, PI) in primary dental care for those with
periodontitis.
l Research is required to better understand the source of WTP values and the extent to which this is
influenced by perceptions and current practice.
l Research is needed to explore the relative value of different data sources for estimating resource use in
dentistry including routine data, patient-reported data and practice records.
Trial registration
This trial is registered as ISRCTN56465715.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction
The subsequent chapters of this monograph describe Improving the Quality of Dentistry (IQuaD), aNational Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme-funded
trial testing the relative effectiveness of different types of oral hygiene advice (OHA) and the optimal
frequency of periodontal instrumentation (PI). The trial protocol has been published.1
The reason for the trial
Background
Epidemiology
Periodontal disease is an inflammatory disease that affects the soft and hard tissues supporting teeth.
This disease is largely preventable, yet it remains the major cause of poor oral health worldwide and is
the primary cause of tooth loss in older adults.2,3 Severe periodontitis is the sixth most prevalent human
disease, with a standardised prevalence of 11.2%.4
The categorisation of periodontal disease is based on which of the tissues surrounding and supporting the
teeth are affected and is classified into two broad categories: (1) gingivitis and (2) periodontitis. Gingivitis
is a reversible condition characterised by inflammation and bleeding at the gingival margin. The gum
becomes swollen and red because of the inflammation and will bleed easily on probing. It is a prerequisite
for periodontitis and is also a risk indicator for caries progression. Periodontitis is the irreversible destruction
and loss of the supporting periodontal structures (periodontal ligament, cementum and alveolar bone).5
The result can be unsightly gingival recession, sensitivity of the exposed root surface, root caries (decay),
mobility and drifting of teeth and, ultimately, tooth loss.
Gingivitis and periodontitis are a continuum of the same inflammatory disease6 but it is currently not
possible to predict if and/or when an individual will progress from the reversible gingivitis to irreversible
periodontitis. Accumulation of microbial dental plaque is the primary aetiological factor for gingivitis and
periodontitis, as well as dental caries. However, progression of the disease is known to be affected by
other factors including genetics (host’s defence mechanisms to bacterial infection), calculus, smoking and
systemic comorbidities including type 2 diabetes mellitus.7–10 Although several risk factors have been
identified, the lack of certainty as to whether or not, and when, they may cause progression to irreversible
periodontitis in an individual causes a challenge for the profession.
The 2009 UK Adult Dental Health Survey (ADHS)11 provides evidence that the majority of UK adults might
be at risk of developing periodontal disease: 66% of dentate adults had visible plaque, indicating that
tooth brushing was ineffective, and 68% had calculus in at least one sextant of the mouth. Gingival
bleeding was demonstrated in 54% of dentate adults and 45% of dentate adults had periodontitis
(defined by at least one site with a clinical probing depth of ≥ 4 mm), increasing with age from 19% in
those aged 16–24 years to 61% in those aged 75–84 years. Indicators of severe disease (at least one site
with a clinical probing depth of ≥ 6 mm) also increased with age, affecting 14% of those aged ≥ 65 years.
Only 17% of dentate adults had excellent periodontal health, which was defined by the ADHS 200911 as
‘no bleeding, no calculus, no periodontal probing depths of 4 mm or more and in the case of adults aged
55 or above, no loss of periodontal attachment over 4 mm or more anywhere in their mouth’.
As microbial dental plaque accumulation is considered the most important risk factor for periodontitis, its
disruption or removal is a key component of prevention, combined with the control/management of other
risk factors (e.g. smoking).12,13
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Prevention strategies aim to prevent the inflammatory process from destroying the periodontal attachment
as well as prevent the recurrence of inflammation in successfully treated patients.14
Individuals and dental care professionals have different roles to play in prevention. Effective individual
self-care (tooth brushing and interdental aids) for plaque control is considered the foundation stone of
successful periodontal prevention and therapy of disease.13 The current annual public spend on oral care
products in the UK alone is £950M.15 The dental care professionals’ role in prevention and periodontal
treatment involves providing patients with OHA (self-care) and PI. There is no agreed published content
of OHA, but the overall aim of this intervention is to encourage effective self-care. PI (or ‘scale and polish’)
comprises removal of plaque and plaque retentive factors [e.g. calculus (tartar) deposits] which, together with
the removal of overhanging restorations (poorly adapted dental fillings), facilitate adequate patient-performed
oral self-care. In the UK, almost all of this treatment is provided by general dental practitioners and dental
hygienists/therapists in the primary care setting. The British Society of Periodontology16 advises that consideration
be given to referral to a specialist periodontist of patients exhibiting severe or aggressive forms of
periodontal diseases.
Periodontal instrumentation is one of the most frequently provided treatments in general dental practices.
In the year 2014/15, there were 2.2 million claims for this simple periodontal treatment in Scotland, costing
£31.5M.17 This represents 8% of the total NHS budget spend of general and public dental services and
25% of the monetary value of all fee-per-item treatments provided in these settings. There were also 2910
claims for intensive scaling, at a cost of £200,000. During this time frame in England, it was estimated that
12.9 million courses of treatment involved PI for adults and approximately 0.9 million courses for children.18
Dental reimbursement in Scotland is a retrospective ‘fee-per-item’ service for which dentists are primarily
reimbursed for the number of individual treatments provided following completion of a course of treatment.
In 2006, England’s dental health service moved from a similar model to a prospective ‘Unit of Dental
Activity’ (UDA) system. Dentists agree contracts in advance with health boards to provide a prespecified
number of UDAs. In both health-care systems, non-exempt patients face a patient copayment. In Scotland,
the copayment equals 80% of the fee-per-item payment up to a prespecified upper limit. In England, there
is a fixed copayment according to the band of treatment provided.
Evidence base
Despite evidence of an association between sustained good oral hygiene and a low incidence of periodontal
disease and caries in adults,19 there is a lack of strong and reliable evidence to inform clinicians of the relative
clinical effectiveness (if any) of different types of OHA that can be delivered in a dental setting.
Prior to the start of the IQuaD trial, a number of relevant systematic reviews20–22 evaluating OHA had
been conducted, with some inconsistency in their findings. A recent systematic review23 of psychological
approaches to behaviour change for improved plaque control in periodontal management reported benefits
of using goal-setting, self-monitoring and planning for improving oral hygiene. Patient understanding of the
benefits of behaviour change and the seriousness of periodontal disease were also considered important by
the authors of the review.23 A number of the included trials were of short duration, had non-experimental
designs and were rated as being at high risk of bias. A meta-analysis of the available trials was not possible
and the results and recommendations should be interpreted with caution.
The evidence to inform clinicians of the clinical effectiveness and optimal frequency of PI is mixed. A
Cochrane systematic review24 of routine scale and polish (PI) for periodontal health in adults found insufficient
evidence to determine the effects of routine PI treatments, providing little guidance for policy-makers, dental
professionals or patients. Only three trials25–27 were eligible for inclusion and all were rated as being at an
unclear risk of bias. Given that PI is routinely provided in general dental practice, it is noteworthy that only
one of the eligible trials25 was conducted in primary care. Following baseline PI, Jones et al.25 compared no PI
delivery with 6-monthly PI or 12-monthly PI, with a 24-month clinical follow-up. The trial25 recruited only
periodontally healthy participants. The Cochrane systematic review24 assessed the body of evidence for PI as
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being of low quality. The need for further well-conducted trials of sufficient duration, including research
investigating patients’ willingness to pay (WTP), was highlighted.28
The relative effectiveness of OHA and PI was assessed in the IQuaD trial, a robust, adequately powered
randomised controlled trial (RCT) in primary dental care.
The questions the IQuaD trial addressed
Aim
The aim of this study was to compare the clinical effectiveness and cost-effectiveness of theory-based,
personalised OHA or PI at different time intervals (no PI, 12-monthly PI or 6-monthly PI), or their
combination, with routine care in improving periodontal health in dentate adults attending general
dental practice.
Objectives
The primary objectives were to test the clinical effectiveness and cost-effectiveness of the following dental
management strategies:
1. personalised OHA versus routine OHA
2. 6-monthly PI versus 12-monthly PI
3. 6-monthly PI versus no PI.
The secondary objectives were to:
1. test the clinical effectiveness and cost-effectiveness of a combination of personalised OHA and PI at
different time intervals
2. measure dentist/hygienist beliefs relating to giving OHA, PI and maintenance of periodontal health.
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Chapter 2 Methods of the study
Study design
This study was a multicentre, cluster randomised controlled, open trial with blinded outcome evaluations
and 3-year follow-ups. The comparisons were made within a factorial design using a combination of
cluster and individual participant randomisation. Dental practices were randomised to either a routine or
personalised OHA group. All participants were seen in the same dental practice by a dentist or hygienist
(a ‘cluster’) and received either routine (current practice) or personalised OHA depending on their dental
practice’s allocation. This was the optimal design to address the concern that contamination could happen
if each dentist delivered routine OHA to some participants and personalised OHA to others. To test the
effects of PI, each individual participant was randomised to one of three groups: (1) no PI, (2) 6-monthly PI
(current practice) or (3) 12-monthly PI (Figure 1).
Ethics approval and consent
Favourable ethics opinion for the IQuaD trial was confirmed by the East of Scotland Research Ethics Service
on 24 March 2011 [Research Ethics Committee (REC) reference number 10/S0501/65].
Participants and procedure
Recruitment and consent of dental practices
Recruitment of dental practices was achieved by a variety of methods. The IQuaD trial was presented at a
number of national conferences and promoted within dental professional publications to raise awareness
of the trial within the dental profession. In addition, the Scottish Dental Practice Based Research Network
and the Faculty of General Dental Practitioners provided trial information to their members. A series of trial
information and recruitment evenings were organised across Scotland and north-east England. Potential
dentist participants were sent personalised invitation letters to these events in which the reasons for the
trial, design of the trial and practice involvement were described, and dental professionals were given the
opportunity to discuss participation with the trial team. Information packs about the trial were posted to
dentists who were unable to attend a meeting.
Dentists randomised
Routine OHA
(n = 30 dentists/hygienists)
(n = 31 patients per dentist/hygienist)
Patients randomised
No PI 6-monthly PI 12-monthly PI 
(n = 310) (n = 310) (n = 310) (n = 310) (n = 310) (n = 310)
Personalised OHA
(n = 30 dentists/hygienists)
(n = 31 patients per dentist/hygienist)
Patients randomised
No PI 6-monthly PI 12-monthly PI 
FIGURE 1 Study design.
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Trial team members telephoned dental practices to follow up the trial information letters and noted
interest of involvement. Principal dentists (usually the owner of the practice) who were interested in the
trial were asked to provide written consent for the dental practice (cluster) to participate. All participating
dentists and hygienists within a dental practice were individually invited to complete a consent form and
the clinician belief questionnaire (CBQ) prior to cluster randomisation. Participating dental practices were
asked to identify dates in advance for training in trial processes and at least three dates for the screening
and recruitment of potentially eligible participants.
Recruitment and consent of participants
The identification of potential participants in each dental practice was supported by the Scottish Primary
Care Research Network in Scotland and the UK Clinical Research Network in England. A variety of patient
appointment management strategies are utilised within dental practices across the UK. Therefore, the
IQuaD trial developed a flexible and pragmatic participant recruitment strategy that aimed to adapt to each
dental practice’s usual appointment management system. Some dental practices arrange routine check-up
appointments for their patients up to 6 months or 1 year in advance, while other practices send letters or
mobile phone text message reminders to their patients when their routine dental examinations are due,
asking them to contact the dental practice to make an appointment. Dental practices were asked to
send an invitation letter to attend a trial screening session, along with a patient information sheet and
baseline questionnaire to potentially eligible participants who were due to attend for a routine dental
examination and who were regular attenders and did not have severe periodontitis [Basic Periodontal
Examination (BPE) score of 4]. This was sent, at most, 6 weeks in advance of the patient’s routine dental
examination appointment. Patients who were not interested in taking part were asked to contact their
practice for an alternative appointment.
Trial outcome assessor (OA) teams, consisting of qualified dental hygienists/dental therapists and dental
nurses employed by the trial, attended the screening and recruitment sessions in participating dental
practices to obtain consent from potentially eligible participants and collect the baseline clinical
measurements and questionnaires of consented participants.
At the screening appointment, the dentist was available to discuss the trial with potential participants and
answer any questions. The OA was present at this appointment and answered any questions specifically
related to the trial. Patients who did not wish to take part were seen by their dentist/hygienist, who
provided an examination, OHA and/or PI as normal. Potentially eligible participants provided written
informed consent to the trial before the baseline clinical outcomes were measured by the OA to confirm
a patient’s eligibility for the trial. Reasons for ineligibility or declining to participate were recorded at this
session. Participants excluded from the trial solely because of a BPE score of 4 or * (furcation involvement)
were not randomised to a PI allocation and were given the opportunity to consent to follow-up by annual
postal questionnaires and clinical follow-up in a separate cohort group (see study documentation, available
at www.journalslibrary.nihr.ac.uk/programmes/hta/090145/#/; accessed October 2017). All participants
received a baseline PI and OHA from their own dentist or hygienist after the baseline outcome measures
and questionnaires were collected by the OA team prior to participants being informed of their randomised
PI allocation.
Inclusion/exclusion criteria
Dental practices
Inclusion criteria
l NHS provider for adult patients.
l Primary care provider.
l Willing to follow protocol.
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Exclusion criteria
l Providing only private dental care to adults.
l Unwilling to follow protocol.
Participants
Inclusion criteria
Adult patients (aged ≥ 18 years) with periodontal health, gingivitis or moderate periodontitis (BPE score of
0, 1, 2 or 3) who:
l were dentate
l had attended for a check-up at least twice in the previous 2 years
l received their dental care in part or in full as a NHS patient.
Exclusion criteria
l Patients with periodontal disease with a BPE score of 4 (clinical probing depth of > 6 mm and/or
furcation involvements or attachment loss of ≥ 7 mm) in any sextant on the basis that more extensive
periodontal care was indicated.
l Patients with an uncontrolled chronic medical condition (e.g. diabetes mellitus, immunocompromised).
Trial outcome assessor training
Before participant recruitment and 3 years’ clinical follow-up, the OA teams were trained in the recording
of the trial clinical outcomes. The training was delivered by trial collaborators who have extensive
experience of clinical periodontal research (PH, GM). The emphasis of the training was on the consistency
of the scoring, both intra- and interassessor, to achieve assessor alignment.
The practical steps of clinical outcome assessment were agreed on in advance, including sequence of
outcome assessment; time allocation; sequence around the mouth; isolation as well as the angulation,
positioning and pressure of the University of North Carolina (UNC)-15 probe to ensure a standardised
approach across the OA teams.
It is widely accepted that methods of assessing gingival inflammation that provoke gingival bleeding do
not allow for repeated assessment.29 The training for the primary outcome of gingival inflammation as
bleeding therefore involved OA group discussion of the technique of assessment, scoring definition,
as well as demonstrated photograph and clinical examples. This was repeated for the outcome of calculus.
Periodontal probing depths were recorded at six sites on all erupted teeth using a probing force of
approximately 25 g on an independent, but similar, cohort of patients to those recruited to the study at
the Newcastle upon Tyne and Dundee dental schools. Assessments by an experienced clinical periodontal
researcher (LH) were used the reference standard. Intra- and interoutcome assessor scores were recorded
and kappa scores of ≥ 0.60 achieved, with over 95% of scores within 1 mm.
Trial interventions
Both cluster-level intervention (OHA) and individual participant-level intervention (PI) were delivered by the
dental practice dentist or dental hygienist in line with each individual dental practice’s usual practice.
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Oral hygiene advice
Routine oral hygiene advice
Routine OHA was defined as the OHA currently being provided by the dental practices. There is no
published information describing ‘routine’ OHA, but anecdotal evidence suggests that it is often minimal
(e.g. ‘you need to brush your teeth more frequently’) or not provided at all.
Personalised oral hygiene advice
The personalised OHA intervention used two well-established psychological models for explaining and
influencing behaviour (Figure 2). The first was a pre-motivational model, social cognitive theory.30 This
theory proposes that a key variable influencing motivation and behaviour is self-efficacy, assessed as
a person’s confidence in their ability to perform behaviour. According to this model, the sources of
self-efficacy are doing the behaviour (performance: cleaning their teeth), seeing someone else do it
(vicarious example/modelling: the dentist demonstrated to patients how to use the oral health-care tools
to clean their teeth on a model of the mouth), being encouraged to perform it (verbal persuasion: the
dentist helped the patient make oral hygiene a habit with the right plan) and how we feel afterwards
(physical state: the dentist discussed biofeedback, highlighting what clean teeth would feel like). Based
on this model, an intervention to influence oral hygiene behaviour should target oral hygiene self-efficacy
via these sources. The second model was implementation intention theory,31 a post-motivational model
designed to help people put their intentions into practice, bridging the gap between motivation and
behaviour. This theory proposes that making an explicit action plan about where and when a behaviour
will be performed increases the likelihood of performing it. Action plans work by setting up a cue to
remind the individual to perform the behaviour. Therefore, oral hygiene behaviours are likely to be very
sensitive to action planning, as they can easily be linked to other behaviours most people do every day,
for example tooth brushing after the cue of eating a meal or before going to bed.
The intervention was tested in a study32 consisting of 84 dental practices and 799 patients. The results
of this pilot study32 supported the theoretically framed intervention as an effective method of influencing
oral hygiene beliefs and behaviour. Participants who received the intervention had significantly better
behavioural (timing, duration, method), cognitive (confidence, planning) and clinical (plaque, gingival
bleeding) outcomes than the participants in the control group receiving routine care.
Training in the delivery of the personalised oral hygiene advice
Training in the delivery of the personalised OHA intervention was provided by a clinical member of the trial
team to all dentists/hygienists within a dental practice randomised to this allocation. The content and the
delivery of the intervention were standardised as a series of steps (see study documentation, available at
Social cognitive theory
(Bandura30)
Tell Show
This is what you need to do
• Brush twice a day
• Brush for 2 minutes
• Use fluoride toothpaste
• Spit, don’t rinse
• Clean teeth feel smooth to
   the tongue
This is how you do it
• Denstist shows tooth
   brushing technique 
   on mouth of model
Now, please clean your
teeth using this toothbrush,
so that I can check your
technique
Dentist
• Corrects if required
• Asks how teeth feel
• Asks if now confident
• Praises
Before you go, can you
tell me when will be the
best time for you to
brush your teeth?
• Dentist elicits an
   action plan
Do Plan
Implementation intention theory
(Gollwitzer31)
FIGURE 2 The OHA intervention behavioural framework.
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www.journalslibrary.nihr.ac.uk/programmes/hta/090145/#/; accessed October 2017) designed to take place
within an average primary care consultation, taking approximately 5 minutes in total.
A training DVD demonstrating a consultation using the steps was also developed and provided on a
memory stick to all practices assigned to personalised OHA intervention (available at http://dentistry.
dundee.ac.uk/nihr-hta-iquad-trial; accessed October 2017). The practices were also provided with
laminated instruction sheets for use in the dental surgery. Dentists/hygienists retained these training
resources in order to be able to undertake self-directed training as required throughout the trial. New
clinicians appointed to any of the IQuaD trial dental practices (clusters) throughout the trial were invited to
take part and provide consent to IQuaD if they had taken over the care of any IQuaD trial participants.
Full training in trial methodology and intervention delivery was provided, as detailed above.
Frequency of oral hygiene advice
At baseline, all participants received OHA in accordance with the cluster-level randomisation allocation.
Reinforcement of OHA was provided at the discretion of the dentist/hygienist during the trial.
Periodontal instrumentation
The definition of PI was as used in standard practice and would include the removal of plaque and calculus
from the crown and root surfaces using manual or ultrasonic scalers, with no adjunctive subgingival
therapy (e.g. antibiotics)33 and the appropriate management of plaque retention factors.
Baseline periodontal instrumentation
A full mouth supra- and subgingival PI was carried out by the practice dentist/hygienist on all participants
prior to the participant or dental clinician being aware of the trial allocation. No time limit was set on this
treatment and dentists/hygienists were instructed to scale the teeth and root surfaces until they were free
of all deposits and were smooth to probing.
Experimental periodontal instrumentation
Experimental groups received a PI at 6- or 12-monthly intervals in accordance with the individual
participant-level randomisation. Participants allocated to the no-PI groups attended their dentist at time
intervals determined by current practice. However, participants and dental practices were advised that
every trial participant should be invited to attend their dentist for a routine examination appointment at
least every 12 months.
Randomisation
Practice allocation to oral hygiene advice group
Recruited dental practices were allocated to routine or personalised OHA by minimisation on two factors:
(1) practice employed a dental hygienist (yes/no) and (2) practice size (one or two dentists in practice/three or
more dentists). This cluster-level randomisation was conducted using the automated, central randomisation
service at the Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen, after the dental
practice consent form was received at the Trial Coordinating Office in Dundee (TCOD) and before any
potential participant had been approached.
Participant allocation to periodontal instrumentation group
Participants were allocated to the PI trial arms using the automated, central randomisation service at the
CHaRT, University of Aberdeen, with access by both telephone and web. Allocation took place once
the OA had completed the baseline outcome assessment and was minimised on (1) absence of gingival
bleeding on probing (yes/no), (2) highest sextant BPE score (BPE score of < 3/BPE score of 3) and (3) currently
smoking (yes/no).
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The OAs were informed that allocation had taken place but were blinded to allocation, with the actual
allocation transmitted to the TCOD. A letter was sent to all participants to inform them of their PI
allocation and all participants received a £25 gift voucher in recognition of their contribution to the study.
The TCOD provided each individual recruited dental practice with a list of projected dates for PI and review
(no-PI group), according to the individual participant-level allocation, to be delivered throughout the trial for
all their trial participants. The list was updated and re-sent by TCOD on an annual basis to each practice.
Descriptive measures
Participant descriptive measures were collected at baseline and annually by self-administered postal
questionnaire. They included the time since the last visit at the dental practice, the type of attendee (regular
vs. non-regular), the self-reported number of PIs and OHA received in the last 12 months and by whom,
smoking status and the type of toothbrush (manual vs. electric). Descriptive measures are presented in Table 1
by year and randomised group, using either mean, standard deviation (SD) or n (%), as appropriate.
TABLE 1 Participant dental characteristics at baseline, by randomised group
Participant dental characteristics
Randomised group, n (%)
PI OHA
No
(N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
Age (years), mean (SD), n 47.8 (15.8),
623
47.9 (15.7),
625
47.8 (15.8),
626
47.4 (16.1),
1008
48.3 (15.3),
866
Male 223 (36) 229 (37) 225 (36) 387 (38) 290 (33)
Date of last visit to the dental practice
< 1 year ago 569 (91) 547 (88) 553 (88) 893 (89) 776 (90)
1–2 years ago 38 (6) 57 (9) 49 (8) 79 (8) 65 (8)
> 2 years ago 5 (1) 4 (1) 6 (1) 9 (1) 6 (1)
Missing 11 (2) 17 (3) 18 (3) 27 (3) 19 (2)
Last course of treatment was
NHS 557 (89) 573 (92) 575 (92) 918 (91) 787 (91)
Private 10 (2) 9 (1) 8 (1) 15 (1) 12 (1)
Combination 40 (6) 23 (4) 24 (4) 41 (4) 46 (5)
Missing 16 (3) 20 (3) 19 (3) 34 (3) 21 (2)
Do you think of yourself as
A regular attendee 565 (91) 561 (90) 574 (92) 903 (90) 797 (92)
Someone who sees a dentist
when in pain or trouble
43 (7) 47 (8) 31 (5) 76 (8) 45 (5)
Missing 15 (2) 17 (3) 21 (3) 29 (3) 24 (3)
Last time you went to the dental practice were you given OHA?
Yes 410 (66) 411 (66) 420 (67) 688 (68) 553 (64)
No 192 (31) 187 (30) 179 (29) 275 (27) 283 (33)
Missing 21 (3) 27 (4) 27 (4) 45 (4) 30 (3)
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TABLE 1 Participant dental characteristics at baseline, by randomised group (continued )
Participant dental characteristics
Randomised group, n (%)
PI OHA
No
(N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
By whom?
Dentist 298 (48) 293 (47) 291 (46) 484 (48) 398 (46)
Hygienist 81 (13) 85 (14) 97 (15) 141 (14) 122 (14)
Both 29 (5) 27 (4) 27 (4) 53 (5) 30 (3)
Missing 215 (35) 220 (35) 211 (34) 330 (33) 316 (36)
Last time you went to the dental practice were you given a scale and polish?
Yes 371 (60) 364 (58) 381 (61) 619 (61) 497 (57)
No 230 (37) 236 (38) 217 (35) 341 (34) 342 (39)
Missing 22 (4) 25 (4) 28 (4) 48 (5) 27 (3)
By whom?
Hygienist 106 (17) 108 (17) 114 (18) 182 (18) 146 (17)
Dentist 247 (40) 236 (38) 244 (39) 394 (39) 333 (38)
Missing 270 (43) 281 (45) 268 (43) 432 (43) 387 (45)
What type of toothbrush do you normally use?
Manual 413 (66) 397 (64) 382 (61) 647 (64) 545 (63)
Electric 180 (29) 192 (31) 205 (33) 300 (30) 277 (32)
Do not use toothbrush 14 (2) 18 (3) 16 (3) 28 (3) 20 (2)
Missing 16 (3) 18 (3) 23 (4) 33 (3) 24 (3)
Do you normally pay for dental treatments?
Yes 453 (73) 436 (70) 452 (72) 716 (71) 625 (72)
No 155 (25) 170 (27) 150 (24) 260 (26) 215 (25)
Missing 15 (2) 19 (3) 24 (4) 32 (3) 26 (3)
Do you have dental insurance?
Yes 19 (3) 20 (3) 24 (4) 32 (3) 31 (4)
No 581 (93) 583 (93) 573 (92) 932 (92) 805 (93)
Missing 23 (4) 22 (4) 29 (5) 44 (4) 30 (3)
How often do you prefer to have a scale and polish?
Never 13 (2) 13 (2) 8 (1) 21 (2) 13 (2)
Once every 2 years 25 (4) 20 (3) 13 (2) 38 (4) 20 (2)
Once a year 117 (19) 122 (20) 121 (19) 193 (19) 167 (19)
Twice a year 269 (43) 268 (43) 289 (46) 451 (45) 375 (43)
Three times a year 65 (10) 65 (10) 59 (9) 89 (9) 100 (12)
Four times a year 67 (11) 71 (11) 56 (9) 103 (10) 91 (11)
More often 26 (4) 19 (3) 25 (4) 32 (3) 38 (4)
Missing 41 (7) 47 (8) 55 (9) 81 (8) 62 (7)
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Outcome measures
Primary outcomes
l Clinical: gingival inflammation/bleeding on probing at the gingival margin at the 3-year follow-up.
l Patient centred: oral hygiene self-efficacy at the 3-year follow-up.
l Economic: net benefits (mean WTP minus mean costs).
Secondary outcomes
l Clinical: (1) calculus, (2) clinical probing depth, (3) additional PI and (4) referral. (All of which were
collected at 3-year follow-up.)
l Patient-centred: (1) dental quality of life (QoL), (2) oral health behaviour and (3) knowledge.
(All of which were collected during 3 years’ annual follow-up.)
l Economic: costs to the NHS and patients; WTP.
l Providers: beliefs relating to giving OHA and maintenance of periodontal health.
Note: the Periodontal Advisory Group considered that clinical attachment loss and plaque cannot be
measured reliably; therefore, neither was included as outcomes.
Collection of clinical outcome measures
Gingival inflammation was measured according to the Gingival Index of Löe34 by running the UNC probe
circumferentially around each tooth just within the gingival sulcus or pocket. After 30 seconds, bleeding
was recorded as being present or absent on the buccal and lingual surfaces. The primary outcome (gingival
inflammation/bleeding) was calculated by adding all the sites at which bleeding was observed and dividing
these sites by the number of sites (twice the number of teeth) and presented as a percentage.
The colour-coded UNC periodontal probe was used to measure clinical probing depth and presence of
calculus. Clinical probing depths were measured for all teeth (excluding third molars) at six sites per tooth:
(1) mesiobuccal, (2) midbuccal, (3) distobuccal, (4) mesiolingual/palatal, (5) mid-lingual/palatal and
(6) distolingual/palatal. Clinical probing depth was calculated as the mean of the six different sites
measured per tooth and it is presented in mm.
Calculus was calculated by adding all the sites where calculus was observed and dividing it by the number
of teeth and presented as a percentage.
The sequence of scoring was gingival inflammation/bleeding, clinical probing depths and calculus.
Collection of patient-centred outcome measures
Patient-centred outcomes were measured at baseline and annually by self-administered postal questionnaire.
The full details of the calculations used to generate each patient-reported outcome are available in
Appendix 1, Section 1: methods for computing patient-reported outcomes.
Oral health belief outcomes
The questions for measuring patient-centred oral health belief outcomes were derived from social cognitive
theory30 and the theory of planned behaviour.31
The primary patient-centred outcome was self-efficacy, assessed as a person’s confidence in their ability to
perform several different oral health behaviours. Each behaviour was measured using a 7-point scale
scored from 1 (not at all confident) to 7 (extremely confident), with 7 being the best outcome.
METHODS OF THE STUDY
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Perceived behaviour control (PBC) outcome, assessed in terms of perceived ease or difficulty of performing
several different oral health behaviours, was measured using a 7-point scale varying from 1 (strongly agree)
to 7 (strongly disagree), with 7 being the best outcome.
Attitude outcome (perceived consequences of the behaviour) was measured using a 7-point scale varying
from 1 to 7 (strongly agree to strongly disagree), with 7 being the best outcome.
Subjective norm outcome (perceptions of social pressure to perform the behaviour) was measured using
three questions with points varying from 1 (strongly agree) to 7 (strongly disagree), with 7 being the
best outcome.
Oral health behaviour outcome
Patient-reported oral health behaviour outcome was measured using four questions (about duration and
frequency of brushing, frequency of flossing and frequency of interdental brushes use). Each response
varied from 0 to 3, with a score of 3 being the best possible behaviour. The best value between flossing
and interdental brushes was used as a measure of interdental cleaning behaviour. The responses for each
question were summed to produce a summary score ranging from 0 to 9, with 9 being the best outcome.
Intention outcome
Intention (motivation to perform a behaviour) was measured using three questions (about duration and
frequency of brushing and frequency of flossing). Each response varied from 0 to 3, with a score of
3 being the best possible intention. The responses were summed to produce a summary score ranging
from 0 to 9, with 9 being the best outcome.
Quality of life
Quality of life was measured using the Oral Health Impact Profile-14 (OHIP-14).35 The OHIP-14 is a
14-question, oral health-specific, patient-centred measure of symptoms experienced in the previous
12 months. The questions are scored from 0 (never) to 4 (very often) and summed to produce a summary
score ranging from 0 to 56, with 56 being the worst outcome.
Additional periodontal instrumentation outcome
The additional PI outcome assessed at the 3-year follow-up was the number of participants self-reporting
in their annual questionnaire that they had received any private PI at any time during the trial. It was based
on the question, ‘In the last 12 months have you received a private scale and polish?’.
Having a plan to floss or brush
Participants were asked in all questionnaires if they had a plan to brush better and if they had a plan to
floss better. If they answered ‘yes’ to either question, they were considered to have a plan. This outcome
was also used as a measure of fidelity of the personalised OHA intervention.
Dentist beliefs
Clinician belief questionnaires were collected at baseline and at the 3-year follow-up. At baseline, the
following variables were measured: self-efficacy, attitude, PBC, intention, subjective norm and action planning.
All of the variables are measured on a scale of 1 to 7, except subjective norm (measured from 1 to 49) and
intention (measured from 0 to 100). At follow-up, the variables measured were the same. Again, all variables
varied from 1 to 7, except for subjective norm (varies from 1 to 49). The full details of the calculations used
to generate each dentist belief outcome are available in Appendix 1, Section 1: methods for computing
patient-reported outcomes.
Post hoc outcomes
Self-reported bleeding was assessed using one question with the scale varying from 1 (never) to 5
(very often) at the 3-year follow-up in the annual questionnaire.
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Tertiary measures
Dental appearance was measured using four different questions (e.g. ’How clean and pleasant do your
teeth look and feel after you brush and after a scale and polish’?). Each scale varied from 1 (not at all
clean/not at all pleasant) to 7 (could not get any cleaner/extremely pleasant) and were summarised
separately using the mean responses, with 7 being the best outcome.
Sensitivity was measured using four different questions. First, it was measured through a binary
(yes/no) question: ‘Do you experience sensitivity in your teeth?’. Second, it was measured through three
different scales, the first varying from rarely sensitive to always sensitive and the other two scales varying
from 1 to 7 (never to all the time, and no pain to worst imaginable pain). These tertiary outcomes were
self-reported at the 3-year follow-up.
Fidelity measures
Fidelity measures were collected at baseline and annually by self-administered postal questionnaire. These
included whether or not participants had a plan to start brushing and/or flossing better and whether or
not, after brushing, the patients did, or intended to, ‘spit, but not rinse’.
Dental practice compliance with the protocol was monitored in two ways: (1) through annual face-to-face
visits by a member of the trial office team and (2) through an annual audit of six participants. All practices
received at least one face-to-face visit between baseline and follow-up. This was to ensure practice
compliance with the protocol and an understanding of their role, to answer any queries the practice staff
had and to build and maintain a rapport with the practices to ensure a smooth transition into the follow-up
phase of the trial. The annual audit of six participants (two from each PI allocation) was conducted with each
practice to check if participants had been contacted to attend an appointment according to their allocated
treatment group. If ≥ 50% of these six random participants had not been contacted or invited to attend,
this triggered a telephone call to the practice to check the trial processes and, if required, a visit to review
protocol was arranged.
Number of periodontal instrumentations received (routine data and
self-report)
The self-reported number of PIs received in the previous 12 months was collected annually by postal
questionnaire. If participants replied that they had not received any PI in the previous 12 months, this
response was recorded as a zero for those 12 months. If participants replied that they received PI in the
previous 12 months but did not indicate how many times, these responses were set as missing. The total
number of received PIs over the 3 years was calculated by summing the number of times the participant
self-reported receiving PI over the course of the trial.
Routine treatment data were obtained from Information Services Division (ISD) Scotland and the NHS
Business Services Authority (BSA) in England for the time period of 2010 to 2016. The routine data
informed on the number of PI received throughout the trial, by counting the number of claims for PIs
made by dentists for each participant. Further details regarding how these variables were calculated can be
found in Chapter 3.
Data collection
Assessment for eligibility and informed consent was achieved at the screening stage. Clinical outcome
assessment was carried out at baseline and the 3-year follow-up. Participants were sent a trial
questionnaire at baseline, 12 months, 24 months and 36 months following recruitment. Clinicians were
asked to complete a belief questionnaire at baseline and at the 3-year follow-up.
METHODS OF THE STUDY
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Baseline
Dentists and/or hygienists were asked to complete the CBQ at baseline, after each individual dental
practice had consented to take part in the IQuaD trial.
Patient-centred outcomes were collected at baseline by self-administered questionnaire.
Arrangement of clinical assessment appointments has been outlined in the recruitment section above.
Clinical outcomes were measured at baseline by trained OAs who were blinded to allocation. Gingival
inflammation/bleeding scores, calculus, clinical probing depth and BPE scores were measured by the OA and
recorded on the baseline clinical chart by the dental research nurse who was a member of the trial team.
At the baseline appointment, the OAs also collected personal details from participants, including preferred
contact method (telephone, e-mail) and contact details.
Annual follow-up
Patient-centred outcomes were collected annually by self-administered postal questionnaires.
Like the baseline questionnaire, the annual follow-up questionnaire contained questions on self-efficacy,
PBC, attitude, subjective norm, behaviour, OHIP-14, dental appearance and sensitivity. Questions designed
to collect the descriptive measures were also included in this questionnaire, as were questions on dental
costs for the health economic outcomes. Annual follow-up questionnaires at year 1 and year 2 post
randomisation were posted from the CHaRT trial office to participants’ home addresses, along with a
covering letter and reply-paid envelope for return of the completed questionnaire. Those participants who
failed to return their questionnaire within 3 weeks were sent a reminder letter, a further copy of the
questionnaire and a reply-paid envelope. If questionnaires were returned to the trial office marked ‘return
to sender’, every effort was made to obtain updated contact details from the participant’s dental practice.
Three-year follow-up
As at baseline, dentists and hygienists were asked to complete the clinician CBQ. These were collected by
the OAs when they visited the dental practices to collect participant clinical outcomes.
Patient-centred outcomes were collected at the 3-year follow-up using the annual follow-up questionnaire,
with an additional question on self-reported bleeding. The questionnaire was sent to participants at least
3 weeks before the date of the first 3-year follow-up appointment made at the dental practice where they
were recruited. Participants who had not returned a questionnaire by the time of their follow-up appointment
were asked to complete a shortened one-page version of the follow-up questionnaire containing questions
on the primary patient-centred outcome (self-efficacy) at that appointment. Participants who did not attend
the follow-up appointment and who had not returned a questionnaire were sent a reminder letter, a further
copy of the questionnaire and a reply-paid envelope to return the completed questionnaire to the CHaRT
trial office.
All trial participants were invited to attend a trial follow-up assessment appointment by their dental
practice either at the time of their routine check-up or at a separate trial assessment appointment at which
the clinical outcomes were measured by trained OAs who were blinded to allocation. As at baseline,
gingival inflammation/bleeding scores, clinical probing depths and calculus were measured by the OAs and
recorded on the follow-up clinical chart by the dental research nurse who was a member of the trial team.
Participants who could not attend were contacted and given the option of attending on at least one other
day or time.
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All participants who attended the follow-up assessment received a certificate of appreciation for their
participation in the trial, details of when the trial results would be published and a £25 gift voucher in
recognition of their contribution.
Sample size
The study was powered to detect a difference of 7.5% in the number of gingival sites showing bleeding
on probing at 3 years’ follow-up between routine and personalised OHA and for each pairwise comparison
across both routine and personalised OHA groups. An OHA exploratory trial32 in the same population
demonstrated that, at baseline, 35% of gingival sites were bleeding on probing with a SD of 25%.The
PI Cochrane review24 suggested that a reduction of 15% of sites with bleeding was a plausible reduction
for 6-monthly PI. If the effect is assumed to be linear, halving the number of PIs should half the expected
difference of 15% of sites. If the effect is non-linear and the difference is > 7.5%, the trial would be
adequately powered. A smaller effect would be of questionable clinical significance. There is some evidence
that personalised OHA can reduce the number of gingival sites that bleed on probing by approximately 7.5%.32
Oral hygiene advice
Assuming a conservative estimate of the intracluster correlation coefficient (ICC) of 0.05, a cluster RCT of
50 dentists collecting information from 25 patient participants each (25 × 25 = 625 patient participants
per arm) was expected to have 90% power to detect a difference of 7.5%. Should the ICC be 0.1, the
trial would still have approximately 80% power to detect a difference of 7.5%.
Periodontal instrumentation
Given that the comparison of routine versus personalised OHA required 625 participants in each arm,
equal randomisation 1 : 1 : 1 (no PI, 12-monthly PI, 6-monthly PI) of participants implied 208 in each of the
six groups. Assuming no interaction effect, the corresponding PI groups could be combined across both
routine and personalised OHA groups, requiring 416 patients allocated to each PI group. Based on a
sample size of 416 in each group, the trial has in excess of 95% power for each pairwise comparison to
detect a difference of 7.5% in the percentage of gingival sites that bleed on probing.
Interaction
A substantive interaction effect between the PI interventions and the personalised OHA was not expected.
Assuming an ICC of 0.05, the trial had 80% power to detect an interaction effect of 7.5%. Should the
ICC be 0.1, the trial had approximately 80% power to detect an interaction effect of 10%.
The total number of dentists required was 50, and the total number of participants was 1248 (6 × 208).
A previous trial36 in general dental practice suggests that we should expect to lose a small number of
dental practices from the trial for reasons such as practices amalgamating with other practices or restricting
NHS patients; a conservative assumption of 17% attrition for dentists and 20% for participants was
anticipated, requiring a minimum of 60 dentists and 1860 participants. Each dentist was required to recruit,
on average, 31 participants to ensure 25 at follow-up.
Collection of providers outcomes
Differences in the frequency of PI visits would have an impact on clinicians’ costs and benefits. The effect
on incomes, job satisfaction and changes to the level of fees on the provision of PI were assessed using
self-reported questionnaires administered to clinicians over the duration of the trial.
METHODS OF THE STUDY
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Statistical analyses of outcomes
Statistical analyses were based on all participants randomised. Three principal comparisons and their
interactions were tested in the factorial design. The principal comparisons were between (1) all those
allocated to routine OHA and all those allocated to personalised OHA, (2) all those allocated to no PI
and those allocated to 6-monthly PI and (3) all those allocated to 12-monthly PI and those allocated to
6-monthly PI.
Reflecting the clustered nature of the data, the clinical outcomes were compared using mixed models
with dental practice as a random effect, and with adjustment for minimisation variables [practice employs
dental hygienist (yes/no) and practice size (one or two dentists in practice/three or more dentists) for the
cluster-level randomisation and absence of gingival bleeding on probing (yes/no), highest sextant BPE score
(BPE score of < 3/BPE score of 3) and currently smoking (yes/no) for the patient-level randomisation] and
participant baseline values (when available) as fixed effects. Patient-centred outcomes were compared
using a mixed model with a random effect for the participant (to take into account the three-level nested
and correlated data structure: a variable number of observations nested within participants and participants
grouped in dental practices) and another for the centre and adjusting for the same variables as before.
Statistical significance was at the 5% level, with corresponding confidence intervals (CIs) derived.
Pre-planned subgroup analyses on the primary outcome included exploration of participant age (< 45 years,
45–64 years or ≥ 65 years), smoking status (non-smoker or smoker), periodontal disease severity (no clinical
signs or presence of gingival bleeding on probing) and intervention provider (dentist or practice hygienist).
Post hoc subgroup analyses were undertaken by region (Scotland or England) and clinical pocket depth
(four or more sites with clinical pocket depth of ≥ 4 mm, or fewer than four sites). These analyses were
conducted by including a subgroup by treatment interaction term in the primary outcome model described
above. Conservative levels of statistical significance (p < 0.01) were sought, reflecting the exploratory
nature of these pre-planned and post hoc subgroup analyses.
Non-response analysis
Descriptive data are presented, comparing the baseline characteristics of participants who did and who did
not attend the 3-year follow-up clinical appointment. The t-test (continuous outcomes) and chi-squared
test (dichotomous outcomes) were used to estimate the statistical significance of the differences between
responders and non-responders.
Missing items
Missing items were dealt with according to the relevant published recommendations for the specific
instruments.35 For missing items with no published recommendation, self-efficacy, PBC, attitude and
subjective norm were calculated as a mean of the items available. Behaviour and intention were calculated
using complete cases.
Sensitivity analysis
To assess the possible effect of outliers, treatment effects by individual dental practices were explored to
assess the influence of between-centre differences in the primary clinical outcome: bleeding. Any practices
where the treatment effect excluded zero from the 99% CI and had at least twice the target difference
estimate (either –15% or 15%) were excluded from the analysis comparing no PI with 6-monthly PI,
as well as from the subgroup analysis.
Trial oversight
The University of Dundee acted as sponsor for the study. The trial was co-ordinated from the TCOD in
the Dental Health Services Research Unit, University of Dundee, which provided day-to-day support for the
dental practices and OAs/research nurses. The TCOD was responsible for transacting the randomisation
of dental practices, collecting trial data (including baseline questionnaires) and co-ordination of participant
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follow-up. CHaRT, in the Health Services Research Unit, University of Aberdeen, provided the database
applications and information technology (IT) programming for the trial, hosted the randomisation system,
co-ordinated the participant follow-up questionnaires, provided experienced trial management guidance
and took responsibility for all statistical aspects of the trial [including interim reports to the Trial Steering
Committee (TSC) and the Data Monitoring Committee (DMC)]. A Project Management Committee (PMG)
met monthly, chaired by the chief investigator, comprising co-investigators in Newcastle upon Tyne and key
members of the TCOD and CHaRT. A Trial Management Committee (TMC) met biannually, chaired by the
chief investigator, comprising co-investigators and key members of the TCOD and CHaRT. A Periodontal
Advisory Group was convened to provide expert clinical advice to the TMC.
Independent TSCs and DMCs were also established. The TSC comprised an independent chairperson
(a professor and honorary consultant of dental public health) and two further independent members (both
members of the public acting as patient representatives). The TSC met approximately annually over the
course of the trial. The DMC comprised an independent chairperson (a professor of restorative dentistry)
and two further independent members (a professor of dental public health and a statistician). The DMC
met approximately annually.
Patient and public involvement
Prior to the start of the IQuaD trial, patients were involved with the trial design and provided invaluable
feedback on trial recruitment and communication strategies. Patients also contributed to the content and
layout of the trial invitation, trial newsletters and the design of patient participant questionnaires. This
ensured that trial participants could understand and easily complete these materials. Members of the
public also contributed to trial oversight through membership of the TSC, including helping to interpret
the trial findings and the preparation of the monograph.
Protocol amendments after trial initiation
A number of protocol revisions were made after trial initiation. These included:
l an amended start date, list of grant holders, TSC members and DMC members
l clarification of the measurement of gingival bleeding and the list of grant holders was updated
l an amended timescale for sending patient information to ‘at most 6 weeks’, in line with routine
practice for scheduling check-up appointments
l an amended end date, in line with approved contract variation.
Adaptations of study administrative processes (e.g. the use of additional letters, revisions to letters) were
also implemented.
METHODS OF THE STUDY
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Chapter 3 Health economic methods
The health economics analysis assessed the cost–benefit of theory-based, personalised OHA or PI at differenttime intervals (no PI, 12-monthly PI or 6-monthly PI), or their combination for improving periodontal health
in dentate adults attending general dental practice. A cost–benefit analysis (CBA) reporting incremental net
benefit, relative to standard care (routine OHA with 6-monthly PI), was conducted alongside the cluster RCT.
Costs were assessed from a NHS perspective and a wider societal perspective including both NHS and participant
costs. Benefits were assessed using a general population’s WTP for personalised OHA and PI, estimated from
a discrete choice experiment (DCE). All analyses were based on the intention-to-treat (ITT) principle.
Cost–benefit analysis is based on the concept of maximising societal welfare including a wider, more
holistic measure of value, going beyond narrow measures, such as quality-adjusted life-years, which are
not appropriate in the context of dentistry. In CBA, both costs and benefits are measured in monetary
terms and net benefits (benefits – costs) can be directly interpreted as either welfare increasing or welfare
decreasing. The CBA conducted here is an incremental analysis of alternative policies of OHA with/without
PI in terms of costs and benefits (WTP). The analysis focuses on whether moving from standard care to an
alternative policy increases or decreases welfare.
Resource use and costs
Health service costs and Participant costs describe the methods for generating NHS and participant
perspective costs, respectively.
Health services costs
Use of NHS dental services
Resource utilisation data for NHS treatments at dental practices over the trial follow-up period were
collected using routine sources held by the ISD of the Scottish Government and the NHS BSA in England.
Dentists are paid on the basis of claims and, therefore, relatively rich and reliable routine data on NHS
dental care provided are available. Dental claims data were linked to the trial data set on an individual level
to each trial participant.
Different remuneration systems are in place across the UK, which has implications for the level of detail
that is available on resource use.
In Scotland, NHS payments are based on fee-for-service contracts. There is a high level of detail, as fees are
attached to each individual item of service. This includes a separate fee for PI. Although there is a separate
fee for intensive hygiene instruction, this cannot be claimed if a PI was claimed within the same course of
treatment or within the previous 5 months.
In England, dentists are reimbursed according to contracts negotiated at (1) national level [General Dental
Service (GDS) contracts negotiated through the British Dental Association] or (2) local level (personal dental
contracts). The former accounts for 85% of dental contracts in England and forms the basis for the trial
costing analysis.37 Under the GDS contracts, each dental practice is contracted to provide an agreed amount
of dental treatment, described in terms of UDAs. Treatments provided to participants are grouped into four
bands based on the complexity of the treatment. Each band carries a set number of UDAs,38 as follows:
1. Band 1 (check-up, radiography, advice, PI) = 1 UDA.
2. Band 2 (band 1 treatments plus fillings, extractions, root canal treatments) = 3 UDAs.
3. Band 3 (band 1 and band 2 work plus crowns, dentures, bridges) = 12 UDAs.
4. Urgent band = 1.2 UDAs.
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A number of services do not fall into any of the patient charge bands in their own right, but are awarded
UDAs when provided outside other banded treatments. The number of UDAs for such treatments is as follows:
l Arrest of bleeding = 1.2 UDAs.
l Bridge repair = 1.2 UDAs.
l Denture repair = 1.2 UDAs.
l Issue of prescriptions = 0 UDAs.
l Removal of sutures = 1 UDA.
As dentists in England are reimbursed on the basis of UDAs, the level of detail on resource use is clearly
much lower than in Scotland. The claim form (FP17) in England collects some further information on
treatments provided, including PI, but these are not associated with additional payments. Given the
structure of the contract, it is less likely that there will be a difference in costs across the different policies
in England as PIs and personalised OHA are not associated with any additional UDAs if they are provided
alongside other treatments such as a dental check-up.
Costs were attached directly to items of service (Scotland) and treatment course bands (England) using the
appropriate NHS unit cost. Unlike other NHS services, patients contribute to the cost of their dental care.
The cost to the NHS is therefore equal to the unit cost minus the appropriate patient charge. The Scottish
Statement of Dental Remuneration – Amendment No 130 Letter39 was used to attach unit costs to the
treatment items in Scotland. In England, the cost of a UDA delivered under the GDS contracts can vary
widely by practice. Determining an average cost per UDA across England is not straightforward. The 2009
Steele report40 suggested that the value of a UDA was approximately £25, but that actual practice-specific
values ranged widely from £17 to £40. Work informing National Institute for Health and Care Excellence
(NICE) public health guidance on oral health promotion41 assumed a mean cost of £25 (95% CI £15 to
£35). We conducted a descriptive analysis of published data for contract payments in England in 2014/1537
and found that the median gross value (prior to deduction of participant charges) of a UDA (after removal
of payments for units of orthodontic activity) is still approximately £25, ranging from £20 to £33 (5th to
95th percentile). Therefore, we use a unit value of £25 per UDA for the analysis. The NHS cost per UDA is
varied in the sensitivity analysis to explore the impact of practice-level variation on results.
Some patients do not pay a co-charge (e.g. those in receipt of income support, pension credit, universal
credit or tax credit, as well as those aged < 18 years, in full-time education or who are pregnant or who
have given birth in the last 12 months). Table 2 summarises the most common breakdown of costs in
England and Scotland. When participants were exempt from treatment charges, the full cost was attributed
to the NHS budget. We tested for any cross-group differences in the proportion of participants exempt from
charges, as any differences could bias predictions of incremental NHS costs. We also repeated the cost
analysis assuming that all participants were exempt, that is, the NHS bears the full cost.
Data are in the form of courses of treatment that have a commencement date and a claim payment date
(Scotland) or a completion date (England). The base-case analysis excludes the baseline and final study
visits, as treatments provided at these visits are not part of routine care nor the trial intervention. The
exception is the provision of personalised OHA at the baseline visit. However, as explained above, these
are typically not associated with additional payments in either region. A sensitivity analysis was conducted
to explore the impact of including an additional fee for personalised OHA.
The baseline visit is excluded from the analysis by removing all treatment claims with an acceptance date
< 90 days following the baseline examination date. Owing to practice-specific approaches to calling
participants for their final study visit, some had their final study visit prior to randomisation and others after
3 years post randomisation. To remove all final visits from the claims data, we excluded all treatment
acceptance dates at > 2.5 years following the baseline study visit. This implies that, after exclusion of all
baseline and final study visits, the follow-up period for the CBA is 2.25 years. Sensitivity analysis explores
the impact on net benefits of including all the baseline and final clinic visits in the analysis.
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Routine data downloads were taken in August 2016 (ISD, Scotland) and November 2016 (NHS BSA,
England). For Scotland, data are a complete and accurate reflection of resource use up to 3 months prior
to data download (i.e. May 2016). For England, the data are likely to be an accurate reflection of resource
use up to April 2016, reflecting the end of the financial year, by which time dental practices are required
to have submitted all relevant information. The final clinic examinations took place in July 2016. Given that
the base-case analysis excludes claims with treatment acceptance dates beyond 2.5 years post randomisation,
the latest treatment claims in the data set have acceptance dates in February 2016 and, therefore, all data are
assumed to provide an accurate and complete reflection of resource use for both regions.
All costs are presented in 2014/15 GBP values and discounted at a rate of 3.5% per annum.42 A sensitivity
analysis varying the discount rate was conducted.
Costs of other NHS services during follow-up
Annual questionnaires collected data on use of other NHS services for problems related to participants’
teeth. These included secondary care resource use [hospital inpatient data, outpatient consultations,
day-case procedures and accident and emergency (A&E) attendances] together with general practitioner
(GP) appointments and contact with NHS 24 (Scotland) or NHS Direct (England). As is common with
participant-reported resource use, a number of conservative assumptions were made to address issues of
discrepancy in the reported data:
l When respondents reported that they did not attend a service but entered a number of visits, it was
assumed that no resource use was incurred.
l When respondents stated that they attended hospital as an inpatient for problems related to their
teeth but provided no further information, it was conservatively assumed that such responses should be
treated as day-case admissions. National data43,44 show that the majority of hospital admissions in the
UK for dental problems are day-case procedures.
Rates of secondary care visits, including outpatient, day-case and hospital admissions, were checked
against practice records and average rates in the general population to assess their validity. The outcomes
of the validation exercise are reported in Chapter 5.
TABLE 2 Summary of UK dental charges, by region
Region
England Scotland
Treatment
category
Total UDA
cost (£)
aPatient
charge (£)38
NHS cost (if charge
is paid) (£) Treatment category
Patient
chargea
NHS
cost
Band 1 25.00 18.50 6.50 Check-ups and case
assessments
0% of
full cost
100% of
full cost
Band 2 75.00 50.50 24.50 Other treatments 80% of
full cost
20% of
full cost
Band 3 300.00 219.00 81.00 Maximum charge per
course of treatment
£384.00 Unlimited
Urgent 30.00 18.50 11.50
a Exceptions and exemptions apply to treatment in both regions when patients do not pay any of the cost (e.g. receiving
income support, aged < 18 years, in full-time education, pregnant or have given birth in the last 12 months, receiving
pension credit, receiving universal credit or receiving tax credit exemptions). Patient charges relate to 2014/15 values.
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Participant costs
Three sources of participant cost were considered for the analysis: (1) charges for NHS dental care,
(2) privately purchased dental care products and treatments and (3) time and travel costs (for participants
and companions) associated with visits to the dental practice.
Charges for NHS dental care
Participant charges were sourced directly from the routine data sets described in Health services costs.
Participant charges were based on the co-charge that should have been collected at the dental practice,
as opposed to the actual value paid by the participant. This reflects the way in which dental practices are paid.
Self-purchased dental care products and private dental care
Participants reported how often they used interdental brushes, electric toothbrushes and manual toothbrushes
in the annual questionnaires, as well as how often they replaced electric toothbrush heads. These resource
use data were combined with an assumed average market price for four commonly available products,
including a range of high- and low-cost items. Details of unit costs applied are provided in Appendix 2,
Section 1: additional detailed methods for costing, the discrete choice experiment and mapping discrete
choice experiment valuations to the trial outcomes. Resource use was multiplied by the average unit cost to
generate a cost per participant.
Furthermore, in each annual questionnaire, participants were asked to recall and report the total cost of
private PI and any other privately purchased dental care that they incurred over the previous year. It should
be noted that, although participants were asked to report how often they received private PI, it may be
difficult in some scenarios to determine whether treatment was private or via the NHS because, for example,
many NHS dentists may also offer private PI. For this reason, there may be a risk of double-counting from
the participant perspective, but only if NHS co-charges were interpreted as private treatment. All reported
data were summed across the questionnaires to generate a cost to each participant of self-purchased dental
care products and stated private care costs.
Costs of time and travel
Participants incur costs travelling to, and attending, NHS dental appointments. The number of visits to the
dentist was collected from the routine data sets, conservatively assuming that each unique treatment
acceptance date (rather than each claimed item) relates to a single dental visit. The true costs may be higher
if a course of treatment involved more than one visit to the dentist. The opportunity cost to participants and
companions of making a return journey to visit the dental practice was estimated using responses to the
participant time and travel cost questions in the baseline questionnaire. It is assumed that the data collected
on opportunity cost at baseline are applicable to each subsequent visit to the dental practice. National unit
cost sources (Table 3) were used to value time commitment of attendance (including travelling to and from)
at a dental appointment, as well as the opportunity cost based on the reported activity forgone through
attendance. The calculated opportunity cost for a single visit was multiplied by the number of treatment courses
from the routine data to generate a total participant level estimate of the opportunity cost of time and travel.
Combined participant and NHS perspective costs
Data from Health services costs and Participant costs were combined to generate a wider combined NHS
and participant perspective of the costing analysis.
Statistical analysis of cost data
Cost data were analysed according to best practice methodology for cluster randomised trials.52–54 We
used multilevel mixed-effects models that account for clustering of the data through a cluster-level random
effect.52 Models for cost data were estimated using the meglm command in Stata® 14 (StataCorp LP,
College Station, TX, USA) specifying a gamma family and log-link function for cost data to account for
skewness of the distribution. The decision to use this model for costs was based on a combination of the
results of a modified Park’s test, which identified both an inverse Gaussian and gamma distribution to
be acceptable, and software restriction (only gamma family allowed within Stata’s meglm command).
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The log-link function was decided on as it allowed easier model convergence and had a preferred Akaike
information criterion score than an identity link. The models were estimated by maximum likelihood.
Incremental costs were estimated as the mean cost difference between randomised policies (relative to the
policy most representative of standard care: routine OHA with 6-monthly PI), together with 95% CIs. All
models were adjusted for baseline characteristics (age, age-squared and sex) as well as minimisation
variables (cluster level: hygienist employed at practice and practice size; individual level: smoker, gingival
bleeding at baseline and BPE score band).
Owing to the high level of completeness, descriptive analyses of NHS dental costs and participant co-charges
were based on complete cases. Participant costs were presented and analysed using multiple imputation of
missing cost data from participant annual questionnaires. For the analysis of total costs within the CBA,
the small proportion of missing routine data were also imputed to complete the data set. The imputation
process followed best practice guidelines.55,56 All imputation was completed using Stata’s multiple
imputation procedure. Missing cost data were imputed at the level of cost component (e.g. missing data
on private PI imputed for each annual questionnaire). Costs were imputed using predictive mean matching
accounting for the repeated measures nature of the costs from the annual participant questionnaires. The
average of the five closest values was used for each imputed data point. Data were imputed separately for
TABLE 3 Unit costs for the opportunity costs of time and travel
Activity Assumptions made
Unit
cost (£) Reference
Paid work Median weekly wage: £528;
39.1 hours per week
13.50 Annual Survey of Hours and Earnings: 2015
Provisional Results, ONS45
Self-employed Average of two reports, 52 weeks,
40 hours per weeka
15.13 The Boox Report 2014, Boox46
Cost Converter, EPPI Centre47
Self-employed Workers in the UK – 2014, ONS48
Transport Cost per mileb 0.45 Expenses and Benefits: Business Travel Mileage
for Employees’ Own Vehicles, HMRC (approved
millage rate)49
Caring for a
relative or friend
Median gross weekly pay: £341;
39.2 hours per weekc
8.70 NHS Pay Review Body, p. 17 (2015 values),
DHSC50
Leisure activities Value of non-working time 6.81 WebTAG: TAG data book, July 2016, TAG51
Childcare Assumed as paid work 13.50 Annual Survey of Hours and Earnings: 2015
Provisional Results, ONS45
Voluntary work Assumed as paid work 13.50 Annual Survey of Hours and Earnings: 2015
Provisional Results, ONS45
Unemployed Value of non-working time 6.81 WebTAG: TAG data book, July 2016, TAG51
Retired Value of non-working time 6.81 WebTAG: TAG data book, July 2016, TAG51
Parking Participant’s individual costs Various Participant questionnaires
Housework Cost of housework in the NHS,
assumed annual salary £21,000
gross, 2012 values inflated to 2015
10.56 NHS Pay Review Body, p. 17 (2015 values),
DHSC50
DHSC, Department of Health and Social Care; EPPI, Evidence for Policy and Practice Information; HMRC, Her Majesty’s
Revenue and Customs; ONS, Office for National Statistics; TAG, Transport Analysis Guidance.
a Average hours worked: 40. Median annual income (two reports): £10,800 + £50,820. 2013/14 prices: £30,810, inflated
to £31,476 (2015 values). £31,476 ÷ 52 weeks ÷ 40 hours/week = £15.13 per hour.
b Based on government-approved travel mileage reimbursement for use of own vehicles.
c Caring, leisure and other service occupations.
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each randomised group to preserve the allocation of participants. Imputation models were adjusted for
cluster, age and sex as well as minimisation covariates. Sixty imputed data sets were used to ensure stable
results and were combined using Rubin’s rules to generate estimates of costs.57
Benefits (willingness to pay)
The main outcome measure in the economic evaluation is WTP, estimated using a DCE administered via
online survey panels to a representative sample of the UK general population. The DCE was administered
to a separate sample from the general population while the trial was ongoing and before the results of
the trial were known. A DCE is a survey method for which participants are asked to make hypothetical
choices between different goods or, in this case, different packages of dental care provided over 3 years
(the follow-up period of the trial). An underlying assumption of all DCEs is that a treatment’s or service’s
value depends on its attributes and the levels of those attributes. By including the price proxy within the
DCE (i.e. the annual cost of each dental package), we can obtain a monetary valuation for any given
dental treatment package. These WTP estimates are used as a measure of benefit within the CBA. Ethics
approval for the conduct of the DCE substudy was obtained from the College Ethics Review Board at the
University of Aberdeen (REF 2015/12/1278).
Selection of attributes and levels
The relevant attributes were, to a large extent, determined by the trial. Preferences needed to be elicited
for the specific interventions (PI and personalised OHA) and for the outcomes that may vary across the arms
of the trial (i.e. self-reported bleeding gums and perception of appearance and feel of cleanliness). We
followed recommended practice to assess whether or not these attributes were important to individuals
and whether or not there were any other important attributes that should be included in the DCE. We
conducted a literature review and focus groups (FGs) with the general population to develop the final
list of attributes and levels to present in the DCE (see Appendix 2, Section 2: research conducted for
questionnaire development). We also engaged with, and sought advice from, a range of stakeholders,
including clinical dental experts, practising dentists and hygienists, and patient representatives on our trial
advisory group about the DCE content. Table 4 shows the final list of attributes and levels included in
the DCE.
Additional levels were added for provider of service (dentist/hygienist) as this was found to be an
important consideration in the FGs. The FGs showed that respondents would have difficulty understanding
and attaching value to the primary clinical trial outcome (gingival inflammation/bleeding). Therefore, we
included the self-reported frequency of bleeding measure from the participant questionnaire instead.
Respondents were informed that having bleeding gums increases the risk of tooth loss in the future. The
look and feel attribute was also based on the measures used within the same questionnaire. The cost
attribute was framed as an annual commitment over a 3-year time period (trial follow-up). The levels of
the cost attribute were determined from a number of sources, including the FGs, baseline trial data on
WTP for PI and a supplementary questionnaire asked to FG respondents. Figure 3 provides an example
choice set included in the DCE.
Experimental design
Choices presented to respondents in the DCE were drawn from the set of all possible attribute and level
combinations. With a single three-level attribute and four five-level attributes, the total number of
combinations in the full factorial is given as 31 × 54 = 1875, resulting in [(1875 × 1874) ÷ 2] = 1.76 million
unique choice sets. Following standard practice in DCE literature, a D-efficient design was used.58 Ngene
version 1.1.2 software (Ngene, ChoiceMetrics Pty Ltd, Sydney, NSW, Australia) was used to create a main
effects design consisting of 30 choice set questions. To ensure a manageable number of choice tasks,
the tasks were split into three blocks, each with 10 questions. Two further choice questions were added
to each block to check the validity of responses as follows: (1) choice 11 repeated choice 5 to test for
consistency of preferences and (2) choice 12 was a non-satiation (dominance) test in which one option
HEALTH ECONOMIC METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
24
should be preferred over its alternatives if individuals value PI polish and personalised OHA. Therefore,
each respondent completed a total of 12 choice tasks. The responses to the internal validity choice tasks
were not included in the analysis; therefore, a total of 10 choice sets were analysed for each respondent.
As respondents were likely to vary considerably in terms of how many PIs they usually receive and the
extent to which they experience bleeding gums, a segmented pivoted design was used to increase realism.
For example, it is unrealistic that a respondent who has no bleeding gums and never has a PI would
suddenly experience bleeding very often if they opt out. Respondents were assigned to one of three
segments [(1) good, (2) moderate or (3) poor dental health] based on self-reported frequency of bleeding
gums and the look and feel of their teeth (both attributes in the DCE). The pivoted design tailored the
presented levels based on the segment to which the respondents were assigned. For example, respondents
categorised as having ‘good’ dental health would never be presented with the worst level of bleeding
gums and unclean teeth, as it would be highly unlikely for dental health to deteriorate so quickly because
of forgoing PI or detailed OHA. The list of attribute levels included in the experimental design for the
good, moderate and poor dental health segments can be found in Appendix 2.
TABLE 4 Attributes and levels included in the DCE
Attributes Levels
Dental advice No detailed or personalised advice
Detailed and personalised advice from the dentist
Detailed and personalised advice from the hygienist
Scale and polish None
One per year from the dentist
One per year from the hygienist
Two per year from the dentist
Two per year from the hygienist
Your teeth will look and feel Very unclean
Unclean
Moderately clean
Clean
Very clean
In 3 years’ time, your gums will bleed Never
Hardly ever
Occasionally
Fairly often
Very often
The cost to you £10 per year (total cost: £30 over 3 years)
£20 per year (total cost: £60 over 3 years)
£50 per year (total cost: £150 over 3 years)
£100 per year (total cost: £300 over 3 years)
£200 per year (total cost: £600 over 3 years)
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FIGURE 3 Example choice task. Note: the example choice set shown here is for a respondent categorised as having poor dental health. See Appendix 2, Section 1: additional
detailed methods for costing, the discrete choice experiment and mapping discrete choice experiment valuations to the trial outcomes, for more information on segmentation
of choice sets based on dental health category. This hypothetical respondent has chosen Dental Care Package B and is willing to pay £100 per year for the package.
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Questionnaire development
Think-aloud interviews were used to test the wording and understanding of the questionnaire. Extensive
piloting was used to assess the best way of reducing hypothetical bias and to ensure that attributes and
levels were sensible, realistic and tradable to the majority of respondents. Full details of all methods used to
select attributes and levels (literature searches and FGs) and test their feasibility in the survey (think aloud
and piloting) are outlined in Appendix 2, Section 2: research conducted for questionnaire development.
The survey was divided into three sections. Section 1 asked about respondents’ experiences of dental care,
how often they attend their dental practice and who they are treated by. Section 2 included questions
about bleeding gums and aesthetic appearance to determine the appropriate version of the DCE to
present. Section 3 concluded the survey with demographic questions and a number of debriefing
questions about respondents’ views and attitudes to dental topics. The questionnaire was designed using
Qualtrics (Provo, UT, USA).
Data collection
Data were collected using Qualtrics online panels. The survey was nationally representative, with
population census quotas for age (among adult population), sex and region sought. We oversampled in
Scotland (n = 125) to enable subgroup analysis across the main participating regions in the trial (England/
Scotland). We further sought to achieve a mix of respondents with recent experience of dental services
and without. During the pilot phase, we attempted to achieve 30% of responses from non-regular
attenders, defined as not having seen the dentist in the previous 2 years.11 However, we were unable to
achieve this sample in the pilot and relaxed the target to a more achievable 10% for the main phase of
data collection. Responses were anonymised and respondents were free to leave the survey at any point
without having to give a reason for doing so. Respondents who completed the survey were reimbursed in
a manner determined by the survey panel from which they were partaking.
Data analysis
The DCE data were analysed using best practice methods59 and followed random utility maximisation
theory.60 The utility of the option (Vj) is a linear function of the attributes and levels presented to the
respondents, where:
V j = αASC + β1Advice D + β2Advice H + β3One PI per year D + β4One PI per year H
+ β5Two PI per year D + β6Two PI per year H + β7Bleed Hardly Ever + β8Bleed Occasionally
+ β9Bleed Fairly Often + β10Bleed Very Often + β11Look unclean + β12Look Moderately Clean
+ β13Look Clean + β14Look very clean + β15Annual Cost.
(1)
Alternative-specific constant (ASC) is accounting for latent or unobserved utility associated with choosing any
package, regardless of the attribute levels, β represents the marginal utilities associated with the attributes
and levels. All categorical variables were included in the model using effects coding. The advantage of
effects coding is that the reference level of an attribute is uncorrelated with the ASC. The reference
categories for the effects coded attributes are no OHA, no PI, never bleeding and having teeth that look
and feel very clean. For example, the value for ‘no advice’, βno advice, is retrieved as the negative sum of
β1 Advice D + β2 Advice H.
The marginal WTP of an attribute level is equal to the marginal rate of substitution between that level
and the cost attribute. For ease of interpretation, we also estimate the difference in WTP between the
reference level and the attribute level. For example, the annual marginal WTP for OHA from the hygienist
compared with the reference level (no OHA) is equal to:
−
β2− βno advice
β15
 
. (2)
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Mixed logistic regression models in preference space were used to analyse the data to determine the
impact of the attributes and levels on preferences for dental care services and outcomes. The ASC was
assumed random and normally distributed for all models, reporting mean and SD. All other attribute levels
were fixed effects, reporting mean coefficients only. The final model was estimated using the maximum
simulated likelihood method, with 2000 Halton draws. All models were estimated using Stata 14 software.
The model was re-estimated separately using interaction terms for several pre-determined subgroups
including (1) sex; (2) region, to determine if system of reimbursement has an impact on preferences;
(3) smoking status, to determine if current or previous smokers’ preferences differ from the overall group;
and (4) household income, to determine if greater ability to pay (annual income of ≥ £20,800) had an
impact on preferences. Further subgroup analyses explored if the preferences of those with experience of
PI or of treatment from a hygienist differed from the overall sample. We planned to conduct subgroup
analysis by dental attendance (regular/non-regular attenders) but were unable to achieve sufficient numbers
of respondents attending the dentist less often than every 2 years to power such an analysis. The impact
that subgroups had on the main attribute level effects was assessed by the significance of interaction terms
between subgroup identifier and attribute level coefficient. Likelihood ratio tests were used to test the joint
significance of the interaction terms.
Estimating benefits (willingness to pay) for each trial participant
Benefits measured as WTP were estimated for each trial participant by attaching WTP values from the
DCE to the relevant treatments provided (PI and personalised OHA) and to the relevant trial outcomes
(self-reported bleeding when brushing and aesthetic outcome). The DCE provided estimates of WTP for
zero, one and two PIs provided per year or a total of zero, three or six PIs over the trial period. A step-wise
linear utility function was used to estimate WTP for the number of PIs other than those presented in the
DCE. It was assumed that the provider of the baseline PI (dentist or hygienist) also delivered the intervention
over follow-up. The impact that the results of this assumption have is also explored in a sensitivity analysis.
Willingness to pay for personalised OHA was attached based on randomised group, as all participating
practices complied with their allocation to provide either personalised or routine OHA at the baseline visit.
For the remaining attributes, including aesthetic outcome and frequency of bleeding gums when brushing,
WTP values were directly attached at an individual level in the trial. The full mapping process for each
attribute to the trial interventions and outcomes can be found in Appendix 2.
Discounting was applied at a rate of 3.5% per annum.42 Discounted marginal WTPs were summed to
generate a total WTP for each trial participant. Total WTP data were analysed using multilevel mixed-effects
models with a random effect capturing cluster effects to account for the hierarchical nature of the trial.
A normal distribution was assumed for benefits data; hence, the analyses were implemented using Stata’s
mixed command. All models were adjusted for individual- and cluster-level minimisation variables, age and
sex. The base-case analysis undertakes statistical imputation of missing data on benefits (i.e. WTP mapped
to trial outcomes). Data were imputed for annual questionnaires at the level of WTP for each outcome
(e.g. bleeding gums), following a similar procedure to that outlined for costs.
Cost–benefit analysis
The CBA compares the costs and benefits of alternative policies of OHA with/without PI with standard care
(routine OHA with 6-monthly PI). Both costs and benefits are measured in monetary terms and net benefits
can therefore be directly estimated (benefits – cost). The incremental net benefits indicate whether moving
from standard care to an alternative policy increases or decreases overall societal welfare.
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Statistical analysis of (incremental) net benefit
The imputed data sets were used to estimate net benefits and incremental net benefits. Net benefit was
calculated for each participant in the trial according to Equation 3:
Net benefit = total benefits − total costs. (3)
Multilevel mixed-effects models were used to analyse the data, implemented using Stata’s ‘mi estimate:
mixed’ command following the approach of Gomes et al.52,53 These models can explicitly recognise
clustering in parameter estimates though the incorporation of cluster-level random effects (ucj , u
e
j ), while
also adjusting for cluster- and individual-level covariates (minimisation variables: age and sex). The model
addresses both individual- and cluster-level correlation between costs and benefits, using a bivariate
normal distribution of the error terms. The model assumes linear additive effects for treatments and
covariates. Restricted maximum likelihood was used to estimate the model for the base-case analysis.
Interaction terms were included to retrieve the true impact of randomisation on costs/benefits.54 Stata’s
mimargins command was used to retrieve the values of the reference category of cost/benefit from the
imputed data sets and the nlcom command was used to calculate incremental costs, incremental benefits
and incremental net benefits across groups, together with 95% CIs.
Presentation of cost–benefit analysis results
The base-case perspective is that of the UK NHS. A wider perspective, including both NHS and participant
costs, was considered as a secondary analysis. All results are presented as incremental costs, incremental
benefits and incremental net benefits, relative to standard care. Note that exclusion of dominated policy
options is not required in the absence of a threshold value of a ratio between costs and benefits (as would
be the case in a cost–utility analysis).
Confidence ellipses, based on parametric calculations using the model variance–covariance matrix, were
used to illustrate the uncertainty in each comparison of costs and benefits graphically on the cost–benefit
plane.61 The confidence ellipses illustrate the probability that each intervention is less/more costly and less/
more beneficial than standard care. All policies with positive incremental net benefits are associated with
higher levels of welfare than standard care. Note that this can be generated by a higher level of benefit
and/or a lower level of cost of the policy. The strategy with the greatest incremental net benefit would be
considered the preferred policy from a welfare perspective. The analysis is solely based on incremental
changes in net benefits between policies and, as is common for economic evaluations alongside trials,
makes no statement about the magnitude of the underlying net benefits of specific policies.
Analysis of uncertainty
The confidence ellipses of the cost–benefit plane illustrate the joint uncertainty surrounding estimates of
incremental costs and incremental benefits on results. Further deterministic sensitivity analyses, outlined in
Table 5, investigated the impact of assumptions around cost data, benefit estimation and model structure
on the results.
Cost–consequences analysis
In addition to the results of the CBA conducted for the primary economic analysis, we further considered
all of the available information across all components of the study, using a narrative cost–consequences
analysis (CCA) framework. The CCA is a useful approach to summarise all the study information succinctly
for decision-makers. We use a balance sheet approach summarising the advantages and disadvantages of
each policy option under consideration. The CCA includes the following information:
l the results of clinical effectiveness, using both primary and secondary outcomes defined in the protocol
l the results of all economic analyses, including costs to the NHS and participants, general population
preferences for PI/OHA (results from the DCE) and overall incremental net benefits
l a summary of information sourced from the CBQ investigating the practitioner’s perception of the
advantages and disadvantages of different policy strategies.
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No attempt was made to quantitatively synthesise the information across different categories. The results
of the CCA are presented qualitatively as a means to aid decision-makers’ understanding of the overall
outcomes of the trial as well as the trade-offs between clinical and economic outcomes.
TABLE 5 Deterministic sensitivity analyses considered
Base-case analysis Sensitivity analysis Justification for approach
Cost of personalised OHA
incorporated according to routine
claims database
Requirement of an additional
consultation to provide
personalised OHA
There was no additional cost of providing
personalised OHA for most participants.
An additional fee is included in sensitivity
analysis according to the SDR for intensive
hygiene instruction
Baseline and final visits excluded
from analysis
Baseline and final treatment visits
included
Base-case analysis pragmatically excludes
treatment initiated at trial-driven visits.
Sensitivity analysis incorporates all visits,
including treatment requirements identified at
baseline (treatment claim acceptance dates on
or after randomisation date) or at follow-up
(treatment acceptance dates included up to
3 years post randomisation) trial visits.
Changes applied to both costs and WTP
Mapping aesthetic DCE outcome to
a Right now response to the trial
data
Mapping aesthetic DCE outcome
to a After brushing teeth response
to the trial data
Analysis conducted to address uncertainty
about the most appropriate trial outcome to
map marginal WTP onto
Unit cost per UDA assigned at the
national average level (£25)
Vary the cost per UDA ± 20% Payment per UDA substantially varies across
practices. The base-case analysis gives the
best estimate for the average cost per UDA
in England, giving the most generalisable
results. The sensitivity analysis explores the
impact of practice level variation
Costs and benefits discounted at a
rate of 3.5% per annum
Varying the discount rate between
0% and 6%
Standard exploration of methodological
uncertainty
Professional delivering baseline
intervention also delivered follow-up
appointments (i.e. dentist or
hygienist)
Explore assumptions in which all
OHA and PI delivered by dentist;
all OHA and PI delivered by
hygienist
Anecdotal evidence from the trial suggests
that the professional delivering baseline
intervention may not have delivered all
treatments for a participant over the
follow-up period. The sensitivity analysis
explores the likely impact of this assumption
on results
SDR, Statement of Dental Remuneration (Scotland).
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Chapter 4 Trial results and clinical effectiveness
This chapter describes the clinical effectiveness results of the IQuaD trial. The chapter starts with anexplanation of how the trial groups were derived. It then describes the study groups at trial entry.
The results at the annual follow-up points are then reported, followed by a formal statistical analysis of
the data for the principal measures of outcome.
Recruitment to the study
Recruitment of dental practices began in October 2011 and continued until May 2013. Participant
recruitment to the trial began in February 2012 and continued until July 2013. Data were closed to
follow-up on 2 September 2016. The derivation of the main study groups and their progress through the
stages of follow-up in the trial is shown in Figure 4, in the form of a Consolidated Standards of Reporting
Trials (CONSORT) flow diagram.
Dental practices
Sixty-eight dental practices were initially recruited in total, with 49 in Scotland and 19 in England: 34
practices were allocated to give routine OHA and 34 to provide personalised OHA. From the 68 practices,
four were excluded post randomisation in the routine OHA arm and one in the personalised OHA arm.
The exclusions were due to a trial procedural error in the early recruitment phase of the study whereby
practices were randomised when a dentist in a practice had verbally given consent to take part but before
the practice principal dentist (usually the owner of the practice) had signed a consent form for the practice
to take part in the trial. The principal dentist did not give permission to use their practice. The practice
study intervention allocation was not known to any potential dentist, practice principal dentist (or patient)
participants at the time of non-consent. Selection bias due to the post-randomisation exclusions was not,
therefore, possible. Hence, there were 63 recruiting practices in total.
Participants
A total of 2341 patients were screened for trial entry and 183 (8%) of the screened patients were found to
be ineligible (Table 6). The primary reason for ineligibility was due to a BPE score of 4 or * (160 patients).
From those ineligible as a result of a BPE score of 4 or *, 144 (90%) patients agreed to join a separate
cohort group. Further details about the cohort participants are given in Chapter 6. There were 281 patients
eligible for the study who were not recruited. The main reason for non-recruitment was that the patient did
not attend the baseline appointment (see Table 6).
Participants were recruited in 63 dental practices (see Appendix 3). A total of 1877 participants were
recruited to the study, with 867 in the routine OHA arm (n = 289 allocated to receive no PI, n = 290
allocated to receive 6-monthly PI and n = 288 allocated to receive 12-monthly PI) and 1010 in the
personalised OHA arm (n = 334 allocated to receive no PI, n = 337 allocated to receive 6-monthly PI and
n = 339 allocated to receive 12-monthly PI). Of the total participants, 1348 (72%) were recruited across
Scotland, including 121 (6%) recruited from the Scottish islands. No dental practice recruited > 2.5% of
the participants. The average cluster size was 30.6 and 28.9 participants for personalised OHA and routine
OHA practices, respectively. Three participants were subsequently identified to be non-NHS patients at
consent (and therefore ineligible) and were thus excluded post randomisation.
Description of the groups at trial entry
Practice characteristics
Table 7 provides the dental practice characteristics and beliefs. The majority of practices employed
hygienists and had three or more dentists. Participating dentists and hygienists completed a questionnaire
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No PI
(n = 334)
12-monthly PI
(n = 339)
Participants randomised
(n = 1010)
Screened participants 
(n = 1239)
Personalised OHA practices
(n = 34; average cluster size = 30.6,
 range = 7– 46)
PRX
(n = 1)
Declined (n = 123)
Ineligible (n = 106)
68 practices randomised
Declined (n = 158)
Ineligible (n = 77)
6-monthly PI
(n = 337)
PRX
(n = 0)
PRX
(n = 1)
PRX
(n = 1)
• Clinical examination,
   n = 334 (100%)
• PAQ, n = 329 (99%)
• Clinical examination,
   n = 338 (100%)
• PAQ, n = 332 (98%)
• Clinical examination,
   n = 336 (100%)
• PAQ, n = 328 (98%)
• Self-efficacy, n = 249 (75%)
• Declined further follow-up,
   n = 0
• Died, n = 0
• Self-efficacy, n = 248 (73%)
• Declined further follow-up,
   n = 1 (0%)
• Died, n = 0
• Self-efficacy, n = 249 (74%)
• Declined further follow-up,
   n = 4 (1%)
• Died, n = 0
• Self-efficacy, n = 223 (67%)
• Declined further follow-up,
   n = 2 (1%)
• Died, n = 0
• Self-efficacy, n = 226 (67%)
• Declined further follow-up,
   n = 4 (1%)
• Died, n = 0
• Self-efficacy, n = 223 (66%)
• Declined further follow-up,
   n = 6 (2%)
• Died, n = 2 (1%)
• Self-efficacy, n = 260 (78%)
• Declined further follow-up,
   n = 3 (1%)
• Died, n = 2 (1%)
• Self-efficacy, n = 259 (77%)
• Declined further follow-up,
   n = 8 (2%)
• Died, n = 1 (0%)
• Self-efficacy, n = 261 (78%)
• Declined further follow-up,
   n = 10 (3%)
• Died, n = 3 (1%)
Participants included
(bleeding)
(n = 234, 70%)
Participants included
(bleeding)
(n = 239, 71%)
Clusters analysed, n = 33a
Declined further follow-up, n = 3
Average cluster size = 23.0, range = 11 – 37
Participants included
(bleeding)
(n = 239, 71%)
No PI
(n = 289)
12-monthly PI
(n = 288)
Participants randomised
(n = 867)
Screened participants 
(n = 1102)
Routine OHA practices
(n = 34; average cluster size = 28.9,
range =13 – 39)
         PRX
(n = 4)
6-monthly PI
(n = 290)
PRX
(n = 0)
PRX
(n = 1)
PRX
(n = 0)
• Clinical examination,
   n = 289 (100%)
• PAQ, n = 286 (99%)
Baseline
Year 1
Year 2
Year 3
Analysis
• Clinical examination,
   n = 287 (100%)
• PAQ, n = 281 (98%)
• Clinical examination,
    n = 290 (100%)
• PAQ, n = 284 (98%)
• Self-efficacy, n = 224 (78%)
• Declined further follow-up,
   n = 0
• Died, n = 0
• Self-efficacy, n = 221 (77%)
• Declined further follow-up,
   n = 2 (1%)
• Died, n = 0
• Self-efficacy, n = 211 (73%)
• Declined further follow-up,
   n = 2 (0%)
Died, n = 0 (0%)
• Self-efficacy, n = 205 (71%)
• Declined further follow-up,
   n = 1 (0%)
• Died, n = 0 (0%)
• Self-efficacy, n = 200 (70%)
• Declined further follow-up, 
   n = 2 (1%)
• Died, n = 0
• Self-efficacy, n = 183 (63%)
• Declined further follow-up,
   n = 6 (2%)
• Died, n = 1 (0%)
• Self-efficacy, n = 233 (81%)
• Declined further follow-up,
   n = 4 (1%)
• Died, n = 1 (0%)
• Self-efficacy, n = 226 (79%)
• Declined further follow-up,
   n = 2 (1%)
• Died, n = 1 (0%)
• Self-efficacy, n = 211 (73%)
• Declined further follow-up,
   n = 7 (2%)
• Died, n = 4 (1%)
Participants included
(bleeding)
(n = 210, 73%)
Participants included
(bleeding)
(n = 208, 72%)
Clusters analysed, n = 30b
Declined further follow-up, n = 0
Average cluster size = 20.5, range = 5 – 36
Participants included
(bleeding)
(n = 197, 68%)
FIGURE 4 The Consolidated Standards of Reporting Trials (CONSORT) diagram. PAQ, patient annual questionnaire; PRX, post-randomisation exclusion. a, one was a
post-randomisation exclution; b, four were post-randomisation exclusions.
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TABLE 6 Screened/declined
Total ineligible/total declined
OHA, n (%)
Personalised (N= 1239) Routine (N= 1102)
Total declined 123 (10) 158 (14)
Unable to complete the study 4 (< 1) 24 (2)
Did not attend baseline appointment 64 (5) 72 (7)
No reason stated 53 (4) 61 (6)
Observing Ramadan – 1 (< 1)
Probes locked in safe and patient could not wait 1 (< 1) –
Did not have time to consider 1 (< 1) –
Total ineligible 106 (9) 77 (7)
BPE score of 4 or * 92 (7) 68 (6)
Uncontrolled medical condition 13 (1) 5 (1)
Too nervous 1 (< 1) 2 (< 1)
Not a regular attendee – 2 (< 1)
TABLE 7 Practice characteristics/beliefs
Dental practices
OHA, n (%)
Personalised (N= 33)a Routine (N= 30)a
Employs hygienists 24 (73) 24 (80)
Has three or more dentists 25 (76) 24 (80)
Region
Scotland 24 (72.7) 20 (66.7)
England 9 (27.3) 10 (33.3)
Health professional beliefs
OHA, n (%)
Personalised (N= 87)b Routine (N= 75)b
Dentist 70 (81) 63 (84)
Hygienist 17 (20) 12 (16)
Beliefs, mean (SD), n
Self-efficacy 5.9 (0.7), 81 5.9 (0.7), 67
Attitude 5.4 (0.7), 81 5.4 (0.7), 67
PBC 3.7 (1.0), 81 3.7 (0.8), 67
Intention 90.0 (14.2), 77 85.7 (17.2), 64
Has a plan to give OHA 2.2 (1.4), 79 2.4 (1.4), 67
Has a plan to give PI 2.2 (1.3), 78 2.3 (1.3), 66
Subjective norm 13.5 (9.2), 78 11.3 (7.3), 67
a Number of practices by cluster randomised allocation.
b Number of responders to the baseline CBQ by cluster randomised allocation.
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at baseline (the CBQ) on their beliefs about providing OHA. Scores for belief variables varied from 1 to 7,
where 7 represented the most positive outcome (e.g. the highest level of confidence or the most positive
attitude). Intention and subjective norm were the exceptions: intention varied from 0 to 100, where
100 represented the highest level of intention, and subjective norm varied from 1 to 49, where 49
represented the highest level of subjective norm. The results suggested that dental professionals had
positive attitudes towards, and high levels of intention of, providing OHA. There was little perceived
influence of peers in the ability of the respondents to provide OHA (subjective norm) (see Table 7).
Overall, there were no important differences between groups on any of the practice characteristics or
beliefs at baseline.
Participant characteristics
Sociodemographic factors and dental characteristics
Participant and sociodemographic characteristics are shown in Table 1. Tables 1 and 8–16 follow a
consistent format to aid interpretation of the main cluster and participant comparisons. Columns 2–4 of
data represent the participant-level comparison and show the no PI, 12-monthly PI and 6-monthly PI
groups, respectively. Columns 5 and 6 of data represent the cluster-level comparison and show
personalised OHA and routine OHA, respectively.
The average age of participants was 48 years; the majority (around 65%) were women and regular attendees
of the dental practice (> 90% reported that their last visit to the dentist was within 2 years prior to baseline).
Around 60% reported having received OHA and a PI at their last dental appointment. For those who
reported receiving one treatment or the other, the dentist was most often the provider of the OHA or PI.
Overall, 64% of patients used a manual toothbrush and > 90% had no dental insurance. There were no
substantive differences between groups on any of the sociodemographic factors or dental characteristics.
Clinical characteristics
Table 8 displays the results of the clinical assessment at baseline. The mean number of teeth per
participant was 24. The highest sextant BPE score was ≤ 2 in two-thirds of the participants. The mean per
cent of sites bleeding was 33%, and 35% of teeth had calculus present. The mean clinical probing depth
was 1.8 mm and between 10% and 12% of participants in each group had four or more sites with a
clinical probing depth of ≥ 4 mm.
There were no important imbalances across the randomised groups.
Patient-reported outcomes
The baseline patient-reported outcomes summary is shown in Table 9. More details about individual
questions that produced the scales are given in Appendix 1.
Self-efficacy, the patient-reported primary outcome, was, on average, 5.2 points (on a scale of 1 to 7 points
with 7 points meaning very confident).
Cognition variables
Perceived behaviour control was, on average, 4.5 points; attitude towards oral health behaviour was
very positive and was, on average, 5.8 points and subjective norm was 5.3 points (scales of 1 to 7,
with 7 meaning very confident).
Behaviour
The mean self-reported oral hygiene behaviour score was 4.7 points. The scale varies from zero (poorest
hygiene behaviour) to 9 (perfect hygiene behaviour). The behaviour scale had space for improvement across
the three behaviours measured: (1) frequency of brushing, (2) duration of brushing and (3) frequency of
interdental cleaning (either flossing or the use of interdental brushes). In both brushing frequency and
duration, around 10% of participants scored the maximum of 3 points (brushed more than twice a day, for
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TABLE 8 Clinical characteristics at baseline, by randomised group
Clinical characteristics
Randomised group, mean (SD), n
PI OHA
No (N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
Present teeth 23.7 (4.5),
623
23.6 (4.5),
625
23.7 (4.7),
626
23.6 (4.6),
1008
23.7 (4.5),
866
Highest sextant BPE score, n (%)
0 – 4 (1) 1 (0) 2 (0) 3 (0)
1 40 (6) 42 (7) 38 (6) 73 (7) 47 (5)
2 376 (60) 374 (60) 377 (60) 590 (59) 537 (62)
3 207 (33) 205 (33) 210 (34) 343 (34) 279 (32)
Gingival bleeding, n (%) 608 (98) 610 (98) 612 (98) 991 (98) 839 (97)
Current smoker, n (%) 135 (22) 143 (23) 147 (23) 213 (21) 212 (24)
% of sites bleeding 33.5 (23.8),
623
32.5 (23.9),
625
32.4 (22.9),
626
34.3 (23.2),
1008
31.0 (23.7),
866
% of teeth with calculus 35.5 (26.3),
623
35.9 (27.4),
625
34.9 (26.8),
626
33.7 (25.8),
1008
37.4 (27.8),
866
Mean clinical probing
depth (mm)
1.8 (0.3), 623 1.8 (0.3), 625 1.8 (0.3), 626 1.8 (0.3), 1008 1.8 (0.3), 866
Four or more sites with
a clinical probing depth
of ≥ 4mm, n (%)
64 (10) 75 (12) 70 (11) 117 (12) 92 (11)
TABLE 9 Patient-reported outcomes at baseline, by randomised group
Patient-reported
outcomes
Randomised group, mean (SD), n
PI OHA
No (N= 623)
12 monthly
(N= 625)
6 monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
Self-efficacy 5.2 (1.1), 612 5.3 (1.2), 607 5.2 (1.2), 607 5.2 (1.2), 976 5.2 (1.2), 850
PBC 4.5 (1.2), 607 4.5 (1.2), 603 4.5 (1.2), 606 4.5 (1.2), 972 4.4 (1.2), 844
Attitude 5.8 (1.2), 611 5.9 (1.1), 605 5.7 (1.3), 607 5.8 (1.2), 977 5.8 (1.2), 846
Subjective norm 5.3 (1.1), 601 5.3 (1.2), 598 5.2 (1.1), 597 5.3 (1.1), 958 5.2 (1.1), 838
Behaviour 4.7 (1.7), 608 4.7 (1.8), 604 4.8 (1.7), 605 4.6 (1.7), 971 4.9 (1.7), 846
Intention 5.5 (1.7), 560 5.5 (1.8), 568 5.6 (1.8), 556 5.4 (1.8), 903 5.6 (1.7), 781
OHIP-14 6.0 (7.4), 595 6.4 (8.1), 591 6.5 (8.3), 591 5.9 (7.6), 952 6.7 (8.3), 825
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longer than 2 minutes). Regarding interdental cleaning, around 20% of participants scored the maximum of
3 points (floss or use interdental brushes every day).
Intention
The mean intention to perform good OHA practice was 5.5 points (on a scale from 0 to 9, with 9 being
the best outcome).
Quality of life
The mean score on the oral health QoL scale, OHIP-14, was 6.3 points on a scale form 0 to 56 (with 0
indicating perfect oral health QoL). The OHIP-14 75th percentile was 9 and the 99th percentile was 39,
illustrating a generally good oral health-related QoL in this population.
The baseline participant self-reported data suggested that participants were confident that they could
perform good toothbrushing practice, thought oral hygiene practice was a positive thing to do, were
influenced by their peers to do it and intended to do it. However, the participants did not currently actually
perform good oral hygiene practice and reported that there were external factors, PBC, that limited
their ability to do so. Overall, across the randomised groups, there were no apparent imbalances in the
patient-reported outcomes.
Trial follow-up
Attendance at 3-year clinical examination
The primary clinical outcome was collected at the 3-year clinical follow-up. Overall, 71% of the participants
attended the appointment (see Appendix 1). Twelve participants were known to have died by the end of
the 3-year follow-up. The main reasons for non-attendance were that the practice was unable to contact
the participant (41%), the participant was unable to attend (30%) and the participant did not want to
attend (13%). There were no important differences between groups for the reasons of non-attendance.
A comparison of baseline characteristics between those who did and those who did not attend the final
appointment was undertaken. The results in Table 10 show that only a few factors differed between
attenders and non-attenders. Attenders were, on average, older (50 vs. 43 years). Although there was a
statistically significant difference in the OHIP-14 score, with the mean score reported by non-attenders
higher than that reported by attenders, the difference of 1.3 points (0.15 of the SD of the score) was not
thought to be clinically important. There was no evidence that non-attenders had different levels of disease,
with BPE scores, bleeding, calculus and probing depths all very similar to those seen in attenders.
Annual questionnaire returns at years 1, 2 and 3
Approximately 77% of participants completed a follow-up questionnaire at 3 years. There were no
substantive differences in response rates between the randomised groups. The overall rates of return of
follow-up questionnaires at 1, 2 and 3 years are shown in Appendix 1.
Participant dental characteristics at 3 years
The participant dental characteristics at 3 years are shown in Table 11. The profile of characteristics is
similar across the groups and similar to baseline responses (e.g. smoking status, type of toothbrush used,
preferences for two PIs per year; see Tables 1 and 8). Characteristics for years 1 and 2 are given in
Appendix 1, Section 2: participant dental characteristics (years 1 and 2).
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TABLE 11 Patient and dental characteristics at 3 years, by randomised group
Patient and dental
characteristics
Randomised group, n (%)
PI OHA
No
(N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
Date of last visit to the dental practice (years ago)
< 1 393 (63) 386 (62) 383 (61) 630 (63) 532 (61)
1–2 17 (3) 21 (3) 12 (2) 24 (2) 26 (3)
> 2 3 (0) 2 (0) – 4 (0) 1 (0)
Missing 210 (34) 216 (35) 231 (37) 350 (35) 307 (35)
Do you think of yourself as
A regular attendee 399 (64) 394 (63) 388 (62) 632 (63) 549 (63)
Someone who sees a dentist
when in pain or trouble
13 (2) 16 (3) 6 (1) 24 (2) 11 (1)
Missing 211 (34) 215 (34) 232 (37) 352 (35) 306 (35)
Last time you went to the dental practice were you given OHA?
Yes 281 (45) 339 (54) 327 (52) 534 (53) 413 (48)
No 131 (21) 70 (11) 67 (11) 121 (12) 147 (17)
Missing 211 (34) 216 (35) 232 (37) 353 (35) 306 (35)
By whom?
Dentist 210 (34) 217 (35) 178 (28) 357 (35) 248 (29)
Hygienist 39 (6) 65 (10) 83 (13) 90 (9) 97 (11)
Both 30 (5) 56 (9) 66 (11) 86 (9) 66 (8)
Missing 344 (55) 287 (46) 299 (48) 475 (47) 455 (53)
continued
TABLE 10 Comparison of baseline characteristics of 3-year follow-up assessment of attenders and non-attenders
Baseline characteristics
Attendance, mean (SD), n
p-valueAttender (N= 1327) Non-attender (N= 547)
Age (years) 49.9 (15.1), 1327 42.7 (16.1), 547 < 0.001
Male, n (%) 490 (37) 187 (34) 0.27
BPE score, n (%) 0.28
0 5 (0)
1 82 (6) 38 (7)
2 788 (59) 339 (62)
3 452 (34) 170 (31)
Bleeding n (%) 0.78
Yes 1295 (98) 535 (98)
No 32 (2) 12 (2)
Self-efficacy 5.2 (1.1), 1306 5.2 (1.2), 520 0.50
OHIP-14 5.9 (7.3), 1276 7.2 (9.2), 501 0.003
% of sites bleeding 32.4 (23.1), 1327 33.9 (24.4), 547 0.20
% of calculus 34.7 (26.3), 1327 37.2 (28.0), 547 0.08
Mean clinical probing depth (mm) 1.8 (0.3), 1327 1.8 (0.3), 547 0.64
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Statistical analyses
Primary outcomes
Gingival inflammation/bleeding
The pre-chosen clinical primary outcome was mean gingival bleeding at the 3-year follow-up. The means
and 95% CI for baseline and follow-up for each randomised group are displayed in Figure 5. All
randomised groups followed a similar pattern: bleeding increased from baseline (mean 32% of sites)
to 3-year follow-up (mean 39% of sites). The differences between groups and corresponding 95% CIs are
shown in Table 12.
TABLE 11 Patient and dental characteristics at 3 years, by randomised group (continued )
Patient and dental
characteristics
Randomised group, n (%)
PI OHA
No
(N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
In the last 12 months, did you receive a scale and polish?
Yes 210 (34) 334 (53) 354 (57) 491 (49) 407 (47)
No 199 (32) 72 (12) 40 (6) 161 (16) 150 (17)
Missing 214 (34) 219 (35) 232 (37) 356 (35) 309 (36)
By whom?
Dentist 145 (23) 212 (34) 198 (32) 317 (31) 238 (27)
Hygienist 54 (9) 111 (18) 138 (22) 151 (15) 152 (18)
Both 8 (1) 8 (1) 13 (2) 16 (2) 13 (2)
Missing 416 (67) 294 (47) 277 (44) 524 (52) 463 (53)
Smoked in the last 12 months?
Yes 50 (8) 55 (9) 45 (7) 76 (8) 74 (9)
No 362 (58) 355 (57) 349 (56) 580 (58) 486 (56)
Missing 211 (34) 215 (34) 232 (37) 352 (35) 306 (35)
What type of toothbrush do you normally use?
Manual 233 (37) 223 (36) 199 (32) 345 (34) 310 (36)
Electric 158 (25) 154 (25) 167 (27) 261 (26) 218 (25)
Do not use toothbrush 21 (3) 31 (5) 27 (4) 48 (5) 31 (4)
Missing 211 (34) 217 (35) 233 (37) 354 (35) 307 (35)
How often do you prefer to have a scale and polish?
Never 19 (3) 12 (2) 11 (2) 24 (2) 18 (2)
Once every 2 years 20 (3) 9 (1) 15 (2) 20 (2) 24 (3)
Once a year 108 (17) 113 (18) 50 (8) 144 (14) 127 (15)
Twice a year 184 (30) 196 (31) 212 (34) 322 (32) 270 (31)
Three times a year 27 (4) 40 (6) 49 (8) 71 (7) 45 (5)
Four times a year 41 (7) 25 (4) 46 (7) 47 (5) 65 (8)
More often 4 (1) 10 (2) 10 (2) 19 (2) 5 (1)
Missing 220 (35) 220 (35) 233 (37) 361 (36) 312 (36)
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FIGURE 5 Gingival inflammation/bleeding (mean and 95% CI), by randomised allocation. (a) OHA delivery and
(b) PI interval.
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Three types of analyses are reported: (1) an unadjusted analysis, (2) an adjusted-for-baseline bleeding
analysis and (3) a fully adjusted model accounting for baseline bleeding and minimisation variables (this
is the prespecified primary model). Under ITT analysis, there was no evidence of a statistical or clinical
difference between those randomised to receive 6-monthly PI and those randomised to receive no PI
(difference 0.87%, 95% CI –1.6% to 3.3%; p = 0.481). Similarly, there was no evidence of a difference
between 6-monthly PI and 12-monthly PI (difference 0.11%, 95% CI –2.3% to 2.5%; p = 0.929). The 95%
CIs were small enough to exclude the prespecified clinically important difference of 7.5% in bleeding. There
was also little evidence of a difference between participants randomised to personalised OHA and those
randomised to routine OHA (difference –2.5%, 95% CI –8.3% to 3.3%; p = 0.393), although the 95% CI
did not entirely rule out a 7.5% reduction. The results were robust to other adjusted/unadjusted models.
The interaction between personalised OHA and 6-monthly PI was 1.7% (95% CI –3.8% to 7.3%). The
interaction demonstrated that a participant receiving both personalised OHA and 6-monthly PI would have
a further 1.7% bleeding reduction compared with just adding the individual effects of 6-monthly PI with
personalised OHA. The interaction term ruled out an additional 7.5% reduction. The ICC at follow-up for
bleeding for all participants was 0.23 (95% CI 0.16 to 0.31). A full description of the means (SD) for gingival
inflammation at each time point is given in Appendix 1, Section 3: clinical and patient-reported outcomes by
year of follow-up.
Self-efficacy
The pre-chosen patient-centred primary outcome was self-efficacy at the 3-year follow-up. The means and
95% CIs for baseline and follow-up for each randomised group are displayed in Figure 6, by randomised
allocation. All groups followed a similar pattern. The score was similar from baseline (mean 5.2 points) up to
the year 3 questionnaire (mean 5.3 points) in both the PI and the OHA groups. The differences between
groups and corresponding 95% CIs are shown in Table 12. Under ITT analysis, there was no evidence
of a difference between those randomised to receive 6-monthly PI and those randomised to receive no PI
(difference –0.028, 95% CI –0.119 to 0.063; p = 0.543). Between those randomised to receive 6-monthly
and those randomised to receive 12-monthly PI, there was a statistically significant difference, favouring the
6-monthly PI (difference –0.097, 95% CI –0.188 to –0.006; p = 0.037). However, this result is not clinically
significant. There was also no evidence of a difference between participants randomised to personalised
OHA and those randomised to routine OHA (difference 0.017, 95% CI –0.089 to 0.123; p = 0.750). The
interaction coefficient between personalised OHA and 6-monthly PI was –0.007 (95% –0.22 to 0.20),
TABLE 12 Treatment effects for primary outcomes
Primary outcomes
Estimate, p-value (95% CI)
No PI vs. 6-monthly PI
12-monthly PI vs.
6-monthly PI
Personalised OHA vs.
routine OHA
Gingival inflammation/bleeding
Unadjusted 0.71 (–2.0 to 3.7), 0.579 –0.53 (–3.4 to 2.3), 0.715 0.02 (–6.3 to 6.4), 0.985
Adjusted for baseline bleeding 0.8 (–1.7 to 3.2), 0.534 0.1 (–2.4 to 2.5), 0.947 –1.9 (–8.1 to 4.3), 0.549
Adjusted for baseline bleeding
and minimisation variables
0.87 (–1.6 to 3.3), 0.481 0.11 (–2.3 to 2.5), 0.929 –2.5 (–8.3 to 3.3), 0.393
Self-efficacy
Unadjusted –0.017 (–0.133 to 0.098),
0.767
–0.082 (–0.198 to 0.033),
0.162
0.002 (–0.144 to 0.147),
0.984
Adjusted for baseline
self-efficacy
–0.098 (–0.189 to –0.007),
0.035
–0.027 (–0.118 to 0.064),
0.564
0.003 (–0.110 to 0.115),
0.962
Adjusted for baseline
self-efficacy and minimisation
variables
–0.028 (–0.119 to 0.063),
0.543
–0.097 (–0.188 to –0.006),
0.037
0.017 (–0.089 to 0.123),
0.750
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FIGURE 6 Self-efficacy score (mean and 95% CI), by randomised allocation. (a) OHA and (b) frequency of PI.
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suggesting no evidence of important interaction between interventions. The self-efficacy ICC for all
participants was 0.06 (95% CI 0.04 to 0.09). A full description of the means (SD) for self-efficacy at each
time point is given in Appendix 1, Section 3: clinical and patient-reported outcomes by year of follow-up.
Secondary outcomes
A full description of the means (SD) for the secondary outcomes at each time point is given in Appendix 1,
Section 3: clinical and patient-reported outcomes by year of follow-up.
The clinical secondary outcomes were calculus and mean clinical probing depth collected at the 3-year
follow-up. The patient-reported secondary outcomes were PBC; attitude; subjective norm; behaviour and
intention collected at 1, 2 and 3 years; and private PI received throughout the trial collected at year 3.
Self-reported bleeding was a post hoc secondary outcome collected at 3 years. The differences between
groups, and corresponding 95% CIs, are shown in Table 13.
Calculus
The calculus means and 95% CIs for baseline and follow-up for each randomised group are displayed in
Figure 7. The mean level of calculus decreased across the no PI, 12-monthly and 6-monthly PI groups.
The calculus level was statistically significantly higher in the no-PI group than in the 6-monthly PI group
(mean 8.0%, 95% CI 5.4% to 10.7%, p < 0.001). There was no evidence of a difference in mean calculus
between 12-monthly PI and 6-monthly PI or between personalised and routine OHA (Table 13).
TABLE 13 Treatment effects for secondary outcomes
Secondary outcomes
Estimate, p-value (95% CI)
No PI vs. 6-monthly PI
12-monthly PI vs.
6-monthly PI
Personalised OHA vs.
routine OHA
Clinical
% of calculus 8.0 (5.4 to 10.7), < 0.001 1.6 (–1.0 to 4.2), 0.231 2.3 (–5.8 to 10.3), 0.577
Mean clinical probing
depth (mm)
0.003 (–0.024 to 0.030),
0.808
0.022 (–0.004 to 0.049),
0.102
–0.024 (–0.084 to 0.036),
0.433
Patient-centred outcomes
PBC 0.02 (–0.09 to 0.13),
0.704
–0.01 (–0.12 to 0.10),
0.838
–0.02 (–0.12 to 0.07),
0.620
Attitude –0.137 (–0.273 to –0.001),
0.048
–0.093 (–0.229 to 0.044),
0.183
–0.019 (–0.134 to 0.097),
0.754
Subjective norm –0.07 (–0.18 to 0.04),
0.198
–0.06 (–0.17 to 0.05),
0.272
–0.04 (–0.14 to 0.06),
0.473
Behaviour –0.125 (–0.256 to 0.007),
0.064
–0.164 (–0.296 to –0.032),
0.015
0.072 (–0.063 to 0.207),
0.297
Intention –0.10 (–0.25 to 0.05),
0.186
–0.14 (–0.29 to 0.00),
0.054
0.09 (–0.06 to 0.25),
0.253
OHIP-14 0.35 (–0.23 to 0.93),
0.239
0.41 (–0.17 to 0.99),
0.169
–0.33 (–0.86 to 0.20),
0.229
Private PIs, odds ratio
(95% CI), p-value
0.5 (0.3 to 0.7), 0.001 0.8 (0.6 to 1.2), 0.302 1.0 (0.7 to 1.6), 0.908
Has a plan to better
brush or floss, odds
ratio (95% CI), p-value
1.1 (0.9 to 1.3), 0.563 0.94 (0.77 to 1.16), 0.635 1.1 (0.9 to 1.4), 0.579
Self-reported bleeding –0.01 (–0.14 to 0.12),
0.886
–0.03 (–0.16 to 0.10),
0.666
–0.06 (–0.17 to 0.06),
0.333
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FIGURE 7 Calculus percentage (mean and 95% CI), by randomised allocation. (a) OHA and (b) frequency of PI.
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Clinical probing depth
The mean clinical probing depth and 95% CI for baseline and follow-up for each randomised group are
displayed in Figure 8. There was no evidence of changes from the baseline clinical pocket depths and no
evidence of differences between any of the randomised comparisons (see Table 13).
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FIGURE 8 Mean clinical probing depth (mean and 95% CI), by randomised allocation. (a) OHA and (b) frequency
of PI.
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Patient-reported outcomes
The patient-reported outcomes (PBC, attitude and subjective norm) are shown in Figures 9–11. There was
no evidence of any clinically important differences between the randomised groups in any of the cognitive
variables at any follow-up time (see Table 13). Attitude was statistically significantly different between
participants randomised to 6-monthly PI and those randomised to no PI, favouring a better attitude to oral
hygiene behaviour in the no-PI group (difference –0.137, 95% CI –0.273 to –0.001; p = 0.048). However,
the 95% CI excludes the possibility of a clinically important difference.
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FIGURE 9 Perceived behaviour control score (mean and 95%CI), by randomised allocation. (a) OHA and (b) frequency of PI.
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FIGURE 10 Attitude score (mean and 95% CI), by randomised allocation. (a) OHA and (b) frequency of PI.
TRIAL RESULTS AND CLINICAL EFFECTIVENESS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
46
Baseline 1 year 2 years
1
2
3
4
5
6
7
3 years
(a)
Routine
Personalised
OHA
Time point
Su
b
je
ct
iv
e 
n
o
rm
 s
co
re
Baseline 1 year 2 years
1
2
3
4
5
6
7
3 years
(b)
Time point
Su
b
je
ct
iv
e 
n
o
rm
 s
co
re
No
12-monthly
6-monthly
PI
FIGURE 11 Subjective norm score (mean and 95% CI), by randomised allocation. (a) OHA and (b) frequency of PI.
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Behaviour score
The mean behaviour score and 95% CI for baseline and follow-up for each randomised group are
displayed in Figure 12. The behaviour score was significantly different between participants randomised
to the 6-monthly PI and those randomised to 12-monthly PI, favouring those in the 6-monthly group
(difference –0.164, 95% CI –0.296 to –0.032; p = 0.015) (see Table 13). However, the 95% CI excludes
the possibility of a clinically important difference. Therefore, there was no evidence of any clinically
important differences between the randomised groups.
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FIGURE 12 Behaviour score (mean and 95% CI), by randomised allocation. (a) OHA and (b) frequency of PI.
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Intention score
The mean intention score and 95% CI for baseline and follow-up for each randomised group are displayed
in Figure 13. There was no evidence of any clinically or statistically significant differences between the
randomised groups for the intention score at any of the follow-up times (see Table 13).
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FIGURE 13 Intention score (mean and 95% CI), by randomised allocation. (a) OHA and (b) frequency of PI.
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Oral Health Impact Profile-14
The OHIP-14 score was overall very low (representing a good oral QoL) across the randomised groups at all
follow-up time points (Figure 14), varying from mean 6.0 at baseline to mean 5.0 at 3 years. There was no
evidence of any clinically important differences between the randomised groups for OHIP-14 scores at any
of the follow-up times (see Table 13).
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FIGURE 14 The OHIP-14 score (mean and 95% CI), by randomised allocation. (a) OHA and (b) frequency of PI.
TRIAL RESULTS AND CLINICAL EFFECTIVENESS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
50
Private periodontal instrumentation received during the trial
There was a significant difference in the self-report of having received at least one private PI during the
trial between the participants randomised to 6-monthly PI and the participants randomised to no PI.
Participants in the 6-monthly PI had 50% greater odds of reporting a private PI than those in the no-PI
group (odds ratio 0.5, 95% CI 0.3 to 0.7; p = 0.001). There was no evidence of a difference between the
other randomised groups in private PI received during the trial (see Table 13). This is likely to reflect the
number of PIs received in each group and a misunderstanding of the difference between a private and
NHS PI rather than a real effect.
Having a plan to brush or floss better
There was no evidence of a difference between PI frequencies or OHA randomised groups in having a plan
to brush or floss better over the course of the trial (see Table 13). This variable was also used as a measure
of fidelity (see Fidelity of interventions).
Self-reported bleeding (post hoc outcome)
There was no evidence of a difference between the randomised groups for self-reported bleeding at 3 years
(see Table 13).
Clinician beliefs at follow-up
The majority (around 78%) of respondents to the CBQ at follow-up were dentists. Every scale regarding
the provider’s beliefs varied from 1 to 7, except for subjective norm, which varied from 1 to 49 (Table 14).
Self-efficacy was high in both randomised groups (around 6 out of 7) and PBC was low. The overall
attitude towards OHA and PI was around 3.5 out of 7, which was worse than at baseline, when the value
was around 5 out of 7. The comparability between the follow-up and baseline CBQ is limited since the
responders to both questionnaires were not always the same clinicians. Professionals did not report strong
feelings of change in self-efficacy regarding both OHA and PI delivery over the course of the trial (mean
of around 3 and similar between randomised groups). There was no evidence of a difference between
randomised groups for any of the provider’s beliefs.
TABLE 14 Clinician belief questionnaire at follow-up
Clinician beliefs
OHA
Personalised OHA vs. routine
OHA, estimate (95% CI; p-valuea)
Personalised
(N= 44)
Routine
(N= 40)
Profession, n (%)
Hygienist 11 (25) 7 (18) –
Dentist 33 (75) 33 (83) –
Clinician beliefs, mean (SD), n
Self-efficacy 6.2 (0.6), 44 6.0 (0.6), 40 0.16 (–0.12 to 0.44; 0.254)
PBC 3.0 (1.0), 44 2.8 (1.0), 40 0.15 (–0.26 to 0.57; 0.472)
Attitude 3.7 (0.5), 44 3.5 (0.7), 40 0.15 (–0.11 to 0.41; 0.270)
Subjective norm 13.2 (7.8), 43 11.3 (8.5), 40 1.87 (–1.49 to 5.22; 0.275)
Intention 5.5 (1.2), 43 5.4 (1.0), 39 0.12 (–0.39 to 0.62; 0.648)
Has the plan about advice
changed throughout the trial?
3.7 (1.8), 43 3.3 (2.1), 39 0.36 (–0.39 to 1.11; 0.350)
Has the plan about providing PI
changed throughout the trial?
3.1 (1.8), 43 3.1 (1.8), 39 –0.02 (–0.77 to 0.73; 0.949)
a These analyses adjust for cluster-level minimisation variables.
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Tertiary outcomes
Appendix 1, Section 4: tertiary outcomes (at baseline and 3 years) provides the self-reported data on
dental sensitivity and appearance for baseline and 3 years. Possible answers to all the questions varied
from 1 point (not clean at all/not at all pleasant) to 7 points (could not get any cleaner/extremely pleasant).
At baseline, patients reported feeling that their teeth were clean after brushing (on average, 5.8 points),
but cleaner after PI (on average, 6.6 points). The same was reported for how clean their teeth look (after
brushing 5.3 points vs. after a PI 6.2 points), how pleasant they feel (5.8 points after brushing vs. 6.3
points after PI) and how pleasant they look (5.1 points after brushing vs. 5.7 points after PI). Around half
of the patients reported feeling sensitivity in their teeth. Dental sensitivity and appearance characteristics
were balanced across randomised groups.
At 3 years, participants reported that their teeth felt and looked clean and pleasant after brushing (on
average, around 5.5 points out of 7 points) and even more clean and pleasant after PI (on average, around
6.4 points out of 7 points). The average scores were similar across randomised groups, indicating that
having fewer PIs throughout the trial did not influence the participants’ perceptions.
Fidelity of interventions
Number of periodontal instrumentations received throughout the trial
Table 15 presents descriptive information from routine data and participant self-reported questionnaire data
regarding the number of PIs claimed during the course of the trial. It includes participants with a clinical
follow-up assessment and routine data available. The number of PIs reported in Table 15 excluded the baseline
PI given to all participants. There was a separation between the number of PIs (claimed or self-reported) in
each randomised PI group: the no-PI group claimed on average one PI throughout the trial, the 12-monthly
TABLE 15 Number of PIs received
Number of PIs received
Randomised group, n (%)
PI OHA
No (N= 427)
12-monthly
(N= 433)
6-monthly
(N= 426)
Personalised
(N= 699)
Routine
(N= 587)
Routine data
0 197 (46) 61 (14) 41 (10) 168 (24) 131 (22)
1 108 (25) 89 (21) 58 (14) 133 (19) 122 (21)
2 60 (14) 192 (44) 56 (13) 176 (25) 132 (22)
3 42 (10) 52 (12) 103 (24) 118 (17) 79 (13)
4 13 (3) 33 (8) 127 (30) 85 (12) 88 (15)
≥ 5 7 (2) 6 (1) 41 (10) 19 (3) 35 (6)
Mean (SD), n 1.0 (1.2), 427 1.8 (1.1), 433 2.8 (1.5), 426 1.8 (1.4), 699 2.0 (1.5), 587
Self-report
0 154 (36) 62 (14) 19 (4) 122 (17) 113 (19)
1 98 (23) 88 (20) 59 (14) 142 (20) 103 (18)
2 66 (15) 94 (22) 81 (19) 128 (18) 113 (19)
3 29 (7) 77 (18) 43 (10) 74 (11) 75 (13)
4 18 (4) 42 (10) 71 (17) 74 (11) 57 (10)
≥ 5 14 (3) 21 (5) 105 (25) 74 (11) 66 (11)
Missing 48 (11) 49 (11) 48 (11) 85 (12) 60 (10)
Mean (SD), n 1.2 (1.4), 379 2.0 (1.4), 384 3.1 (1.6), 378 2.1 (1.6), 614 2.1 (1.7), 527
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PI group claimed around two PIs and the 6-monthly PI group claimed three PIs. Personalised and routine OHA
had a similar number of PIs throughout the trial. The self-reported number of PIs was similar to the routinely
collected data; however, the similarity was due to participants over- or underestimating PIs compared with the
routine data (25% of the participants self-reported the same number of PIs as those claimed in the routine
data; 47% self-reported having more PIs than those claimed; and 28% self-reported having fewer PIs than
those claimed). There was clear evidence of a separation in the number of PIs given as randomised.
In addition to using the routine and self-reported data, the dental practice data monitoring showed that all
practices were compliant. A telephone call was made to each practice on two occasions; however, no
practices required further follow-up by the trial manager.
Routine check-ups were similar across the randomised groups, with an overall mean of 3.8 visits and a SD
of 1.6 (i.e. participants attended the dental practice with the same frequency across groups).
Personalised and routine oral hygiene advice
Personalised OHA was given as intended to all participants at the baseline visit. Four questions in the
participant annual questionnaire were used to further measure the continued fidelity of the OHA:
(1) ‘Usually, when you finish brushing your teeth do you . . .?’, (2) ‘What do you intend to do when you
finish brushing your teeth in the future?’ (related to the use of mouth wash after brushing), (3) ‘Do you
have a plan about when you will start brushing your teeth better?’ and (4) ‘Do you have a plan about
when you will start flossing your teeth better?’. Correct answers to the first two questions (i.e. ‘I do spit
but not rinse after brushing’ or ‘I should spit but not rinse after brushing’), as well as having a plan about
when to start brushing or flossing better, were considered as proxy indicators that the personalised OHA
was delivered. At baseline, the routine and personalised groups were balanced for each question (around
28% of participants answered that they spit but do not rinse after brushing, 28% that they intended to do
that and 25% that they had a plan to brush or floss better). At year 1, 29% of participants in the routine
group said that they spit but do not rinse, or intended to do so, compared with around 40% in the
personalised group. At the end of the trial, in the 3-year follow-up questionnaire, around 29% of the
participants in the routine arm reported that they spit but do not rinse or intended to do so, compared
with 39% in the personalised arm. Around 20% of the participants in either arm had a plan to brush or
floss better. This was similar across the years. Participants did not necessarily need to have a plan to brush
or floss better if they did not need one (one of the options in the questionnaire). There was evidence, from
the answer ‘I do spit but not rinse after brushing’, that the personalised OHA group retained/received the
OHA as intended.
Subgroup analyses
Prespecified subgroup analyses for gingival bleeding included currently a smoker (yes/no), BPE score
(of < 3 or of 3), age (< 45/45–64/> 64 years) and whether or not the practice employed a hygienist (yes/no).
Post hoc subgroup analyses were undertaken for participants with four or more sites with a clinical
probing depth of ≥ 4 mm (yes/no) and region (Scotland/England). Figures 15 and 16 show the means and
99% CIs for the differences in bleeding at 3 years in the subgroups for PI frequency and OHA, respectively.
There was no evidence that any of the subgroups were statistically significantly different at the 1% level
(Table 16).
Sensitivity analyses
Missing data
Possible mechanisms of missingness were investigated by modelling baseline predictors of participants
missing the final examination (see Table 10). Only age was identified as a predictor. Clinical severity of
disease indicators (bleeding, calculus and clinical pocket depths) were not predictors. There were no
differences between randomised groups in the proportion of missing data. In addition, the main reason for
missing the final examination was that the participant was no longer contactable by the dental practice
and, therefore, unlikely to be related to the study interventions. Given these findings, no further missing
data sensitivity analyses were undertaken.
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Outliers
To test the sensitivity of the primary outcome to outliers, we explored potential between-practice
differences influencing the primary analyses. Practices where the treatment difference was twice the target
difference (either –15% or +15%) and excluded zero from the 99% CI were excluded from the analysis
comparing no PI with 6-monthly PI. A positive treatment difference was found in favour of the 6-monthly
PI versus other PI. Three practices in England met the criteria and were excluded as part of the sensitivity
analysis. They had the following treatment difference estimates +19.4; +24.2; and +24.7. After excluding
the three outlier practices from the main analysis, the treatment effect of 6-monthly PI versus no PI was
–0.38 (95% CI –2.9 to 2.1), of 6-monthly PI versus 12-monthly PI was –0.18 (95% CI –2.7 to 2.3) and of
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FIGURE 16 Subgroup results for OHA allocation: difference between arms, by subgroup.
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FIGURE 15 Subgroup results for PI allocation: difference between arms, by subgroup.
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personalised OHA versus routine OHA was –2.1 (95% CI –8.1 to 4.0). The overall I2 for the practice effects
in the trial was 27%. When the outliers were removed, the I2 was 0% and the interaction mean in the
subgroup analysis for region changed from –4.8 (95% CI –11 to 1.4; p = 0.048) to –2.3 (95% CI –9.0 to
4.5; p = 0.387).
TABLE 16 Interaction mean for 6-monthly PI vs. other PI and personalised OHA vs. routine OHA, by subgroup
Subgroups
Mean (99% CI; p-value)
Other PI vs. 6-monthly PI Personalised OHA vs. routine OHA
Scotland vs. England –4.8 (–11.0 to 1.4; 0.048) –2.9 (–19.5 to 13.6; 0.649)
BPE score of 3 vs. < 3 4.7 (–1.1 to 10.5; 0.038) –2.5 (–8.1 to 3.1; 0.254)
Smoker vs. non-smoker 0.0 (–7.3 to 7.4; 0.992) –0.3 (–7.2 to 6.7; 0.922)
Employs hygienist vs. does not 2.1 (–4.3 to 8.5; 0.396) –11.3 (–29.0 to 6.5; 0.102)
Clinical pocket depth (mm) ≥ 4 vs. < 4 2.8 (–6.1 to 11.6; 0.417) 0.8 (–7.7 to 9.2; 0.811)
Age (years) 45–64 vs. < 45 2.5 (–3.7 to 8.8; 0.291) 0.4 (–5.5 to 6.3; 0.855)
Age (years) > 65 vs. < 45 2.2 (–5.9 to 10.2; 0.487) 3.9 (–3.6 to 11.4; 0.177)
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Chapter 5 Results of economic analysis
Resource use and costs
NHS dental care resource use
Data were linked for 1337 out of 1346 (99%) trial participants randomised in Scotland (after
post-randomisation exclusion) and 477 out of 525 (91%) trial participants randomised in England. It was not
possible to link data for 11 participants in Scotland, but data were available for two participants randomised
in England having some dental treatment in Scotland. Linkage was not possible for 48 participants in
England. A further participant had claims in both Scotland and England. For this individual, claims were
summed across both data sets, with the participant remaining allocated to their region of randomisation
for the purposes of reporting results.
Table 17 describes the total number of treatment claims provided to all randomised participants with
linked data over the 2.25-year follow-up period (excluding baseline and final study visits) by randomised
group. The majority of claims in England fell into band 1 treatments. There were relatively few emergency
claims and free treatments across all groups. The highest number of claims in Scotland was for diagnostic
assessments, including clinical examinations and radiographs. There were 2516 periodontal treatments
provided, accounting for 23% of claims. Among the remaining categories, the greatest number of
claims were for conservative treatments [2506 claims (23%)] such as fillings, with relatively few surgical
extractions or more intensive treatments. There were clear differences across groups in terms of numbers
of periodontal treatments reflecting the different number of PIs delivered in each randomised trial arm.
Overall, owing to the restrictions of the reimbursement system, there were only 11 claims for ‘preventative
care’ (including intensive hygiene instruction), all in the personalised OHA cluster. Detailed information on
items claimed in Scotland can be found in Appendix 2, Section 3: detailed claims for Scottish routine data.
Table 18 shows that the numbers of PIs delivered to all randomised participants with linked data were
evenly balanced across clusters. The mean number of reported PIs was lower in England than in Scotland.
It should be noted that the number of PIs in England may be under-reported as only one qualifying
procedure for a band 1 treatment needs to be reported when filling in the clinical data set (e.g. a
clinical examination).
NHS dental care costs
Table 19 presents complete-case NHS dental costs for the UK and at the regional level based on the
appropriate region-level unit costs applied to resource use data. Incremental differences are presented for
each randomised policy, compared with standard care.
The mean cost per trial participant over the 2.25-year follow-up period (excluding baseline and final
study visits) ranged from £62.42 to £85.43 across the randomised groups. The SDs are generally large,
suggesting relatively large variation in costs across participants. Data were somewhat skewed to the left,
with some outliers incurring very high costs; however, these were spread evenly across groups.
The average cost is lowest for the no-PI groups. However, none of the differences in mean cost between
standard care (routine OHA and 6-monthly PI) and the other policies considered was statistically significant
at a 5% level. The largest difference in costs is between standard care and a policy of no PI with
personalised OHA (mean difference –£14.91; 95% CI –£34.18 to £4.36).
Table 19 also reports the NHS costs by region. This is important given the differences in reimbursement
systems and the level of detail on resource use. Average per-participant costs are higher in England than
in Scotland. However, the overall results are the same across the two regions: there are no statistically
DOI: 10.3310/hta22380 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 38
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Ramsay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
57
TABLE 17 Number of treatment claims
Region
OHA, n
Overall total, n
Routine Personalised
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
Scotland (N = 192) (N = 193) (N = 195) (N = 580) (N = 250) (N = 255) (N = 252) (N = 757) (N = 1337)
Category of claima
Diagnosis 679 666 698 2043 873 894 912 2679 4722
Preventative care 0 0 0 0 7 4 0 11 11
Periodontal 268 343 530 1141 251 466 658 1375 2516
Conservative treatments 370 351 361 1082 462 495 467 1424 2506
Surgical treatments 59 86 62 207 83 98 69 250 457
Prostheses 28 36 19 83 39 63 54 156 239
Orthodontic 1 4 0 5 0 0 0 0 5
Other 53 55 72 180 67 110 85 262 442
Total 1458 1541 1742 4741 1782 2130 2245 6157 10,898
England (N = 79) (N = 80) (N = 88) (N = 247) (N = 77) (N = 77) (N = 76) (N = 230) (N = 477)
Band 1b 156 173 204 533 118 161 156 435 968
Band 2 74 75 62 211 52 66 63 181 392
Band 3 15 18 12 45 8 17 13 38 83
Band urgent 24 20 27 71 24 24 20 68 139
Free 1 1 0 2 0 6 0 6 8
Total 270 287 305 862 202 274 252 728 1590
SDR, Statement of Dental Remuneration (Scotland).
a Categories are taken from the respective sections of SDR. Examples include: diagnosis (e.g. examinations/films); preventative (e.g. intensive instruction preventative surface applications);
periodontal (e.g. PI); conservative treatments (e.g. fillings/restorations/inlays/crowns); surgical treatments (e.g. extractions); prostheses (e.g. dentures, including fitting, repair and
amendments); orthodontic treatments (including construction, repair); other (e.g. stoning or smoothing a tooth surface/treatment of sensitive cementum or dentine/urgent
treatment/prescriptions).
b Differences in UDAs across groups would not pick up differences in the number of PIs delivered that are likely to get masked by the banding system, which assigns the same band to a
check-up or a check-up plus PI.
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TABLE 18 Number of participants having PIa in the routine data setb
Region
OHA, n
Overall total, n
Routine Personalised
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
Scotland (N = 192) (N = 193) (N = 195) (N = 580) (N = 250) (N = 255) (N = 252) (N = 757) (N = 1337)
0 68 29 28 125 109 35 21 165 290
1 50 49 24 123 70 54 45 169 292
2 28 74 31 133 40 111 40 191 324
3 30 23 32 85 24 37 66 127 212
4 11 14 63 88 6 14 70 90 178
≥ 5c 5 4 17 26 1 4 10 15 41
Mean (SD) 1.4 (1.4) 1.8 (1.2) 2.7 (1.7) 2.0 (1.6) 1.0 (1.1) 1.8 (1.2) 2.6 (1.4) 1.8 (1.4) 1.9 (1.5)
England (N = 79) (N = 80) (N = 88) (N = 247) (N = 77) (N = 77) (N = 76) (N = 230) (N = 477)
0 40 20 25 85 44 27 20 91 176
1 28 16 18 62 16 15 17 48 110
2 7 35 14 56 9 22 12 43 99
3 1 7 10 18 7 4 13 24 42
4 1 2 9 12 0 8 8 16 28
≥ 5c 2 0 12 14 1 1 6 8 22
Mean (SD) 0.8 (1.1) 1.4 (1.0) 2.0 (1.9) 1.4 (1.5) 0.8 (1.2) 1.4 (1.4) 1.9 (1.6) 1.4 (1.5) 1.4 (1.5)
SDR, Statement of Dental Remuneration (Scotland).
a ‘PI’ refers to any claim for PI including simple PI (SDR item 10A); treatment of periodontal disease, including PI (SDR item 10B); and more intensive treatment over 3 visits, including deep
scaling (SDR item 10C).
b It should be noted that the number of PIs reported here refer to all participants with linked data, whereas Table 15 reports the number of PIs for participants attending the final clinic
visit. As such, these numbers should not be directly compared.
c The maximum number of PIs provided to any individual participant over the time frame (90 days to 2.5 years post baseline clinic examination) was nine.
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TABLE 19 NHS costs (£) of dental care
Region
OHA, n
Routine Personalised
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
UK (N = 271) (N = 273) (N = 283) (N = 827) (N = 327) (N = 332) (N = 328) (N = 987)
Total 73.23 118.04 81.37 141.64 73.75 104.78 76.10 122.16 62.42 116.13 85.43 131.62 82.84 134.19 76.94 127.87
Mean (95% CI) cost
difference vs. routine OHA
with 6-monthly PI
–3.12
(–18.18 to 11.93)
0.14
(–15.42 to 15.69)
– N/A –14.91
(–34.18 to –4.36)
11.67
(–11.00 to 34.33)
6.23
(–15.70 to 28.16)
N/A
Scotland (N = 192) (N = 193) (N = 195) (N = 580) (N = 250) (N = 255) (N = 252) (N = 757)
Diagnosis 24.27 10.43 24.30 11.08 24.88 12.36 24.49 11.31 23.24 10.83 23.93 11.90 25.46 11.10 24.21 11.31
Prevention 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 1.54 0.17 2.35 0.00 0.00 0.12 1.63
Periodontal 7.72 12.70 9.90 12.76 14.20 16.73 10.63 14.43 5.65 11.03 10.27 13.45 11.53 12.06 9.16 12.47
Conservative 23.40 55.90 22.66 46.77 25.15 61.25 23.74 54.90 25.54 77.32 33.53 86.20 32.02 97.44 30.39 87.35
Surgical 1.06 3.19 2.01 6.36 1.99 11.64 1.69 7.90 1.53 6.34 1.73 7.58 1.33 4.90 1.53 6.37
Prosthesis 5.04 34.19 7.34 37.11 4.87 32.32 5.75 34.55 3.49 23.70 7.65 33.28 7.09 32.13 6.09 30.05
Orthodontic 1.22 16.88 0.44 6.07 0.00 0.00 0.55 10.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other 0.95 3.30 0.68 2.24 1.02 3.33 0.88 3.00 1.58 14.61 1.49 6.32 1.38 5.95 1.49 9.77
Total 63.68 86.38 67.32 82.51 72.12 93.08 67.73 87.37 61.24 102.71 78.76 120.40 78.82 119.90 72.99 114.83
Mean (95% CI) cost
difference vs. routine OHA
with 6-monthly PI
–9.11
(–23.62 to 5.41)
–6.60
(–21.39 to 8.20)
– N/A –13.54
(–33.83 to 6.76)
5.45
(–17.37 to 28.28)
4.16
(–18.46 to 26.75)
N/A
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Region
OHA, n
Routine Personalised
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
England (N = 79) (N = 80) (N = 88) (N = 247) (N = 77) (N = 77) (N = 76) (N = 230)
Band 1 19.65 24.90 21.65 22.88 20.40 26.63 20.56 24.82 13.73 £17.37 22.41 24.49 20.11 19.73 18.74 20.98
Band 2 32.31 59.37 42.38 113.02 26.49 46.21 33.50 77.58 23.77 £41.97 36.37 78.65 35.51 57.62 31.87 61.31
Band 3 38.63 130.37 46.57 133.00 25.08 97.55 36.38 120.48 23.39 £111.83 39.70 114.59 35.96 123.45 33.00 116.40
Urgent 5.49 21.48 4.31 11.24 5.42 13.31 5.08 15.81 5.38 £15.13 6.10 15.23 4.58 10.82 5.35 13.84
Free 0.35 3.15 0.36 3.24 0.00 0.00 0.23 2.56 0.00 £0.00 1.84 9.61 0.00 0.00 0.62 5.61
Total 96.44 170.85 115.27 225.57 77.39 127.47 95.75 177.72 66.27 £152.54 106.41 162.10 96.16 173.67 89.59 163.14
Mean (95% CI) cost
difference vs. routine OHA
with 6-monthly PI
23.24
(–22.22 to 68.70)
22.09
(–23.63 to 67.80)
– N/A –17.67
(–62.30 to 26.95)
33.73
(–27.62 to 95.08)
13.87
(–40.83 to 68.60)
N/A
N/A, not applicable.
Note
NHS costs are based on the amount paid to the dentist for each participant, accounting for all exemptions. Cost model analysed using mixed-effects generalised linear model, gamma
family, link log with a random effect for centre. Models adjusted for cluster- and individual-level minimisation covariates, age, age2 and sex.
D
O
I:10.3310/hta22380
H
EA
LTH
TECH
N
O
LO
G
Y
A
SSESSM
EN
T
2018
VO
L.22
N
O
.38
©
Q
ueen
’s
Printer
and
C
ontroller
of
H
M
SO
2018.
This
w
ork
w
as
produced
by
Ram
say
et
al.
under
the
term
s
of
a
com
m
issioning
contract
issued
by
the
Secretary
of
State
for
H
ealth
and
SocialC
are.
This
issue
m
ay
be
freely
reproduced
for
the
purposes
of
private
research
and
study
and
extracts
(or
indeed,
the
fullreport)
m
ay
be
included
in
professional
journals
provided
that
suitable
acknow
ledgem
ent
is
m
ade
and
the
reproduction
is
not
associated
w
ith
any
form
of
advertising.
A
pplications
for
com
m
ercialreproduction
should
be
addressed
to:
N
IH
R
Journals
Library,
N
ationalInstitute
for
H
ealth
Research,
Evaluation,
Trials
and
Studies
C
oordinating
C
entre,
A
lpha
H
ouse,
U
niversity
of
Southam
pton
Science
Park,
Southam
pton
SO
16
7N
S,
U
K
.
61
significant differences in costs between standard care and the other five groups. The CIs for incremental
costs are generally wider for England, which is not surprising given the smaller sample sizes.
The Scottish data provide much more detail on resource use than the English data and can, therefore,
provide additional insights into differences in different cost categories. The costs of periodontal treatments
were expected to be lower for no PI and 12-monthly PI than for standard care, and this was found to
be the case. Mean cost differences of periodontal treatments in Scotland for each randomised group,
compared with routine OHA and 6-monthly PI were as follows: routine OHA, no PI, –£7.47 (95% CI
–£11.22 to –£3.72); routine OHA, 12-monthly PI, –£5.11 (95% CI –£8.96 to –£1.26); personalised OHA,
no PI, –£9.31 (95% CI –£13.30 to –£5.32); personalised OHA, 6-monthly PI –£2.00 (95% CI –£6.76 to
£2.75); and personalised OHA, 12-monthly PI, –£3.78 (95% CI –£8.29 to £0.73). There were no significant
differences across groups in any of the other categories of cost. Given the relatively low average NHS costs
of PI, the differences in PI costs did not lead to differences in the total costs.
Participant exemptions from NHS co-charges can have an impact on the split of dental charges between NHS
and participant. Therefore, it is important to explore whether or not there are differences in the proportion
of participants exempt across the randomised groups. Table 20 shows that around 24% of participants
were exempt from charges. There were no significant differences across randomised groups in terms of the
proportion of participants exempt from payment (χ2 6.82; p-value of 0.234). As a robustness check, we also
analysed the data assuming that all participants are exempt, that is, the NHS pays the full cost of dental care
provided. Relative to standard care, for this exploratory analysis, incremental costs were as follows: routine
OHA, no PI, –£4.76 (95% CI –£30.53 to £21.01); routine OHA, 12-monthly PI, –£1.89 (95% CI –£28.04 to
£24.27); personalised OHA, no PI, –£25.65 (95% CI –£53.15 to £1.85); personalised OHA, 12-monthly PI,
£10.95 (95 CI –£20.17 to £42.06); and personalised OHA, 6-monthly PI, £11.21 (95% CI –£19.97 to
£42.40). Furthermore, using similar regression models as for the main results, there was no evidence that
exemption status had an impact on the number of PIs delivered (p = 0.518). The main conclusion was the
same: there was no statistically significant difference in costs across the randomised groups.
Other NHS-incurred costs
The analysis protocol set out to measure costs to the NHS of primary and secondary care, based on annual
questionnaire data, for problems related to participants’ teeth. There were 193 out of 1630 (12%) participants
who reported at least one contact with secondary care services over the 3 years of follow-up. This relatively
high number of participants reporting secondary care use was unexpected given the relatively good dental
health of the trial population. A validation exercise was conducted by comparing secondary care contacts from
the trial with the general population using routine data and by checking self-report data against practice
records. In terms of the routine data, the average annual rate of outpatient consultations in the trial (1 : 19)
was six times greater than the corresponding number of consultations in the general population in Scotland
(1 : 121) and three times greater than the corresponding rate in England (1 : 70). A similar result was found
when inpatient admissions were compared, with an average annual rate among trial participants (1 : 70)
10 times higher than the general population in Scotland (1 : 722) and over three times higher than the general
population rate in England (1 : 249). It should be noted that the general population rates for England and
Scotland should not be directly compared as the data are based on different assumptions. For 80 out of the
193 trial participants reporting resource use (23 in England and 57 in Scotland), data were checked against
dental practice records for evidence of referral for secondary care treatment (across all hospitals, dental or
otherwise). Fewer than one in four reports were validated against practice records. Table 21 summarises the
results of the validation exercise.
Given the poor level of validation of other NHS resource use against routine data, the lack of evidence of
dental care referrals in practice records and the fact that the general population may be expected to have,
on average, poorer rather than better dental health, the data on use of NHS resources have been excluded
from the base-case analysis. Appendix 2, Section 4: participant-reported contact with non-dental health
services presents descriptive data for primary and secondary care resource use falling outside the dental
budget for information only. The data are excluded from all subsequently reported results.
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TABLE 20 Exemptions from NHS dental charges
Region
Proportion
charge to
participant
(%)
OHA, n (%)
Overall
total
Routine Personalised
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
UK (N = 271) (N = 273) (N = 283) (N = 827) (N = 327) (N = 332) (N = 328) (N = 987) (N = 1814)
Exempt Region-specific 62 (23) 68 (25) 81 (29) 211 (26) 71 (22) 88 (27) 70 (21) 229 (23) 440 (24)
Non-exempt 209 (77) 205 (75) 202 (71) 616 (74) 256 (78) 244 (73) 258 (79) 758 (77) 1374 (76)
Scotlanda (N = 192) (N = 193) (N = 195) (N = 580) (N = 250) (N = 255) (N = 252) (N = 757) (N = 1337)
Employment support
allowance
0 4 (2) 1 (1) 4 (2) 9 (2) 4 (2) 3 (1) 5 (2) 12 (2) 21 (2)
Pay full patient charge 100 152 (79) 141 (73) 134 (69) 427 (74) 193 (77) 186 (73) 201 (80) 580 (77) 1007 (75)
Help with health care Various 0 (0) 2 (1) 3 (2) 5 (1) 2 (1) 3 (1) 2 (1) 7 (1) 12 (1)
Income support 0 3 (2) 11 (6) 7 (4) 21 (4) 4 (2) 7 (3) 10 (4) 21 (3) 42 (3)
Jobseeker’s allowance 0 2 (1) 8 (4) 8 (4) 18 (3) 8 (3) 8 (3) 6 (2) 22 (3) 40 (3)
Maternity/newborn 0 7 (4) 3 (2) 3 (2) 13 (2) 7 (3) 9 (4) 5 (2) 21 (3) 34 (3)
Pension/tax credits 0 24 (13) 27 (14) 36 (18) 87 (15) 32 (13) 39 (15) 23 (9) 94 (12) 181 (14)
England (N = 79) (N = 80) (N = 88) (N = 247) (N = 77) (N = 77) (N = 76) (N = 230) (N = 477)
Child 0 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (1) 1 (1) 2 (1) 2 (0)
Exempt 0 22 (28) 16 (20) 20 (23) 58 (23) 14 (18) 18 (23) 18 (24) 50 (22) 108 (23)
Not exempt According to
band
57 (72) 64 (80) 68 (77) 189 (77) 63 (82) 58 (75) 57 (75) 178 (77) 367 (77)
a Note that exemptions are based on the most commonly reported exemption for each individual participant across the follow-up period. Initially, linked data in Scotland had a small
number of claims detailing exemptions for children. However, after checking with the trial database and identifying all participants as aged ≥ 18 years, these were superseded with the
full payment of charges for the participant.
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Participant-incurred costs
Participant charges for NHS dental care
Table 22 reports complete-case data on participant-incurred charges for NHS dental treatments,
provided to all randomised participants with linked routine data. The average charge to participants
over the 2.25-year follow-up period ranged from £48.95 to £61.33.
Opportunity costs of time and travel to dental appointments
Appendix 2, Section 5: unit opportunity cost of time and travel to dental appointments reports the
descriptive data used to calculate the unit opportunity costs of time and travel for trial participants attending
NHS dental appointments. Overall, 1308 out of 1873 (70%) participants completed the appropriate baseline
questions and had linked routine data on the number of visits to the dentist to enable a full calculation of
per-participant unit opportunity costs of attending dental appointments (for both participants and any
companions they took with them to the dentist). The average opportunity cost of time and travel for a single
dental visit ranged from £9.85 to £11.07 across groups. The average companion cost was much lower,
TABLE 21 Validation of the rates of other NHS secondary care resource use
Validation against routine
ISD data
Trial data
(UK)a
Trial data
(England)a
General
population rate
(England)b,c
Trial data
(Scotland)a
General population
rate (Scotland)c
Outpatients
Year 1 1 : 18 1 : 19 1 : 70b 1 : 15 1 : 121d
Year 2 1 : 18 1 : 18 1 : 17
Year 3 1 : 23 1 : 22 1 : 26
Average annual rate 1 : 19 1 : 20 1 : 19
Inpatients
Year 1 1 : 40 1 : 41 1 : 249b 1 : 39 1 : 722e
Year 2 1 : 42 1 : 46 1 : 35
Year 3 1 : 129 1 : 164 1 : 85
Average annual rate 1 : 70 1 : 84 1 : 53
Validation against practice
records
% with a referral
in practice notes
% with a referral
in practice notes
One or more contacts with
secondary care over 3 yearsf
1 : 10 1 : 11 3 : 23 (13) 1 : 10 16 : 57 (28)
a All trial data conservatively refer to ‘at least one consultation’ over 1 year (many will have had more than one).
b Data for general population in England were sourced from Hospital Episode Statistics data62,63 for outpatient and
inpatient consultations. Data conservatively assumes that all oral surgery procedures were related to dental care for the
purposes of the validation exercise. Note that general population routine data should not be compared across regions as
assumptions are unlikely to be directly comparable.
c An estimate of the adult (aged ≥ 18 years) populations of 4.5 million (Scotland) and 43.1 million (England) were used to
calculate general population rates.64
d Validation from ISD records (Scotland, 2015 data)44 for outpatient reports is based on nurse-led clinics (ISD R045;
n= 2450 consultations), allied health professionals (ISD R046; n= 9997 consultations) and consultant-led outpatients
(ISD R044; n= 24,606 patients). There is likely an overestimate as it assumes each new nurse-led clinic and allied health
professionals visit is for a new patient.
e Validation from ISD records (Scotland, 2015 data)44 for inpatient reports based on inpatient admissions (ISD R040;
n= 129 admissions) and day cases (ISD R042; n = 6104 admissions). There is likely an overestimate as it assumes each
admission was for a new patient.
f Validation against practice notes applies to referrals from the dental practice and any notes the practice may have of a
patient’s contact with secondary care services for dental-related problems. There may be rare cases in which the practice
was not aware of a patient’s attendance for secondary care services.
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TABLE 22 Participant-incurred co-charges (£) for dental carea
Region
OHA, co-charges (£)
Routine Personalised
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
UK (N = 271) (N = 273) (N = 283) (N = 827) (N = 327) (N = 332) (N = 328) (N = 987)
Total 59.96 80.16 53.94 68.50 60.97 70.65 58.32 73.21 48.95 67.12 60.64 99.87 61.33 77.92 56.99 82.95
Scotlandb,c (N = 192) (N = 193) (N = 195) (N = 580) (N = 250) (N = 255) (N = 252) (N = 757)
Diagnosis 3.15 4.69 2.35 3.25 2.73 3.54 2.74 3.88 3.47 4.31 3.34 6.09 2.95 4.07 3.25 4.91
Prevention 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.66 0.09 0.79 0.00 0.00 0.05 0.59
Periodontal 11.78 15.34 13.95 13.58 22.08 20.37 15.97 17.25 8.27 11.42 14.54 13.38 23.38 18.71 15.41 16.05
Conservative 30.41 55.62 23.07 38.94 26.23 50.89 26.56 48.99 30.27 59.32 31.92 76.69 25.65 55.99 29.29 64.67
Surgical 1.65 5.51 1.76 6.31 1.42 4.48 1.61 5.48 1.85 7.72 1.48 4.47 1.14 4.68 1.49 5.80
Prosthesis 4.33 22.77 1.19 9.70 1.06 8.47 2.19 15.12 3.32 18.41 5.55 26.21 5.14 27.99 4.68 24.57
Orthodontic 0.00 0.00 1.75 24.28 0.00 0.00 0.58 14.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other 0.57 2.34 1.00 2.78 0.76 2.51 0.77 2.55 0.70 2.00 0.98 2.79 1.19 4.53 0.96 3.29
Total 51.88 76.16 45.07 55.86 54.27 64.49 50.42 66.01 47.94 71.22 57.89 102.78 59.46 77.36 55.13 85.05
England (N = 79) (N = 80) (N = 88) (N = 247) (N = 77) (N = 77) (N = 76) (N = 230)
Treatment band 1 27.44 28.89 30.02 29.07 33.93 30.79 30.59 29.64 22.32 23.63 26.82 24.76 27.82 28.00 25.64 25.52
Treatment band 2 33.06 48.67 24.30 42.46 24.10 37.27 27.03 42.88 23.85 42.42 23.24 39.64 23.03 42.33 23.37 41.30
Treatment band 3 16.17 56.77 18.16 67.66 14.35 53.36 16.16 59.17 2.84 24.96 16.40 66.36 13.64 61.89 10.95 54.38
Urgent 2.93 9.67 2.87 8.15 3.44 9.34 3.09 9.05 3.20 6.82 2.52 7.96 3.05 9.35 2.92 8.08
Free 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total 79.61 86.53 75.34 88.97 75.82 81.12 76.88 85.13 52.20 51.85 68.97 89.20 67.54 79.97 62.88 75.40
SDR, Statement of Dental Remuneration (Scotland).
a Participant charges based on each individual’s exemption status.
b All costs are inflated to 2015 (SDR 130) values.
c No participants reached maximum treatment course charge (£384).
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TABLE 23 Participant-incurred costs (£)
Region
OHA, cost (£)
Routine Personalised
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
UK (N = 289) (N = 287) (N = 290) (N = 866) (N = 334) (N = 338) (N = 335) (N = 1007)
Private PI 5.75 20.59 5.67 23.10 12.04 34.56 7.83 26.94 4.23 20.88 7.71 26.23 9.18 24.51 7.04 24.06
Other private dental care 33.26 142.49 31.58 94.19 30.22 109.12 31.68 116.98 20.54 90.63 18.54 80.00 23.78 87.21 20.94 86.01
Electric toothbrushes 19.24 38.94 18.00 34.67 25.04 44.36 20.77 39.63 17.91 31.86 23.20 52.44 15.91 31.47 19.02 39.95
Manual toothbrushes 20.59 12.46 19.65 12.51 18.83 12.61 19.69 12.54 18.46 12.47 19.14 12.95 19.10 12.78 18.90 12.73
Interdental brushes 101.28 191.70 120.06 202.15 129.81 208.14 117.06 200.95 101.17 194.15 104.98 189.31 120.49 197.30 108.88 193.62
Electric toothbrush
(heads)
19.40 21.77 19.95 21.94 21.27 20.92 20.21 21.55 18.74 20.72 21.05 20.98 19.00 22.86 19.60 21.55
Participant NHS charges 60.30 80.75 54.72 69.17 61.44 71.10 58.83 73.84 49.00 67.19 60.49 99.50 61.20 77.76 56.92 82.76
Time and travel costs 43.55 51.33 47.31 57.12 46.44 48.35 45.77 52.36 34.57 36.17 42.75 56.46 44.36 50.95 40.57 48.81
Total participant costs 303.38 281.03 316.95 267.39 345.10 301.61 321.85 284.02 264.62 249.57 297.85 271.66 313.02 263.00 291.87 262.16
Mean (95% CI) cost
difference vs. routine
OHA with 6-monthly PIa
–39.80
(–83.94 to 4.33)
–23.48
(–70.00 to 23.04)
– N/A –64.11
(–112.33 to –15.88)
–16.64
(–68.28 to 35.00)
–30.28
(–81.59 to 21.03)
N/A
Scotland (N = 196) (N = 195) (N = 195) (N = 586) (N = 252) (N = 255) (N = 252) (N = 759)
Private PI 4.62 13.89 4.92 22.18 5.89 18.76 5.14 18.57 3.01 14.92 6.11 21.41 7.24 18.71 5.45 18.63
Other private dental care 30.41 135.64 30.89 95.63 22.06 78.27 27.79 105.95 16.03 60.77 15.17 69.50 22.72 87.20 17.96 73.32
Electric toothbrushes 15.96 30.60 16.96 34.88 25.30 42.44 19.40 36.49 18.01 32.95 19.03 35.54 15.40 29.86 17.49 32.88
Manual toothbrushes 20.23 12.04 20.18 12.15 19.02 12.55 19.81 12.24 18.87 12.24 18.77 12.74 19.62 12.76 19.08 12.58
Interdental brushes 79.08 170.38 97.77 182.56 107.58 192.33 94.78 182.11 99.52 193.14 93.75 177.23 107.55 185.92 100.25 185.41
Electric toothbrush
(heads)
18.01 21.53 17.26 20.62 20.99 20.70 18.75 21.00 17.81 20.24 20.44 20.85 17.98 21.98 18.75 21.05
Participant NHS charges 51.75 75.85 45.07 55.80 54.51 64.53 50.45 65.93 47.91 71.13 58.12 102.86 59.46 77.36 55.17 85.02
Time and travel costs 39.86 44.44 46.53 56.87 43.28 45.98 43.22 49.41 38.16 37.63 45.27 60.37 48.16 54.86 43.87 52.02
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Region
OHA, cost (£)
Routine Personalised
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Total participant cost 259.92 249.03 279.58 246.81 298.64 245.20 279.34 247.21 259.32 240.28 276.66 259.72 298.11 252.42 278.03 251.19
Mean (95% CI) cost
difference vs. routine
OHA with 6-monthly PIa
–44.10
(–93.67 to 5.47)
–24.78
(–77.38 to 27.81)
– N/A –41.13
(–93.09 to 10.82)
–27.65
(–80.89 to 25.60)
–3.78
(–59.28 to 51.72)
N/A
England (N = 93) (N = 92) (N = 95) (N = 280) (N = 82) (N = 83) (N = 83) (N = 248)
Private PI 8.14 30.15 7.28 24.96 24.68 51.98 13.47 38.47 8.00 32.90 12.62 37.05 15.06 36.41 11.91 35.51
Other private care 39.27 156.39 33.04 91.42 46.98 153.28 39.84 137.02 34.41 148.49 28.88 105.68 26.99 87.56 30.08 116.25
Electric toothbrushes 26.17 51.84 20.19 34.28 24.48 48.22 23.63 45.41 17.57 28.38 36.00 84.64 17.45 36.04 23.70 56.15
Manual toothbrushes 21.35 13.32 18.54 13.22 18.44 12.76 19.44 13.14 17.20 13.13 20.25 13.58 17.53 12.77 18.33 13.20
Interdental brushes 148.08 224.00 167.30 232.34 175.44 231.56 163.68 228.94 106.23 198.18 139.46 219.77 159.80 224.89 135.28 215.02
Electric toothbrush
(heads)
22.32 22.05 25.65 23.59 21.85 21.41 23.25 22.37 21.59 21.98 22.92 21.36 22.12 25.20 22.21 22.85
Participant NHS charges 78.32 87.89 75.17 88.16 75.68 81.50 76.39 85.61 52.37 53.53 67.79 88.56 66.51 79.17 62.26 75.34
Time and travel costs 51.34 62.90 48.98 57.86 52.93 52.46 51.10 57.75 23.53 28.69 35.01 41.47 32.83 34.26 30.49 35.48
Total participant costs 394.98 321.23 396.15 292.16 440.48 376.48 410.80 331.94 280.89 277.00 362.93 297.55 358.29 289.51 334.25 289.59
Mean (95% CI) cost
difference vs. routine
OHA with 6-monthly PIb
–25.41
(–113.77 to 62.95)
–14.18
(–109.65 to 81.29)
– N/A –125.59
(–219.85 to –31.33)
–20.18
(–132.27 to 91.91)
–43.81
(–148.79 to 61.16)
N/A
MEGLM, mixed-effects generalised linear model; N/A, not applicable.
a MEGLM analysis, gamma distribution, log link, with random effect for cluster and adjustment for cluster- and individual-level covariates, age and sex.
b MEGLM with gamma distribution, log link did not converge for the English data. Therefore, a mixed model with assumed normal distribution was used for English data with random
effect for cluster and adjustment for cluster- and individual-level covariates, age and sex.
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ranging from £0.85 to £1.35, because only a small proportion (≈15%) of participants were accompanied to
their dental appointment. The total number of visits to a dental practice for NHS care was between three
and four across the groups.
Other private dental care costs
Participant-reported costs for dental care items include the cost of toothbrushes, replacement heads,
interdental brushes and private dental care costs, including PI and other private care. Respondents in the
6-monthly PI group were more likely to self-report having private PI. However, as noted in Chapter 4,
this potentially reflects a misunderstanding of what constitutes private care. Furthermore, an assessment
of the validity of self-reported PI indicated a mismatch between self-reported data and routine information
on PIs. Therefore, there is the potential for double-counting of participant-incurred costs as NHS-provided
treatments may have been interpreted as private PIs in some cases. For this reason, the reader should
exercise caution when interpreting any differences in participant-reported private PI costs.
Twenty respondents reported exceptionally high cost values for ‘other private treatment’, > £1000
(maximum = £11,100) for private dental care in at least one annual questionnaire (some reported high-cost
items in more than one questionnaire). These high-cost items were unevenly spread across the randomised
groups (n = 4, 1, 5, 3, 5 and 2) and led to skewed distributions and potentially misleading mean estimates.
Such treatments included crowns, dentures and orthodontics. These high-cost items were verified with the
practice in 14 out of 22 (64%) cases, with the remainder having no record of private treatments at their
NHS practice. These high-cost items (> £1000 per year) were removed from the analysis given that there is
no feasible clinical link between these treatments and the provision of PI or OHA.
Total participant costs
Table 23 details all participant-incurred costs. Overall, charges for NHS care represented a small proportion
of total participant costs (< 20%), with the largest cost attributed to the purchase of interdental brushes.
Total participant costs ranged from £265 to £345 across the groups. No PI with personalised OHA was less
costly from the participant’s perspective (mean difference, compared with routine OHA and 6-monthly PI,
–£64.11, 95% CI –£112.33 to –£15.88). The between-group difference is driven primarily by differences in
the use of interdental brushes in England. There were no other significant differences between groups
from the participant perspective. Owing to missing data across specific questions in each of the three
annual participant questionnaires, participant costs are reported on the basis of multiple imputation of
missing cost component data (at the item and questionnaire level). Missing opportunity costs of time and
travel are imputed at the total cost level (number of visits multiplied by the calculated unit cost).
Benefits
Discrete choice experiment
Participant characteristics
The DCE was administered online and 667 respondents completed the full questionnaire. Each respondent
completed 10 choice tasks (after exclusion of dominance and consistency checks), leading to a total
of 20,010 observations in the data set. The average median survey completion time was 17 minutes
(interquartile range 13–24 minutes). Table 24 shows the characteristics of the DCE respondent sample.
Most respondents were from England, but there was over-representation of the general population in
Scotland to enable region-level subgroup analysis. In total, 67% of the sample never smoked. There was
an even spread across the sample regarding educational attainment and 77% of the sample were either in
paid work or retired. Overall, the majority of respondents reported that they were in fair or better general
health and dental health. A total of 37 (6%), 232 (35%) and 398 (60%) respondents completed the
worst, moderate and best segmented versions of the DCE, respectively.
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TABLE 24 Characteristics of DCE participants
Characteristic Mean SD
Age (years) 51 16
Number of participants (n= 667) % of total
Sex
Male 308 46.18
Female 359 53.82
Currently living in
England 482 72.26
Scotland 125 18.74
Wales 44 6.60
Northern Ireland 14 2.10
Isle of Man 2 0.30
Currently a smoker
Yes 98 14.69
No 447 67.02
Previously a smoker 122 18.29
Annual gross income (£)
< 20,800 247 37.03
20,800–41,600 211 31.63
≥ 41,600 119 17.84
Prefer not to answer/blank 90 13.49
Educational attainment
O levels/SVQ (level 1 or 2)/1 A level 183 27.44
≥ 2 A levels/SVQ (level 3) 101 15.14
Degree 164 24.59
Professional qualifications 81 12.14
Apprentice qualification 13 1.95
Vocational/foreign/other/none 125 18.74
Employment
Any paid employment 326 48.88
Unemployed or seeking work 24 3.60
Retired 185 27.74
Student 20 3.00
Other 112 16.79
continued
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Table 25 presents descriptive statistics detailing the DCE participants’ experience of dental care services.
Most respondents were registered with a dental practice. A range of methods of payment for dental care
were reported. A total of 62% of the sample had seen a dental hygienist in the past and 87% of the
sample had had a PI in the past, with 77% having one at least annually. Respondents in the sample had
more experience of contact with dental hygienists and having a PI than the general population: 47% had
experienced treatment from a hygienist and 80% had had a PI.11 Overall, the majority in the sample were
regular dental attenders (86%), defined as seeing the dentist every 2 years or more often. By comparison,
our sample had fewer regular attenders than the general population (the ADHS 200911 found that 71% of
respondents attend the dentist at least every 2 years). This may be due to an element of self-selection into
the DCE survey.
Results of analysis models
The results of the mixed logit model are presented in Table 26.
The positive value for the ASC indicates a preference among the general population to have any package
of dental care as opposed to none. The significance of the SD around the constant term indicates the
presence of significant preference heterogeneity for opting into a dental care package, with some
respondents more likely to opt out (choosing no dental care package). Across all choice sets, 288 (43%)
respondents always opted in to the choice task and 45 (7%) always opted out, choosing no dental
care package.
Respondents valued having both personalised OHA and PI regardless of provider. They preferred to receive
personalised OHA and 12-monthly PI from the dentist. However, who provided the care was less important
for the 6-monthly PI. As expected, respondents prefer to have gums that do not bleed and teeth that look
and feel clean. The negative coefficient on the annual cost attribute indicates that respondents prefer
dental packages that cost less.
Willingness-to-pay estimates, together with their CIs, should be interpreted as the general population’s
valuation of each attribute and level. The differences between WTP values indicate how much the general
population values moving from one health-care package to another. For example, the general population
would be willing to pay an additional £90.53 per year over 3 years to move from having bleeding gums
TABLE 24 Characteristics of DCE participants (continued )
Number of participants (n= 667) % of total
Self-reported dental health
Very poor 6 0.90
Poor 28 4.20
Fair 200 29.99
Good 315 47.23
Very good 118 17.69
Self-reported general health
Very poor 10 1.50
Poor 47 7.05
Fair 169 25.34
Good 343 51.42
Very good 98 14.69
A level, advanced level; O level, ordinary level; SVQ, Scottish Vocational Qualification.
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very often (very often: –£54.13) to never having bleeding gums (never: £36.40). They would be willing to
pay £145.50 per year to move from having teeth that look and feel very unclean to teeth that look and
feel very clean. The difference between these valuations indicates that the general population attaches a
greater value to shifts in average aesthetic outcome than to changes in frequency of bleeding 3 years after
signing up to the dental package.
The WTP estimates can thus be used to calculate the general population’s WTP for packages of dental
care. Assuming that a participant in the trial received no OHA/6-monthly PI from the dentist, hardly ever
had bleeding gums at the final annual questionnaire and had teeth that, on average over the period,
looked and felt moderately clean, the general population would be willing to pay £93.93 per year for this
package (i.e. £43.95 – £13.50 + £29.83 + £20.55 + £13.10). Following a similar approach, the results of
the DCE are mapped to each individual to enable a CBA to be completed alongside the trial.
TABLE 25 Participant dental care experience
Characteristic Number of participants % of total
Registered with a dental practice
Yes 636 95.35
No 26 3.90
Do not know 5 0.75
Normally pay for dental care
Co-charge 307 46.03
NHS pays all cost 127 19.04
Private: pay full cost 143 21.44
Dental treatment plan 65 9.75
Dental insurance 12 1.80
Never had dental care 6 0.90
Do not know 7 1.05
Ever been to visit a dental hygienist
Yes 414 62.07
No 213 31.93
Do not know 40 6.00
Normally have a PI
> every 3 months 10 1.52
Every 3 months 65 9.89
Every 6 months 309 47.03
Every year 121 18.42
Every 2 years 22 3.35
< every 2 years 46 7.00
Never 84 12.79
Regular attendancea
Attends at least every 2 years 570 85.84
Attends less often 94 14.16
a Three respondents had missing data on this question.
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TABLE 26 Results from general population DCE: mixed logit model
Attribute/level
Model
estimates
WTP (£)
Mean WTP
compared with
mean attribute level 95% CI
Mean WTP
compared with
reference level
No OHAa –0.143*** –13.50 –18.56 to –8.45 –
Personalised OHA from dentist 0.122*** 11.50 6.61 to 16.39 25.00
Personalised OHA from
hygienist
0.021 2.00 –2.89 to 6.90 15.50
No PIa –0.721*** –68.24b –76.52 to –59.96 –
12-month PI from dentist 0.194*** 18.31b 10.68 to 25.93 86.55
12-month PI from hygienist –0.067* –6.32b –13.63 to 0.98 61.92
6-month PI from dentist 0.315*** 29.83b 22.23 to 37.43 98.07
6-month PI from hygienist 0.279*** 26.43b 19.21 to 33.65 94.67
Bleeding gums
Nevera 0.385*** 36.40 26.82 to 45.98 –
Hardly ever 0.307*** 29.03 20.55 to 37.52 –7.37
Occasionally –0.046 –4.40 –11.40 to 2.61 –40.80
Fairly often –0.073 –6.90 –16.61 to 2.80 –43.30
Very often –0.572*** –54.13 –73.37 to –34.90 –90.53
Teeth look and feel
Very unclean –0.899*** –85.03 –104.55 to –65.52 –
Unclean –0.393*** –37.12 –47.24 to –27.01 47.91
Moderately clean 0.139*** 13.10 5.97 to 20.23 98.13
Clean 0.514*** 48.59 39.91 to 57.26 133.62
Very cleana 0.639*** 60.47 50.76 to 70.18 145.50
Annual cost –0.011*** – – –
ASC
Mean 0.465*** 43.95 29.49 to 58.41 –86.42c
SD 1.470***
Log likelihood –5174.58
Number of observations 20,010
Number of respondents 667
AIC 10,383
BIC 10,518
*p< 0.1, **p< 0.05, ***p < 0.01.
AIC, Akaike information criterion; BIC, Bayesian information criterion.
a Indicates reference level.
b The WTP tariffs given for no PI, 12-monthly PI and 6-monthly PI can also be interpreted as 0, 3 and 6 PIs over a 3-year
period. Following the step-wise linear calculation of intervening PIs outlined in Chapter 3, WTP tariffs for 0–9 PI provided
by the dentist are –£68.24, –£39.39, –£10.54, £18.31, £22.15, £25.99, £29.83, £33.67, £37.51 and £41.35,
respectively. WTP tariffs for 0–9 PI provided by the hygienist are –£68.24, –£47.60, –£26.96, –£6.32, £4.59, £15.51,
£26.43, £37.35, £48.26 and £59.18, respectively.
c The WTP for package with all attributes at reference level.
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Validity of responses
The estimates of annual WTP for PI (relative to none) fall within a feasible range of prices charged in the
private market for PI (i.e. between £49 and £86 per PI provided by the dentist). In terms of the internal
validity checks, 535 (80%) respondents passed the consistency of preferences check (i.e. answering the
same way for exactly the same choice twice). A total of 498 (75%) respondents passed the non-satiation
(dominance) test. Very few respondents failed both tests (≈5%). The high percentage passing such tests is
in line with other DCE studies.65
Analysis of subgroups
Subgroup analyses were conducted for participant characteristics by sex, region and income, as well
as experience of PI and dental hygienists. Table 27 describes the impact of subgroup membership on
preferences, through interaction terms between effects coded categorical variables and attribute-level
main effects. Subgroup effects were considered significant at a p-value of < 0.01.
The likelihood ratio tests show no overall effect on preferences (jointly across all model parameters) for
UK region or smoking status. For subgroups for which the tests indicated an impact of subgroup on
preferences, the following findings were observed:
l Respondents with experience of the hygienist valued the dental care packages more highly (disutility
associated with cost attribute was lower). They also gained less utility from teeth that look and feel
only moderately clean.
l The significant interaction effect on the ASC with experience of PI indicates that those with experience
of PI are more likely to commit to a dental care package. They also valued the dental care packages
more highly.
l Neither experience of seeing the dental hygienist or of having PI affected the preferences of respondents
for having these services, or for whether it is the dentist or hygienist who provides the service.
l Females in the sample gained greater utility from dental care packages in which teeth look and feel
clean or very clean. Similarly, they experienced greater disutility from teeth that look and feel
moderately clean or unclean.
l As expected, the cost attribute had less of an impact on the preferences of higher-income respondents.
The subgroup analyses indicate that, although there were some differences across subgroups, in general,
the direction of attribute-level effect remained similar with respondents preferring PI and personalised
OHA, less bleeding and teeth that look and feel clean and healthy, as well as preferring lower-cost dental
care packages.
Benefits: willingness to pay
Table 28 presents the mean WTP values across randomised groups, including the component parts of total
WTP based on the mapping of DCE results to treatment received and trial outcomes. The average total
benefits in terms of WTP ranged from £79.09 to £207.65 across the groups. The policy of 6-monthly PI
and personalised OHA is associated with the highest average benefit. The difference in benefits between
this policy and standard care (routine OHA and 6-monthly PI) is statistically significant. Compared with
standard care, having no PI or a 12-monthly PI and routine OHA is associated with significantly lower
benefits. There was no significant difference between the benefits for personalised OHA with either
12-monthly PI or no PI and standard care, implying that a reduction in PI can be compensated for by the
provision of personalised OHA. The findings were consistent across regions. The average benefit was
generally lower in England, as PIs were more likely to be provided by hygienists in England than in
Scotland (following the assumption that the provider of baseline OHA/PI would consistently provide the
trial intervention over follow-up).
The differences in benefits observed between groups were driven primarily by the differences in WTP for PI
and personalised OHA. For example, the 6-monthly PI with routine OHA had a higher WTP (–£27.43)
associated with PIs than no PI with routine OHA (–£82.92), a difference of £55.49. Note that the negative
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TABLE 27 Analysis of DCE subgroups
Attribute levels Base case Hygienist experiencea Region (Scotland)b Sex (f)c Income (> £20,800)d Smoker (ever)e Experience of PIf
Main effects
Personalised OHA from dentist 0.122*** 0.133*** 0.143*** 0.124*** 0.121*** 0.140*** 0.144***
Personalised OHA from hygienist 0.021 0.016 0.027 0.019 0.022 0.011 –0.027
12-monthly PI from dentist 0.194*** 0.199*** 0.232*** 0.194*** 0.193*** 0.208*** 0.170***
12-monthly PI from hygienist –0.067* –0.065 –0.089* –0.071* –0.065* –0.100** –0.171***
6-monthly PI from dentist 0.315*** 0.309*** 0.316*** 0.323*** 0.315*** 0.319*** 0.280***
6-monthly PI from hygienist 0.279*** 0.274*** 0.281*** 0.283*** 0.277*** 0.294*** 0.261***
Bleeding gums
Hardly ever 0.307*** 0.313*** 0.337*** 0.303*** 0.312*** 0.301*** 0.280***
Occasionally –0.046 –0.032 –0.094** –0.055 –0.043 –0.053 –0.143**
Fairly often –0.073 –0.058 –0.012 –0.073 –0.084 –0.055 –0.057
Very often –0.572*** –0.599*** –0.591*** –0.556*** –0.573*** –0.608*** –0.429**
Teeth look and feel
Very unclean –0.899*** –0.989*** –0.887*** –0.845*** –0.868*** –0.901*** –0.719***
Unclean –0.393*** –0.368*** –0.308*** –0.392*** –0.400*** –0.398*** –0.311***
Moderately clean 0.139*** 0.183*** 0.109** 0.120*** 0.134*** 0.138*** 0.049
Clean 0.514*** 0.497*** 0.448*** 0.494*** 0.508*** 0.506*** 0.402***
Annual cost –0.011*** –0.011*** –0.011*** –0.011*** –0.011*** –0.011*** –0.012***
ASC
Mean 0.465*** 0.402*** 0.448*** 0.459*** 0.472*** 0.417*** 0.239**
SD 1.470*** 1.435*** 1.476*** 1.473*** 1.459*** 1.464*** 1.420***
Interaction terms for subgroup with main attribute level effects
Personalised OHA from dentist –0.034 0.032 0.011 –0.018 0.044 –0.023
Personalised OHA from hygienist 0.017 0.010 0.022 0.021 –0.028 0.058
12-monthly PI from dentist –0.007 0.062 –0.021 –0.009 0.036 0.030
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Attribute levels Base case Hygienist experiencea Region (Scotland)b Sex (f)c Income (> £20,800)d Smoker (ever)e Experience of PIf
12-monthly PI from hygienist 0.013 –0.032 0.027 –0.025 –0.082* 0.130**
6-monthly PI from dentist 0.020 –0.001 0.103** 0.053 0.012 0.055
6-monthly PI from hygienist 0.001 –0.004 0.071* 0.069* 0.033 0.025
Bleeding gums
Hardly ever –0.022 0.045 0.069 0.098** –0.018 0.033
Occasionally –0.046 –0.075* 0.004 0.076** –0.018 0.110
Fairly often –0.036 0.094 –0.080 –0.059 0.057 –0.026
Very often 0.057 –0.024 –0.075 –0.204** –0.083 –0.160
Teeth look and feel
Very unclean 0.187 0.028 –0.334*** 0.117 –0.004 –0.213
Unclean –0.077 0.124* –0.216*** –0.067 –0.003 –0.106
Moderately clean –0.111*** –0.047 0.160*** –0.047 –0.004 0.104
Clean 0.070 –0.102* 0.177*** –0.014 –0.020 0.140*
Annual cost 0.002*** 0.000 –0.002*** 0.001*** –0.001** 0.002***
ASC (mean) 0.307*** –0.024 –0.064 0.081 –0.134* 0.320***
Likelihood ratio test
Likelihood ratio 2176 2068 2177 2163 2132 2148 2025
χ2 (df= 16) 86.44 16.82 93.27 42.23 20.02 81.19
p-value 0.0000 0.3976 0.0000 0.0004 0.2195 0.0000
*p< 0.1, **p< 0.05, ***p< 0.01.
df, degrees of freedom; f, female.
a Experience of hygienist (1 = ever visited a hygienist; –1= never visited).
b Region (1 = Scotland; –1 = rest of the UK).
c Sex (1 = female; –1=male).
d Income (1 =moderate/high income reported, ≥ £20,800 per year; –1= low income <£20,800 per year).
e Smoker (1= current or previous smoker; –1= never smoked).
f Experience of PI (1 = ever had a PI; –1 = never had a PI).
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TABLE 28 Benefits
Region
OHA, WTP (£)
Routine OHA Personalised OHA
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
UK (N = 289) (N = 287) (N = 290) (N = 866) (N = 334) (N = 338) (N = 335) (N = 1007)
Constant 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00
OHA –30.38 0.00 –30.38 0.00 –30.38 0.00 –30.38 0.00 19.80 9.66 19.99 9.56 19.88 9.62 19.89 9.60
PI –82.92 70.59 –56.55 60.80 –27.43 76.87 –55.60 73.29 –93.73 63.83 –51.77 61.96 –21.60 70.98 –55.65 71.97
Bleeding 30.02 45.86 35.28 41.60 29.98 47.63 31.74 45.15 33.86 45.78 33.48 42.39 35.25 44.17 34.19 44.10
Look and feel 63.12 61.06 67.05 59.84 75.61 58.32 68.60 59.96 69.52 61.83 66.69 62.00 75.24 58.34 70.47 60.84
Total WTP 79.09 97.68 114.25 95.04 146.46 104.91 113.30 103.01 128.46 104.80 167.28 95.92 207.65 116.31 167.87 110.72
Mean (95% CI) benefit
difference vs. routine
OHA with 6-monthly PI
–67.65
(–86.50 to –48.81)
–30.75
(–48.65 to –12.85)
– N/A –17.72
(–39.37 to 3.93)
19.70
(–1.64 to 41.04)
61.67
(40.19 to 83.14)
N/A
Scotland (N = 196) (N = 195) (N = 195) (N = 586) (N = 252) (N = 255) (N = 252) (N = 759)
Constant 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00
OHA –£30.38 0.00 –30.38 0.00 –30.38 0.00 –30.38 0.00 23.16 7.13 23.03 7.28 23.25 7.03 23.14 7.14
PI –69.16 74.79 –45.71 61.52 –9.42 72.91 –41.47 74.08 –89.21 64.70 –42.46 58.52 –8.77 66.05 –46.80 71.16
Bleeding 24.97 45.56 31.52 43.20 26.13 49.98 27.52 46.37 34.40 45.06 31.86 41.91 35.07 45.42 33.77 44.13
Look and feel 62.85 60.67 65.45 61.41 73.63 £59.80 67.31 60.76 69.88 63.25 66.36 61.97 75.74 56.53 70.64 60.76
Total WTP 87.75 101.92 119.81 99.26 158.86 106.56 122.15 106.57 137.12 105.57 177.67 93.15 224.17 112.50 179.65 109.82
Mean (95% CI) benefit
difference vs. routine
OHA with 6-monthly PI
–71.63
(–94.39 to –48.86)
–39.09
(–61.03 to –17.14)
– N/A –22.58
(–45.90 to 0.74)
14.31
(–8.62 to 37.24)
64.09
(40.95 to 87.22)
N/A
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Region
OHA, WTP (£)
Routine OHA Personalised OHA
No PI 12-monthly PI 6-monthly PI Total No PI 12-monthly PI 6-monthly PI Total
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
England (N = 93) (N = 92) (N = 95) (N = 280) (N = 82) (N = 83) (N = 83) (N = 248)
Constant 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00 98.89 0.00
OHA –30.38 0.00 –30.38 0.00 –30.38 0.00 –30.38 0.00 9.45 9.07 10.68 9.75 9.65 9.20 9.93 9.32
PI –111.93 49.83 –79.52 52.57 –64.42 71.67 –85.16 62.04 –107.61 59.31 –80.38 63.77 –60.55 71.58 –82.75 67.67
Bleeding 40.66 44.84 43.15 36.97 37.89 41.45 40.54 41.17 32.17 48.04 38.46 43.62 35.79 40.34 35.49 44.05
Look and feel 63.67 62.04 70.44 56.33 79.71 55.07 71.31 58.18 68.40 57.29 67.71 62.17 73.72 63.75 69.96 61.13
Total WTP 60.92 85.69 102.59 84.67 120.74 96.88 94.81 92.56 101.50 97.95 135.36 97.61 157.50 113.78 131.70 105.67
Mean (95% CI) benefit
difference vs. routine
OHA with 6-monthly PI
–59.82
(–89.86 to –29.78)
–15.06
(–44.61 to 14.48)
N/A –12.45
(–51.68 to 26.79)
25.39
(–13.44 to 64.21)
45.46
(6.08 to 84.86)
N/A
N/A, not applicable.
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mean WTPs for PI across all groups are due to the relatively few PIs provided across all groups, and the use
of effects coding in which WTP values are estimated relative to the mean of the attribute. In terms of
interpretation, the focus should therefore be on differences in WTP for PI across groups. Similarly, for
example, 6-monthly PI with personalised OHA had a higher WTP for the OHA component (£19.88) than
did 6-monthly PI with routine OHA (–£30.38), an additional WTP of £50.26 for the OHA provided in the
personalised group. There were some differences in benefits across regions, driven by the provider of care
(more treatments assumed to be provided by hygienists in England than in Scotland). The differences
across groups appear to be driven mainly by the services provided rather than the bleeding or aesthetic
outcomes. This observation matches the findings reported in the clinical effectiveness chapters.
Cost–benefit analysis
Base-case analysis: NHS perspective
The CBA reports incremental net benefits (incremental benefits – incremental costs) for each policy, compared
with standard care (routine OHA, with 6-monthly PI). Table 29 shows results from the base-case NHS dental
health-care cost perspective. The average incremental net benefit ranged from –£69 to £48 across the groups.
For the base-case analysis, personalised OHA with 6-monthly PI is associated with the highest positive
incremental net benefit compared with standard care and the difference is statistically significant. Therefore,
this is the preferred option from a welfare-maximising perspective. The only other policy that is associated
with positive incremental net benefits is personalised OHA with 12-monthly PI, although it should be noted
that the difference in net benefits between this policy and routine care is not statistically significant.
Confidence ellipses on the cost-effectiveness plane for each comparison are reported in Appendix 2 and
show that personalised OHA with 6-monthly PI has a high probability of generating a positive incremental net
benefit (i.e. with plots to the right of the diagonal line on the cost–benefit plane). Routine OHA with either
no PI or 12-monthly PI is associated with negative incremental net benefits compared with standard care,
and the differences in net benefits are statistically significant. Figure 19, Appendix 2 shows that there is more
uncertainty surrounding the incremental net benefits associated with personalised OHA (no PI or 12-monthly
PI) relative to routine OHA (6-monthly PI), with confidence ellipses crossing the diagonal.
The main conclusion is consistent across regions, although the difference in positive incremental net
benefits for personalised OHA and 6-monthly PI is not statistically significant for England. This may be
caused by the relatively smaller sample in England.
Wider perspective cost–benefit analysis
Table 30 presents the CBA results using the NHS and participant perspectives for costs. The preferred
policy option is the same as in the base-case analysis, namely personalised OHA with 6-monthly PI. The
incremental net benefit is higher than in the base-case analysis (£68 vs. £48). Note that the CI is much
wider, reflecting the relatively large variation in participant costs. The preferred policy varies across regions
when using the wider perspective. For England, personalised OHA with no PI generates the largest
incremental net benefit. This result is driven by the lower cost of this policy compared with standard care.
As noted in Total participant costs, this appears to be driven mainly by the lower costs of interdental
brushes. The extent to which this can be attributable directly to the intervention is questionable.
Furthermore, conclusions about participant-reported costs should be interpreted in the light of concerns
about double-counting of private/NHS PI.
This result may have also caused the second preferred policy for the UK as a whole to be different from
the base-case analysis. The second preferred policy for the base-case analysis was personalised OHA with
12-monthly PI (incremental net benefit of £3) while the second preferred policy when taking the wider
perspective was personalised OHA with no PI (incremental net benefit of £58).
RESULTS OF ECONOMIC ANALYSIS
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TABLE 29 Cost–benefit analysis results: base case – NHS dental perspective costs (£)a
Region
Mean (SD)
costs
Mean difference
in costsb (95% CI)
vs. routine OHA
(6-monthly PI)
Mean (SD)
benefits
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI)
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI)
UK
Routine OHA
6-monthly PI (n = 289) 74 (106) – 146 (105) – –
No PI (n = 288) 75 (122) 2 (–19 to 22) 79 (98) –67 (–86 to –48) –69 (–97 to –41)
12-monthly PI (n= 285) 81 (140) 8 (–12 to 29) 114 (95) –30 (–48 to –12) –38 (–65 to –12)
Personalised OHA
No PI (n = 333) 62 (116) –6 (–28 to 16) 128 (105) –17 (–38 to 4) –11 (–37 to 15)
12-monthly PI (n= 338) 86 (133) 18 (–4 to 40) 167 (96) 21 (0 to 42) 3 (–23 to 29)
6-monthly PI (n = 335) 83 (134) 15 (–8 to 37) 208 (116) 63 (42 to 84) 48 (22 to 74)
Scotland
Routine OHA
6-monthly PI (n = 195) 72 (93) – 159 (107) – –
No PI (n = 195) 64 (87) –9 (–28 to 11) 88 (102) –71 (–94 to –48) –63 (–92 to –34)
12-monthly PI (n= 193) 67 (83) –4 (–23 to 16) 120 (99) –39 (–61 to –17) –35 (–64 to –6)
Personalised OHA
No PI (n = 252) 61 (103) –5 (–28 to 18) 137 (106) –23 (–49 to 3) –18 (–46 to 10)
12-monthly PI (n= 255) 80 (121) 12 (–11 to 35) 178 (93) 14 (–11 to 40) 2 (–25 to 29)
6-monthly PI (n = 252) 79 (120) 12 (–11 to 35) 224 (112) 64 (38 to 89) 52 (24 to 79)
England
Routine OHA
6-monthly PI (n = 94) 79 (129) – 121 (97) – –
No PI (n = 93) 99 (172) 25 (–25 to 74) 61 (86) –59 (–90 to –29) –84 (–143 to –25)
12-monthly PI (n= 92) 111 (214) 32 (–17 to 81) 103 (85) –15 (–44 to 15) –47 (–104 to 11)
Personalised OHA
No PI (n = 81) 65 (149) –13 (–68 to 43) 102 (98) –10 (–49 to 29) 3 (–57 to 62)
12-monthly PI (n= 83) 107 (161) 31 (–25 to 87) 135 (98) 28 (–11 to 66) –3 (–62 to 56)
6-monthly PI (n = 83) 95 (169) 19 (–37 to 74) 157 (114) 48 (9 to 87) 29 (–30 to 89)
a Costs and benefits rounded to the nearest whole pound.
b Note that mean difference in costs presented here are based on imputed data, accounting for correlation in costs and
benefits, and, therefore, cannot be directly compared with Table 19.
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Sensitivity analysis results
Table 31 reports the incremental net benefit results for a range of sensitivity analyses. All sensitivity analyses
were conducted using NHS-perspective dental care costs. Further details of mean and incremental costs and
benefits are presented for each analysis in Appendix 2, Section 6: detailed results of further health economics
analyses, at a regional and UK level. Overall, the conclusions of our analyses remain robust to the range of
sensitivity analyses undertaken. In all cases, a policy of personalised OHA with 6-monthly PI was associated
with the greatest incremental net benefit relative to standard care. This was statistically significant for all
scenarios except those for which an additional charge was included for personalised OHA. This analysis was
conducted to reflect the likely opportunity cost of time spent delivering personalised OHA if it were to be
rolled out as a policy. However, under current reimbursement structures, such a charge is unlikely to be
directly incurred by the NHS. In all cases, routine OHA with no PI was associated with the lowest incremental
net benefit relative to standard care. It should be noted that, across all sensitivity analyses, the results were
driven by high estimates of WTP for PI in particular. Therefore, our results and conclusions are most
applicable to decision-makers wishing to maximise societal welfare.
TABLE 30 Cost–benefit analysis results: NHS and participant perspective costs (£)a
Region
Mean (SD)
costs
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI)
Mean (SD)
benefits
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI)
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI)
UK
Routine OHA
6-monthly PI (n = 289) 420 (323) – 146 (105) – –
No PI (n= 288) 378 (312) –41 (–93 to 11) 79 (98) –68 (–86 to –49) –26 (–81 to 28)
12-monthly PI (n = 285) 398 (302) –17 (–69 to 36) 114 (95) –31 (–49 to –13) –14 (–70 to 42)
Personalised OHA
No PI (n= 333) 327 (279) –75 (–126 to –25) 128 (105) –17 (–39 to £4) 58 (7 to 110)
12-monthly PI (n = 338) 384 (302) –21 (–73 to 30) 167 (96) 20 (–1 to 41) 41 (–11 to 94)
6-monthly PI (n = 335) 396 (295) –6 (–57 to 46) 208 (116) 62 (41 to 83) 68 (15 to 120)
Scotland
Routine OHA
6-monthly PI (n = 195) 371 (257) – 159 (107) – –
No PI (n= 195) 323 (264) –49 (–106 to 8) 88 (102) –72 (–94 to –49) –23 (–83 to 37)
12-monthly PI (n = 195) 347 (255) –25 (–83 to 33) 120 (99) –39 (–61 to –17) –14 (–75 to 47)
Personalised OHA
No PI (n= 252) 320 (266) –41 (–96 to 14) 137 (106) –22 (–47 to 2) 18 (–38 to 74)
12-monthly PI (n = 255) 356 (291) –13 (–68 to 42) 178 (93) 14 (–10 to 38) 27 (–29 to 84)
6-monthly PI (n = 252) 377 (284) 15 (–40 to 70) 224 (112) 64 (40 to 88) 49 (–7 to 105)
England
Routine OHA
6-monthly PI (n = 94) 520 (411) – 121 (97) – –
No PI (n= 93) 494 (371) –20 (–125 to 86) 61 (86) –60 (–90 to –29) –40 (–148 to 68)
12-monthly PI (n = 92) 507 (360) 6 (–102 to 115) 103 (85) –15 (–45 to 15) –21 (–131 to 89)
Personalised OHA
No PI (n= 81) 346 (319) –154 (–265 to –43) 102 (98) –12 (–52 to 28) 142 (31 to 253)
12-monthly PI (n = 83) 469 (320) –14 (–129 to 100) 135 (98) 26 (–14 to 66) 40 (–73 to 153)
6-monthly PI (n = 83) 453 (322) –40 (–153 to 72) 157 (114) 46 (5 to 86) 86 (–27 to 200)
a Costs and benefits rounded to the nearest whole £.
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Cost–consequences analysis
The balance sheet of costs and outcomes outlined in Table 32 narratively summarises the advantages and
disadvantages of the different policy considerations within a cost–consequences framework. The analysis
makes no attempt to conduct any further quantitative synthesis of economic findings.
TABLE 31 Main sensitivity analysis results
Policy
Incremental net benefits (95% CI) (£) vs. routine OHA (6-monthly PI)
Base-case
analysis
Including
baseline and
final visits
Discounting at
0%
Discounting at
6%
Assuming all
PI and OHA
delivered by
dentist
Assuming all
PI and OHA
delivered by
hygienist
Routine OHA
6-monthly PI
(n= 289)
– – – – – –
No PI
(n= 288)
–69 (–97 to –41) –68 (–103 to –33) –70 (–99 to –42) –67 (–93 to –40) –70 (–98 to –43) –61 (–88 to –34)
12-monthly
PI (n= 285)
–38 (–65 to –12) –33 (–67 to 1) –40 (–68 to –12) –38 (–65 to –11) –37 (–65 to –10) –37 (–64 to –10)
Personalised OHA
No PI
(n= 333)
–11 (–37 to 15) 9 (–24 to 42) –13 (–40 to 15) –10 (–36 to 15) –8 (–34 to 19) –18 (–44 to 8)
12-monthly
PI (n= 338)
3 (–23 to 29) 25 (–8 to 57) 1 (–26 to 28) 4 (–22 to 29) 8 (–18 to 35) –13 (–39 to 13)
6-monthly PI
(n= 335)
48 (22 to 74) 69 (36 to 102) 49 (21 to 76) 47 (22 to 73) 55 (28 to 82) 29 (2 to 55)
Policy
Incremental net benefits (95% CI) (£) vs. routine OHA (6-monthly PI)
Base-case
analysis
Additional cost
for
personalised
OHA
Decreasing
the unit price
of a UDA
(–20%)
Increasing the
unit price of a
UDA (+20%)
Alternative mapping of
aesthetic outcome from the DCE
Routine OHA
6-monthly PI
(n= 289)
– – – – –
No PI
(n= 288)
–69 (–97 to –41) –68 (–101 to –36) –66 (–91 to –40) –68 (–97 to –39) –64 (–89 to –39)
12-monthly
PI (n= 285)
–38 (–65 to –12) –39 (–70 to –7) –36 (–61 to –10) –40 (–69 to –10) –37 (–61 to –12)
Personalised OHA
No PI
(n= 333)
–11 (–37 to 15) –54 (–104 to –4) –12 (–37 to 13) –9 (–38 to 19) –5 (–29 to 18)
12-monthly
PI (n= 338)
3 (–23 to 29) –48 (–100 to 5) 3 (–21 to 28) 2 (–27 to 30) 7 (–16 to 31)
6-monthly PI
(n= 335)
48 (22 to 74) 28 (–15 to 70) 49 (23 to 74) 48 (20 to 77) 44 (20 to 68)
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TABLE 32 Cost–consequences analysis: narrative summary
Policy Analysis Advantages/positives Disadvantages/negatives
Routine OHA
(6-monthly PI): SC
DCE 6-monthly PI is preferred by the
general population
Personalised is preferable to
routine OHA
Clinical effectiveness – No evidence of clinical benefit
Incremental costs (£)
(vs. SC)
N/A N/A
Incremental benefits (£)
(vs. SC)
N/A N/A
INB (£) (vs. SC) N/A N/A
Routine OHA
(no PI)
DCE – Least preferred policy by the
general population
Clinical effectiveness A policy of full disinvestment in PI
would not adversely affect bleeding
gums
–
Incremental costs (£)
(vs. SC)
NHS –3 (95% CI –18 to 12) N/A
Participant –40 (95% CI –84 to 4)
Incremental benefits (£)
(vs. SC)
N/A –68 (95% CI –87 to –49)
INB (£) (vs. SC) N/A –69 (95% CI –97 to –41)
Routine OHA
(12-monthly PI)
DCE – 12-monthly PI preferred to
none but 6-monthly OHA
would be more highly valued
Clinical effectiveness – No evidence of clinical benefit
of PI
Incremental costs (£)
(vs. SC)
Participant –23 (95% CI –70 to 23) NHS 0 (95% CI –15 to 16)
Incremental benefits (£)
(vs. SC)
N/A –31 (95% CI –49 to –13)
INB (£) (vs. SC) N/A –38 (95% CI –65 to –12)
Personalised OHA
(no PI)
DCE Personalised OHA preferred to
routine
Policies with delivery of
12-monthly or 6-monthly PI
would be preferred
Clinical effectiveness – No evidence of clinical benefit
Incremental costs (£)
(vs. SC)
NHS –15 (95% CI –34 to 4) N/A
Participant –64 (95% CI –112 to –16)
Incremental benefits (£)
(vs. SC)
N/A –18 (95% CI –39 to 4)
INB (£) (vs. SC) N/A –11 (95% CI –37 to 15)
Personalised OHA
(12-monthly PI)
DCE Personalised OHA preferred to
routine; reduction in PI could, in
part, be compensated for by
personalised OHA
–
Clinical effectiveness – No evidence of clinical benefit
Incremental costs (£)
(vs. SC)
Participant –17 (95% CI –68 to 35) NHS 6 (95% CI –16 to 28)
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The data presented in the balance sheet indicate the trade-offs decision-makers need to consider when
determining the most efficient policy of PI and OHA to implement. It shows that, although personalised
OHA with 6-monthly PI is the most cost-beneficial policy, owing to the high value placed on the service by
the general population, there is no clear evidence of clinical benefit, or changes to provider beliefs. The
preferred policy depends on the viewpoint taken. If the aim is to maximise welfare from a fixed NHS
budget, then the CBA analysis shows that personalised OHA with 6-monthly PI is the preferred policy. If
the aim is to maximise health from a fixed NHS budget, then it could be argued that no PI is the preferred
policy given the lack of evidence of clinical benefit and given that it was associated with the lowest
average costs (although it should be noted that differences were not significant).
TABLE 32 Cost–consequences analysis: narrative summary (continued )
Policy Analysis Advantages/positives Disadvantages/negatives
Incremental benefits (£)
(vs. SC)
20 (95% CI –2 to 41) N/A
INB (£) (vs. SC) 3 (95% CI –23 to 29) N/A
Personalised OHA
(6-monthly PI)
DCE Most preferred policy by the general
population
–
Clinical effectiveness – No evidence of clinical benefit
Incremental costs (£)
(vs. SC)
Participant –30 (95% CI –82 to 21) NHS 12 (95% CI –11 to 34)
Incremental benefits (£)
(vs. SC)
62 (95% CI 40 to 83) N/A
INB (£) (vs. SC) 48 (95% CI 22 to 74) N/A
INB, incremental net benefit; N/A, not applicable; SC, standard care.
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Chapter 6 Cohort
Introduction
The pragmatic design of the IQuaD trial (reported in Chapter 2) outlined recruitment of healthy individuals
or those with mild to moderate forms of periodontal disease. As one of the intervention groups received
no PI, the IQuaD Periodontal Advisory Group recommended that potential participants exhibiting more
severe forms of disease, as defined by BPE scores of 4 or *, should not be recruited into the experimental
trial. The most advanced form of periodontal disease affects only a relatively small percentage of the
population11 and there is a paucity of long-term data for these individuals in the primary care setting.
A prospective longitudinal cohort study was therefore conducted in conjunction with the IQuaD trial,
involving those individuals who were found to be ineligible for the IQuaD trial but who consented to be
followed up for 3 years.
Methods
The IQuaD cohort study was conducted in conjunction with the IQuaD trial and the recruitment protocol of
dental practices and participants is summarised in Chapter 2.
Ethics approval
Favourable ethics approval for the IQuaD trial was confirmed by the East of Scotland Research Ethics
Service on 24 March 2011 (REC reference number 10/S0501/65).
Recruitment and consent
The IQuaD trial and IQuaD cohort recruitment were conducted in 63 IQuaD trial dental practices in Scotland
and north-east England from February 2012 to July 2013. All participants in the cohort study had previously
consented to participate in the IQuaD trial. Following baseline clinical screening and outcome measurement,
potential participants were advised that they were not eligible to be included in the trial if they were found
to have a BPE score of 4 or * or had an uncontrolled medical condition. They were then invited to participate
in the IQuaD cohort study and signed consent to take part in this prospective longitudinal study. The IQuaD
cohort study participants subsequently received a routine dental examination from their general dental
practitioners, who were advised that the patient was ineligible for the IQuaD trial. The IQuaD cohort study
participants received usual care and were not part of the experimental design.
Outcomes
The clinical and patient-centred outcomes were the same as the IQuaD trial outcomes (outlined in methods).
The IQuaD cohort participants completed the same baseline questionnaire as the IQuaD trial participants
and were also sent an annual questionnaire for 3 years.
Statistical analyses
No statistical analyses were planned and only descriptive data of the longitudinal cohort were reported.
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Results
Baseline characteristics
Of the 2341 potential participants who attended for a baseline clinical outcome assessment, 160 were
found to have a BPE score of 4 and/or *. These potential participants were invited to participate in the
IQuaD cohort study, with 16 (10%) declining to participate (reasons outlined in Table 6), resulting in
144 (90%) participants being recruited to the longitudinal study.
Clinical outcomes
Clinical outcome assessment, measurement and outcome mean calculations followed the same protocol
as the IQuaD trial (outlined in Chapter 2, Collection of clinical outcome measures). At baseline, the 144
cohort participants had a mean number of 22 (SD 4.7) teeth present, with gingival inflammation/bleeding
recorded in 35.1% (mean) (SD 23.4%) of sites. Supragingival calculus was recorded on 40.6% (mean)
(SD 30.2%) of teeth and the mean clinical probing depth of the cohort patients was 2.2 mm (SD 0.4 mm).
Similar to the IQuaD trial, a number of recruited participants were not available for follow-up clinical
assessment; 85 (59%) IQuaD cohort participants attended for follow-up clinical assessment at approximately
3 years following recruitment. When considering only the 85 participants who attended for both clinical
assessment appointments, the baseline clinical characteristics were as follows: a mean number of 21.6 (SD 5)
teeth present, 37.0% (mean) (SD 24%) of sites with recorded gingival inflammation, mean supragingival
calculus of 36.0% (SD 27%) and mean clinical probing depth of 2.2 mm (SD 0 mm). A total of 97% (n = 82)
of these participants had a BPE score of 4 or * at baseline; the remaining three participants, who were
ineligible due to medical history reasons, had a BPE score of 3 (1%, n = 1) or 2 (2%, n = 2).
Patient-centred outcomes
The collection, assessment and mean score calculations of the participant-centred outcomes are the same
as in the IQuaD trial outlined in Chapter 2.
At baseline, the cohort participants’ self-efficacy, assessed as confidence in one’s ability to perform a
behaviour and measured using a 7-point scale scored from 1 (not at all confident) to 7 (extremely
confident), was, on average, 5.0 points (SD 1.2 points; completed the questionnaire, n = 131).
Cognitions
Perceived behaviour control score, assessed in terms of perceived ease or difficulty of performing the
behaviour and measured using a 7-point scale varying from 1 (strongly agree) to 7 (strongly disagree),
was, on average, 4.1 points (SD 1.4 points; completed the questionnaire, n = 131).
Attitude towards oral health behaviour, measured using a scale varying from 1 (strongly agree) to 7 (strongly
disagree), was very positive, averaging 5.6 points (SD 1.2 points; completed the questionnaire, n = 131).
Subjective norm, assessed as attitude towards the behaviour and perceptions of social pressure to perform
the behaviour and measured using a scale of 1 (strongly agree) to 7 (strongly disagree) scored, on average,
4.9 points (SD 1.3 points; completed the questionnaire, n = 131).
The score of mean intention to perform good oral hygiene practice was 5.5 points (SD 1.8 points;
completed the questionnaire, n = 114), which was measured using questions to which responses were
scored from 0 to 3 (the best possible intention), with 9 being the best possible score.
Behaviour
On the self-reported oral hygiene behaviours scale, which ranges from 0 to 9, with 9 being the best
possible behaviour, the cohort group had an average score of 4.9 points (SD 1.7 points; completed the
questionnaire, n = 130). Like the IQuaD trial participants, the cohort group showed room for improvement
on this scale.
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Quality of life
The self-reported QoL was measured using the OHIP-14, a 14-item oral health-specific patient-centred outcome
referring to symptoms in the past 12 months. Each item is scored from to 0 to 4 (very often) and the scores are
summed to produce a summary score ranging from 0 to 56, with 56 being the worst outcome. The cohort
participants’ mean score at baseline was 8.5 points (SD 9.5 points; completed the questionnaire, n= 126).
Follow-up characteristics
Clinical
Follow-up examinations were conducted from May 2015 to July 2016. At the 3-year clinical follow-up, the
85 participants had an average of 21.2 (SD 5.4) teeth with mean gingival inflammation/bleeding recorded
at 41% (SD 25.5%) of sites. More teeth (mean 43.5%, SD 33.1%) exhibited supragingival calculus and
the mean clinical probing depths had increased minimally by 0.1 mm to 2.3 mm (SD 0.5 mm).
Patient-centred outcomes
At the 3-year follow-up, the cohort participant patient-centred outcomes were similar to the baseline
scores. The average self-efficacy score was 5.1 points (SD 1.1 points; completed the questionnaire,
n = 101) on a scale of 1–7.
Cognitions
The average PBC, attitude and subjective norm scores were 4.4 points (SD 1.3 points; completed the
questionnaire, n = 87), 5.2 points (SD 1.6 points; completed the questionnaire, n = 87) and 4.5 points
(SD 1.4 points; completed the questionnaire, n = 86), respectively, with each measured on a scale of 1–7.
The 3-year follow-up average intention score was 5.4 points (SD 1.8 points; completed the questionnaire,
n = 83) on a scale from 0 to 9, with 9 being the best possible score.
Behaviour
On the self-reported oral hygiene behaviours scale, which ranges from 0 to 9, with 9 being the best
possible behaviour, the cohort group had a mean score of 5.4 points (SD 1.8 points; completed the
questionnaire, n = 87).
Quality of life
The mean score on the OHIP-14, which measures self-reported QoL, was 7.8 points (SD 8.0 points;
completed the questionnaire, n = 83).
Discussion
The IQuaD cohort study provided a unique opportunity to monitor NHS primary care patients with severe
periodontal disease over a 3-year time period. The end-point outcome of periodontal disease is tooth loss,
which is thought to be concentrated in a relatively small number of individuals with severe periodontal
disease. There is a general paucity of long-term data on individuals with severe periodontal disease in
primary care receiving routine care (which may include specialist periodontist referral). Among the
85 participants with baseline and follow-up data, there were only minimal changes in the mean scores
of present teeth (–0.4 teeth), gingival inflammation (+4%), supragingival calculus (+7.5%) and mean
clinical probing depths (+0.1 mm). Similarly, there were only minimal changes in participant-reported
outcomes: self-efficacy (+0.1 points; 1–7 scale), PBC (+0.2 points; 1–7 scale), attitude (–0.3 points;
1–7 scale), subjective norm (–0.4 points; one to seven scale), behaviour (+0.3 points, 0–9 scale) and
intention (no change). Interestingly, the patient-centred outcome scores (including QoL) were largely
similar to those of the IQuaD trial participants.
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The IQuaD cohort study has a number of limitations, including the high attrition rate, with only 59% of
participants being available for 3-year clinical follow-up. The recruitment strategy of the IQuaD trial meant
that only those individuals who had a BPE score of ≤ 3 at their most recent examination appointment
were invited to the trial recruitment sessions. Therefore, it is unclear how representative this relatively
self-selecting group of participants was, considering that the participants were all regular attenders at their
primary care dental practice who had previously shown no signs of severe periodontal disease (as defined
by a BPE score of 4).
It would be inappropriate to draw definitive conclusions from the outcomes, but it appears that periodontal
condition and participant-centred outcomes did not markedly deteriorate or improve in the 85 IQuaD cohort
participants over the course of this 3-year study.
COHORT
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Chapter 7 Discussion/conclusions
The IQuaD trial involving regular adult NHS dental attenders (with no or early signs of periodontitis) hasshown that, over a 3-year period, scheduling 6-monthly or 12-monthly PIs has no additional beneficial
effect (over not providing this treatment unless desired or recommended) on primary clinical (gingival
inflammation/bleeding) and patient-centred (self-reported) outcomes and that there is no difference
between personalised OHA and routine OHA (current practice). However, patients value, and are willing to
pay for, both interventions, with greater financial value placed on PI than on OHA.
The IQuaD trial is the first pragmatic cluster RCT to evaluate PI and OHA in NHS dental practices. These
interventions are the most frequently performed treatments in dentistry, with considerable cost to the NHS and
society. The aim of this RCT in primary care dental practice was to provide evidence for the benefit or not of
these routine treatments on the periodontal health of adults with no or early signs of periodontal disease.
The primary clinical outcome, gingival inflammation/bleeding, is a measure of gingivitis, a recognised
precursor of periodontitis, caused by plaque retention, and is reversible with effective plaque removal.
The PI in the IQuaD trial involved professional mechanical removal of plaque and calculus. Effective oral
hygiene (self-care) involves tooth brushing with appropriate interdental cleaning, which, if undertaken
effectively, will be sufficient to prevent or resolve gingivitis.
At baseline, most participants (98%) experienced gingival inflammation/bleeding, with, on average, 33%
of sites affected. The prevalence of gingival inflammation/bleeding measured at baseline was similar to
that reported in other studies25 and confirmed that, if effective, the trial interventions had the opportunity/
potential to improve periodontal health.
At the 3-year follow-up, there was no evidence of a difference in gingival inflammation/bleeding between
those randomised to PI on a 6-monthly basis and those who were randomised to receive no PI (difference
0.87%, 95% CI –1.6% to 3.3%; p = 0.481). Similarly, there was no evidence of a difference between
scheduled 6-monthly PI and scheduled 12-monthly PI (difference 0.11%, 95% CI –2.3% to 2.5%;
p = 0.929). We are confident in the finding of no clinical benefit for 6-monthly PI over other frequencies of
PI because the 95% CIs were small enough to exclude the prespecified clinically important difference in
bleeding of 7.5%. Of the secondary clinical outcomes, a difference between groups was found only for
calculus, with those participants in the no-PI group having 8% (95% CI 5.4% to 10.7%; p = 0.001) more
sites with calculus than the 6-monthly PI group after 3 years. Although there was a statistically significant
difference, the clinical significance or relevance of this result has to be questioned because there was no
associated improvement in the primary clinical outcome of gingival inflammation/bleeding.
All participants received PI at baseline and were then randomised to be offered this treatment 6-monthly,
12-monthly or not at all for the 3-year duration of the trial. Participants’ dental practices were asked to
recall their participants for PI in keeping with their randomised allocation; however, a PI could be provided
if either the participant requested it or the clinician thought it necessary. The pragmatic nature of the trial
meant that scheduling of dental appointments and the intervals between PIs varied, as they do in routine
practice. Prior to and since the publication of NICE dental recall guidelines,66 common practice is to provide
a PI at the same time as a dental recall visit and for this to be planned every 6 months. The intention was
that participants randomised to the 6-monthly PI group would receive this frequency of care.
The claims recorded in the routine data collected for the IQuaD trial confirmed that the number and
interval between PIs varied within groups and demonstrated clear separation in the mean number of PIs
between groups. At the 3-year follow-up, there was a threefold difference in the mean number of PIs (1.1,
2.0 and 3.0 for the no-PI, 12-monthly and 6-monthly groups, respectively). National routine data67 suggest
that, in the NHS, the most frequent interval between visits with a PI is 9 months and this reflects the
experience of participants in the 6-monthly PI group. The finding that 46% of participants randomised to
DOI: 10.3310/hta22380 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 38
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Ramsay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
89
the no-PI group did not request, and were not thought to need, this treatment (PI) indicates that almost
half of participants were not clinically compromised for the duration of the trial and would not have
experienced any benefit had this treatment been provided.
Although participants with moderate to severe periodontal disease (BPE score of 4 or *) were excluded
from the trial, adults with a spectrum of periodontal disease and a wide age range were included. Using
the baseline data, these groups were included in subgroup analyses along with dental practice/cluster
employment of a hygienist, smoking habit and a post hoc criterion for moderate periodontitis evidenced
by four or more pockets with a clinical probing depth of ≥ 4 mm. The IQuaD trial found no evidence of
statistically significant differences at the 1% level for the prespecified and post hoc subgroup analyses and
the primary clinical outcome of gingival inflammation/bleeding. However, the results suggest that there
may be some clinical benefit of 6-monthly PI compared with other frequencies for participants with BPE
scores of 3 at baseline (difference –4.7% 99% CI –10.5% to 1.1%; p = 0.038). Current clinical guidance
from the British Society of Periodontology16,68 recommends providing PI for early signs of periodontitis
(BPE score of 3 with bleeding or other risk factors) and these results suggest a possible benefit to such a
targeted approach.
The IQuaD trial found no evidence of a difference between participants randomised to personalised OHA
and those randomised to routine advice (current practice) for any outcome. Although the 95% CI for the
difference in gingival inflammation/bleeding (–2.5%, 95% CI –8.3% to 3.3%; p = 0.393) does not exclude
the prespecified clinically important difference of 7.5%, it is unlikely that the personalised OHA has any
impact > 8%. The results were robust to other adjusted/unadjusted models. Similarly to PI frequency,
there was no evidence that any of the subgroup analyses were statistically significant at the 1% level.
Although we found no evidence of a difference between the two OHA interventions, we have evidence
of intervention fidelity from participant-reported responses in their follow-up questionnaires about
desired oral health behaviours such as spit but not rinse, which leads us to believe that the personalised
intervention was indeed delivered as intended. Participants having a plan for brushing or flossing better
was another variable assessed. The randomised groups (personalised vs. routine) had similar levels of
participants reporting to have a plan. This might reflect the fact that the question was asked too late (it
would have been around 1 year between the participants making a plan with their clinicians and receiving
their first participant annual questionnaire). Regardless, there is no good evidence that clinicians in the
personalised arm delivered the intervention in a way that promoted planning of oral hygiene behaviour.
The personalised OHA was designed as a brief intervention (under 10 minutes) appropriate to be delivered
in primary care dental practice. OHA is considered integral within a NHS recall/check-up appointment and
only rarely attracts an additional fee. The trial intervention was designed 10 years ago using psychological
behaviour change models; since that time national clinical guidance documents that provide similar advice
have been disseminated in both England16 and Scotland.69 Dentists randomised to deliver routine OHA
were asked to conform to their current practice. Therefore, one possible explanation of the outcome is
that the personalised OHA was similar to current practice and therefore did not result in any additional
benefit compared with current practice.
The confidence (self-efficacy) of participants to perform effective oral hygiene (i.e. to clean their teeth and
gums regularly and well) was chosen to be the primary patient-centred outcome because gingivitis can be
prevented with effective oral hygiene.34 The IQuaD trial found participants to be moderately confident in
performing good oral hygiene and the frequency of PI or type of OHA did not make a difference. The
statistically significant difference found between those randomised to receive 6-monthly and 12-monthly
PI, favouring 6-monthly PI (difference –0.097, 95% CI –0.188 to 0.006; p = 0.037), is most likely due to
the very precise CI. The difference considered clinically significant was one-quarter of a SD around 0.275 in
the self-efficacy scale and the CI excludes that value.
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For all other clinical and patient-centred outcomes, the IQuaD trial found no evidence to suggest that the
frequency of PI or whether or not OHA was personalised made a difference.
The health economics analysis assessed the costs and benefits of alternative policies of OHA with or
without PI in terms of costs and benefits (WTP). The analysis focused on whether moving from standard
care to an alternative policy increases or decreases welfare. The results showed that there were no
statistically significant differences in total NHS costs for any of the policies compared with standard care
(6-monthly PI and routine OHA). In terms of point estimates of total mean NHS costs, the policy of no PI
and personalised OHA was associated with the lowest NHS costs (£62.42), followed by the policy of no PI
and routine OHA (£72.23).
In Scotland, the fee-for-service structure allowed an assessment solely of the costs of periodontal treatments.
Relative to standard care, and given the structure of current contracts, a policy of no PI (with routine OHA)
would significantly reduce NHS spending on periodontal treatments by £7.47 per person over 2.25 years.
A policy of offering routine OHA with 12-monthly PI would save £5.11 per person on periodontal treatments
over the same time frame. However, we cannot definitively conclude cost savings to the overall NHS dental
budget. To make this statement would require the assumption that the lack of statistical significance in
total NHS costs is due to a lack of statistical power and the relatively large SDs around high-cost treatments,
rather than any causal effects of disinvesting from PI. Given the lack of evidence of any clinical differences
across policies, it could be argued that such an assumption may be valid, and that cost savings could be
achieved, at least in the Scottish system, without having an adverse impact on the primary clinical outcome
(gingival inflammation/bleeding).
When taking a wider perspective (NHS and participant), the policy of personalised OHA and no PI was less
costly than standard care. However, this difference was mainly driven by the lower costs of interdental
brushes in England and it is questionable whether or not it is attributable to the policy. The total cost
differences between all other policies and standard care were not statistically significant.
The results of the DCE show strong evidence that the general population valued both PI and personalised
OHA even when controlling for frequency of bleeding gums and aesthetics (the look and feel of teeth).
Owing to the relatively high value placed by the general population on PI and personalised OHA, the policy
of 6-monthly PI and personalised OHA was associated with the highest incremental benefit compared with
standard care (£61.67). The policy of 12-monthly PI and personalised OHA was also associated with a
positive but lower incremental benefit (£19.70) but the difference was not statistically significant.
The results of the CBA showed that the policy of 6-monthly PI with personalised OHA was associated with
the largest incremental net benefit compared with standard care [£48 when taking a NHS cost perspective
and £68 when taking a wider perspective (NHS and participant)]. The most efficient approach depends
on the perspective taken. From a welfare maximisation perspective, the analysis shows that personalised
OHA with 6-monthly PI is cost-beneficial, with the greatest incremental net benefit relative to standard
care. It should be noted that this finding was driven primarily by differences in benefits rather than
NHS-incurred costs.
From a health maximisation perspective, the no-PI approach generates the lowest average costs (though
differences are not statistically significant), without detrimentally affecting clinical outcomes. The overall
health economic conclusions were robust to a range of sensitivity analyses undertaken to explore the
impact of uncertainty in key assumptions on results.
Comparisons with other randomised clinical trials
The Cochrane systematic review24 of routine scale and polish (PI) for periodontal health in adults (updated
in 2013) reported that there was insufficient evidence to determine the effects of routine PI treatment.
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Three studies25–27 were identified, one of which was conducted in a similar setting to the IQuaD trial (three
NHS general dental practices in England, involving 369 participants). The trial inclusion criteria were less
pragmatic than those in the IQuaD trial, with individuals with BPE scores of > 2, diabetes mellitus and
those aged > 60 years excluded. Jones et al.25 compared PI intervals of 6-monthly PI, 12-monthly PI or
24-monthly PI (no PI throughout the trial). There was no evidence of any clinical differences between these
different PI intervals provided for gingival health (gingival inflammation/bleeding). The Cochrane review is
currently being updated by two authors of the monograph and will include the results of the IQuaD trial.
The updated search of 5 December 2016 identified the IQuaD trial as the only new eligible study to be
included in the updated review. When synthesising the data of both trials, the treatment effect is mean
difference 0.00 (95% CI –0.03 to 0.03; p = 0.87) in gingival health, as shown in Figure 17.
A recent systematic review23 of psychological approaches to behaviour change for improved plaque control
in periodontal management reported benefits of using goal-setting, self-monitoring and planning for
improving oral hygiene. A number of the included trials were of short duration, of a non-experimental
design and were rated as having a high risk of bias. A meta-analysis was not possible and the results
and recommendations should be interpreted with caution. An ongoing Cochrane systematic review
of delivering one-to-one oral hygiene in a variety of dental settings has identified a number of trials
investigating enhanced oral hygiene techniques (Soldani FA, Young L, Jones K, Walsh T, Clarkson JE.
Bradford District Care NHS Foundation Trust. 2017). The intensity of the interventions varied greatly and
for a number of trials the risk of bias is rated as unclear or high. We have presented a diagrammatic
display of the studies’ effects to demonstrate the spread of effect size, direction and lack of CI overlap,
highlighting the uncertainty of treatment clinical effectiveness (Figure 18).
Strengths
The IQuaD trial was a pragmatic trial in primary care dental practice designed to provide evidence for the
clinical effectiveness and cost-effectiveness of the most frequently provided treatment in dentistry, PI,
and the impact of personalised OHA. Despite the length of time that has elapsed since the trial began,
uncertainty still exists for providers of dental care worldwide regarding the benefit of these common
components of routine dental care.
Surprisingly, there have been few studies comparing different frequencies of PI, and none that have
combined it with different approaches to providing OHA in a setting such as the NHS. Reviews evaluating
PI frequency have included studies that involve few providers and recruit only participants with no or very
early signs of periodontal disease (BPE scores of 0–2). One review concluded that there was little value in
providing PI without OHA; this was largely influenced by the results of a study with an intensive advice
programme involving several 45-minute appointments, which does not reflect routine NHS practice.74
The strengths of the IQuaD trial include the recruitment and retention of a large number of centres
(n = 63), with wide representation of geographical, clinical and dental practice characteristics and
operating in two different contractual systems in the UK. Recruitment and retention in trials is a frequent
challenge, but an achievement for the IQuaD trial was the recruitment of 87% of the potentially eligible
patients and the retention at 3 years of 1450 participants with 1327 (71%) providing clinical data. The
randomised groups were balanced/similar at baseline and the reasons for loss to follow-up were related to
the inability of practices to contact their patients; therefore, we were confident in the robustness of the
results regardless of the missing data. The dental behaviour and clinical characteristics of the participants
mean that the findings of the IQuaD trial are generalisable to regular dental attenders in the NHS and,
therefore, similar third-party funding systems. The cohort study provided long-term data on NHS primary
care patients with moderate to severe periodontal disease, which has previously been lacking.
DISCUSSION/CONCLUSIONS
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FIGURE 17 Routine PI for periodontal health in adults. (a) Forest plot of comparison 1: PI vs. no PI (control), outcome 1.1 gingivitis at 24 months; and (b) forest plot of
comparison 1: PI vs. no PI (control), outcome 1.2 calculus at 24 months. df, degrees of freedom; IV, inverse variance.
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FIGURE 18 One-to-one OHA provided in a dental setting for oral health. Forest plot of comparison 1: personalised OHA vs. routine OHA, outcome 1.1 gingivitis. IV, inverse variance.
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The pragmatic design of the trial did not prevent fidelity to the interventions with evidence of separation
in the frequency of PIs between groups and of the delivery of personalised OHA. Conducting the trial
in a primary care NHS setting with a design that involved minimal requirements for the dental practices,
blind outcome assessment and access to routine data are strengths. The interventions delivered were not
independently observed; however, we believe that they were delivered as in current dental practice and
the fidelity information supports this.
The health economic evaluation has a number of strengths. To our knowledge, this trial provides the
only evidence worldwide regarding the efficient allocation of NHS resources to the delivery of PI and
personalised OHA. Uniquely among clinical trials of dental care interventions, we implement a CBA, using
a DCE to capture the value placed on both the processes and outcomes of care by the general population.
The values of the general population are most relevant as they provide the funding for health care in a
tax-based system such as the NHS. The approach is novel within dentistry and has a number of distinct
advantages over traditional cost-effectiveness and cost–utility analyses as it incorporates the simultaneous
valuation of multiple processes and outcomes which are relevant to dental care recipients.
In terms of the within-trial analysis, we use best practice methodology, incorporating the most advanced
recommendations for analysis of cluster randomised trials together with the appropriate use of missing
data models to minimise the potential for bias.
Limitations
As with all evaluations, it is important to acknowledge the limitations of the trial.
A weakness was not collecting detailed information about the reasons for additional PIs. A possible weakness
is that gingival inflammation, measured as bleeding on probing, is a measure for which calibration is not
possible. The difference in bleeding measures between baseline and follow-up probably reflects assessor’s
measurement error, but they were equally distributed across practice and participant randomised allocations,
avoiding bias between randomised groups. The ICC for the primary clinical measure, bleeding on probing,
was higher (0.24) than originally planned for (0.10), and most likely the observed difference was influenced by
the ‘assessor effect’. The trial was still powered to detect the clinically important difference due to statistical
adjustment for other factors such as the baseline measures of bleeding and the minimisation variables.
The different contracts across Scotland and England provided several challenges to the health economic
evaluation. First, the differences in costs across the policies were likely to vary across the regions as PI
attracts a separate payment in Scotland while it is included in band 1 treatments in England (which also
include clinical check-ups). Second, the different contracts may provide different incentives for providing
care. Some evidence suggests that health-care providers have a tendency to supply more services under
fee-for-service than under other reimbursement contracts, but, in the IQuaD trial, we found no evidence of
this, as average costs were actually higher in England than in Scotland. One could also make an argument
that different contracts may have an impact on the private–public mix of services, for example the referral
rate for private PI. These issues potentially limit the direct comparability of Scottish and English cost
data. However, this difference did not bias average UK results, as the ratio of English to Scottish practices
was similar across the different arms of the trial. Furthermore, although subgroup analyses exploring
regional-level resource use, cost and incremental net benefits show substantial variation across regions,
the overall recommendations from the CBA remain unchanged.
Although the DCE was a useful method for obtaining WTP estimates for PI, personalised OHA and trial
outcomes, it did not provide insights into why individuals value these attributes. Although source of value
is not relevant from a CBA perspective, policy-makers may want some insights into this given the current
climate of severe financial constraints. The results showed that the public value PI and personalised OHA
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even when controlling for self-reported bleeding and aesthetics. There are a number of potential
explanations for this finding:
l Respondents may have assumed that PI and personalised OHA were associated with clinical benefits
other than bleeding and aesthetics.
l PI and personalised OHA represent another interaction with a dentist or hygienist, which provides an
opportunity to identify any dental health issues and to provide reassurance.
l Respondents may simply value PI because that is what they always have (habitual behaviours) and/or
their dentist has always recommended that they have a PI.
l Respondents might value having the option of PI and personalised OHA in a dental care package
(option value).
l Respondents might want to minimise the regret that they may feel if their dental health gets worse and
they did not have PIs or personalised OHA.
l It is possible that the general population value the additional PI service received as part of attending
for a band 1 treatment in England. It is possible that withdrawal of PI may have an impact on the
attendance for routine check-ups; however, that consequence was not observed in the trial participants
when all groups continued to attend for dental check-ups at a similar rate.
Further research is required to explore the reasons behind the positive value attached to PI.
The economic analysis is based on the price paid by the NHS for dental treatments under the current
contracts and structures in place in England and Scotland. Thus, our analysis is the most accurate reflection
of the current impact on NHS budgets of delivering alternative policies. However, there are limitations
associated with this. First, the price may not be an accurate reflection of the cost of time and materials to
the dentists of delivering the respective interventions. Owing to contract structures, it is likely that there
are substantial differences between price and cost. Second, if the way in which dental practices are paid
were to change substantially under new contracts, the results of our costing analyses would need to be
considered in the light of such changes. Third, we have not explicitly estimated the opportunity costs of
alternative policies (i.e. the benefits forgone from not having those resources available to expand or
implement other policies). This is an important consideration, given a fixed NHS budget; however, the
issue is rarely explicitly incorporated within economic evaluation frameworks. It should be noted that, for
this study, incremental net benefit results were driven by differences in benefits rather than costs, so the
notion of opportunity costs is less relevant in this scenario, as NHS costs were similar across policies.
The majority of economic evaluations of health-care interventions tend to extrapolate trial outcomes over a
longer time horizon using decision-modelling studies. For this study, we have conducted a CBA alongside the
RCT. We have not attempted to extrapolate trial results as there is a paucity of evidence to directly predict
the probability of final clinical end points (such as tooth loss or long-term caries), or to determine when such
events may happen. This is a limitation of our analysis. However, to attempt such a modelling exercise, given
the paucity of available data, could generate misleading conclusions for policy-makers. Furthermore, given
that there was no evidence of short-term clinical benefit, one would not expect any differences in long-term
tooth loss or caries across different policy options in this population with relatively healthy dentitions.
Compared with other areas of health economic evaluation, there is a lack of evidence generally to inform the
population of economic decision models in dentistry and further research is required to bridge this gap.
Despite attempting to collect information on the wider NHS perspective, it was found that rates of
secondary care consultations exceeded what might be expected in the general population. After a
validation exercise, the data were excluded. Reasons for the poor validity may include a participant’s
difficulty in determining what was meant by the questionnaire text asking to report ‘admissions for
problems related to your teeth’ or issues of recall bias over a full year of recall, or the question may have
been misinterpreted, with participants providing details of all contacts with secondary care, rather than
dental care-specific attendances. Future studies should explore direct linkage to Scottish Morbidity Reports
data in Scotland and Hospital Episode Statistics data in England to obtain more accurate estimates at a
DISCUSSION/CONCLUSIONS
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participant level. The impact of omitting these data on the results is likely to be minimal, given that
resource use was evenly distributed across groups.
Patient and public involvement and engagement
Prior to the start of the IQuaD trial, patients were involved with the trial design and provided invaluable
feedback on trial recruitment and communication strategies. Patients also contributed to the content and
layout of the trial invitation, trial newsletters and the design of patient participant questionnaires. This
ensured that trial participants could understand and easily complete these materials. Members of the
public also contributed to trial oversight through membership of the TSC, including helping to interpret the
trial findings and preparation of the monograph. We found that the most effective feedback was provided
in face-to-face meetings with trial staff and patient and public involvement (PPI) personnel. This provided
an opportunity for clarification and more comprehensive and constructive feedback. In preparation for
oversight committee meetings and the final PMG meeting, the PPI representative found that the
opportunity for a pre-meeting session to clarify issues made their participation of these meetings easier.
The results were discussed with the Periodontal Advisory Group and Chief Dental Officers of the UK.
Generalisability
The IQuaD trial was designed pragmatically to investigate OHA and PI delivery to NHS patients in dental
primary care that did not exhibit moderate or severe periodontitis.
The 63 recruiting dental practices were situated across Scotland and the north-east of England, with 72%
of practices employing dental hygienists and 75% having three or more dentists working in the practice.
In the year to 31 March 2014, 84.4% of the population of Scotland was registered with a NHS dentist,
76.4% of whom had attended the dentist in the past 2 years. The ADHS 200911 reported that over half of
the UK population had attended a dental practice within the last 3 years. The IQuaD trial recruited a total
of 1877 participants at their routine dental examination, with 1348 (72%) of these participants recruited
across Scotland, including 121 (6%) recruited from the Scottish islands. Over 90% of participants reported
having attended a dental practice at least once over the previous 2 years.
At baseline, around 60% of participants reported having received OHA and a PI during their last dental
appointment. The mean percentage of sites with gingival inflammation/bleeding was 33%, and 35% of
teeth had calculus present. The mean clinical probing depth was 1.8 mm. Two-thirds of participants had
BPE scores of ≤ 2, and between 10% and 12% of participants in each group had four or more pockets
with a clinical probing depth of ≥ 4 mm.
We are confident that the practices and participants recruited to the IQuaD trials are a true representation
of those adults who are periodontally healthy or have very early periodontal disease and attend NHS dental
practices across Scotland and England.
Recommendations for research
l Research is needed to assess the clinical effectiveness and cost-effectiveness of providing multifaceted
periodontal care packages (e.g. OHA, oral care products, PI) in primary dental care for those
with periodontitis.
l Research is required to better understand the source of WTP values and the extent to which this is
influenced by perceptions and current practice.
l Further research is required to explore the relative value of different data sources for estimating
resource use in dentistry including routine data, patient-reported data and practice records.
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patient data is vital to improve health and care for everyone. There is huge potential to make better use of
information from people’s patient records, to understand more about disease, develop new treatments,
monitor safety and plan NHS services. Patient data should be kept safe and secure, to protect everyone’s
privacy, and it’s important that there are safeguards to make sure that it is stored and used responsibly.
Everyone should be able to find out about how patient data are used. #datasaveslives You can find out
more about the background to this citation here: https://understandingpatientdata.org.uk/data-citation.
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Appendix 1 Clinical effectiveness outcomes
Section 1: methods for computing patient-reported outcomes
Table 33 describes the calculations used to produce the outcomes in the CBQ at baseline.
Table 34 describes the calculations used to produce the outcomes in the CBQ at follow-up.
Table 35 describes the calculations used to produce the patient-reported outcomes. All outcomes were
calculated for each year of the patient annual questionnaire (baseline and years 1, 2 and 3).
TABLE 33 Calculations for outcomes in the CBQ at baseline
Outcome
Questionnaire
item(s) Scoring
Self-efficacy Q1 (a) to (g) Mean of all Q1
Attitude Q2 (a) to (d) Mean of: 2(a) + 2(b)+ 2(c) + 2(d)+ 4(a) + 4(b)+ 4(c)R* + 3(a)+ 3(b) + 3(c) +
3(d)+ 5(a) + 5(b)+ 5(c)R*
Q3 (a) to (d)
Q4 (a) to (c)
Q5 (a) to (c)
PBC Q4 (d), Q5 (d) Mean of: 4(d) + 9(a)+ 9(b)+ 9(c) + 9(d) + 9(e)+ 9(f) + 9 (g) + 5(d)
Q9 (a) to (f)
Intention Q7 (a) to (c) Mean of: 7(a) + 7(b)
Subjective norm Q11 (a) to (c) Mean of: subjective norm advice + subjective norm treat
Subjective norm advice =mean of 11(a) × 13(a) + 11(b) × 13(b) + 11(c) × 13(c)
Subjective norm treat =mean of 12(a) × 13(a) + 12(b) × 13(b) + 12(c) × 13(c)
Q12 (a) to (c)
Q13 (a) to (c)
Has a plan to give OHA Q8 8(a)
Has a plan to give PI 8(b)
R*, reverse score.
TABLE 34 Calculations for outcomes in the CBQ at follow-up
Outcome
Questionnaire
item(s) Scoring
Self-efficacy Follow-up CBQ Mean of all Q1 items
Q1 (a) to (g)
Attitude Follow-up CBQ Mean of: 2(a) + 2(b)+ 2(c) + 2(d)+ 4(a) + 4(b)+ 4(c)R* + 3(a)+ 3(b) + 3(c) +
3(d)+ 5(a) + 5(b)+ 5(c)R*
Q2 (a) to (d)
Q3 (a) to (d)
Q4 (a) to (c)
Q5 (a) to (c)
continued
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TABLE 34 Calculations for outcomes in the CBQ at follow-up (continued )
Outcome
Questionnaire
item(s) Scoring
PBC Follow-up CBQ Mean of: 4(d) + 9(a)+ 9(b)+ 9(c) + 9(d)+ 9(e)+ 9(f) + 9(g)+ 5(d)+ 10(a) +
10(b) + 10(c) + 10(d) + 10(e) + 10(f) + 10(g)
Q4 (d)
Q5 (d)
Q6 (d)
Q9 (a) to (g)
Q10 (a) to (g)
Intention Follow-up CBQ Mean of: 7(a) + 7(b)
Q7 (a) to (b)
Subjective norm Follow-up CBQ Mean of: subjective norm advice + subjective norm treat
Subjective norm advice =mean of 11(a) × 14(a)+ 11(b) × 14(b)+ 11(c) × 14(c)
Subjective norm treat=mean of 12(a) × 14(a)+ 12(b) × 14(b)+ 12(c) × 14(c)
Q11 (a) to (c)
Q12 (a) to (c)
Q14 (a) to (c)
Has a plan to give
OHA
Follow-up CBQ
Q8
8(a)
Has a plan to give PI 8(b)
R*, reverse score.
TABLE 35 Calculations for patient-reported outcomes
Outcome
Questionnaire
item(s) Scoring
Self-efficacy Section 3 Mean of all Q1 items
Q1 (a) to (g)
PBC Section 3 Mean of: 2(a)R* + 2(b) + 2(c) + 2(d)+ 2(e) + 3(a)+ 3(b)+ 3(c)
Q2 (a) to (e)
Q5 (a) to (c)
Subjective norm Section 3 Mean of: 4(a)R* + 4(b) + 4(f)
Q4 (a), (b) and (f)
Attitude Section 3 Mean of: 3(a)R* + 3(b) + 3(c)R*+ 3(d)R* + 3(e)R* + 3(f)R* + 3(g)R* + 5(d)R*
+ 5(e)R*
Q3 (a) to (f)
Q5 (d) and (e)
Behaviour Section 2 Q1 +Q2 +Q8 or Q12 (the highest of the two)
Q1, Q2, Q8 and
Q12
Intention Section 2 Q4 +Q5 +Q10
Q4, Q5 and Q10
OHIP Section 4 According to instrument instructions
Q1–14
R*, reverse score.
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Section 2: participant dental characteristics (years 1 and 2)
Section 2 shows the participant dental characteristics at follow-up at year 1 (Table 36) and at year 2 (Table 37).
TABLE 36 Participant dental characteristics at year 1
Participant dental characteristics
Randomised group, n (%)
PI OHA
No (N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 860)
Date of last visit to the dental practice (years ago)
< 1 449 (72) 445 (71) 458 (73) 715 (71) 637 (74)
1–2 23 (4) 23 (4) 4 (1) 31 (3) 19 (2)
> 2 – 1 (0) 1 (0) – 2 (0)
Missing 151 (24) 156 (25) 163 (26) 262 (26) 208 (24)
Do you think of yourself as
A regular attendee 452 (73) 446 (71) 457 (73) 718 (71) 637 (74)
Someone who sees a dentist when in
pain or trouble
20 (3) 22 (4) 6 (1) 28 (3) 20 (2)
Missing 151 (24) 157 (25) 163 (26) 262 (26) 209 (24)
In the last 12 months, did you receive OHA?
Yes 343 (55) 378 (60) 406 (65) 635 (63) 492 (57)
No 124 (20) 88 (14) 51 (8) 103 (10) 160 (18)
Missing 156 (25) 159 (25) 169 (27) 270 (27) 214 (25)
By whom?
Dentist 241 (39) 233 (37) 209 (33) 395 (39) 288 (33)
Hygienist 61 (10) 89 (14) 110 (18) 132 (13) 128 (15)
Both 43 (7) 59 (9) 89 (14) 116 (12) 75 (9)
Missing 278 (45) 244 (39) 218 (35) 365 (36) 375 (43)
In the last 12 months, did you receive a scale and polish?
Yes 269 (43) 353 (56) 434 (69) 575 (57) 481 (56)
No 201 (32) 115 (18) 27 (4) 172 (17) 171 (20)
Missing 153 (25) 157 (25) 165 (26) 261 (26) 214 (25)
By whom?
Dentist 180 (29) 219 (35) 253 (40) 354 (35) 298 (34)
Hygienist 79 (13) 120 (19) 154 (25) 189 (19) 164 (19)
Both 6 (1) 12 (2) 22 (4) 24 (2) 16 (2)
Missing 358 (57) 274 (44) 197 (31) 441 (44) 388 (45)
Smoked in the last 12 months?
Yes 66 (11) 77 (12) 70 (11) 109 (11) 104 (12)
No 407 (65) 394 (63) 392 (63) 642 (64) 551 (64)
Missing 150 (24) 154 (25) 164 (26) 257 (25) 211 (24)
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TABLE 36 Participant dental characteristics at year 1 (continued )
Participant dental characteristics
Randomised group, n (%)
PI OHA
No (N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 860)
What type of toothbrush do you normally use?
Manual 283 (45) 280 (45) 266 (42) 443 (44) 386 (45)
Electric 168 (27) 166 (27) 167 (27) 271 (27) 230 (27)
Do not use brush 21 (3) 26 (4) 28 (4) 38 (4) 37 (4)
Missing 151 (24) 153 (24) 165 (26) 256 (25) 213 (25)
How often do you prefer to have a scale and polish?
Never 17 (3) 14 (2) 7 (1) 22 (2) 16 (2)
Once every 2 years 19 (3) 15 (2) 7 (1) 23 (2) 18 (2)
Once a year 109 (17) 127 (20) 70 (11) 149 (15) 157 (18)
Twice a year 233 (37) 213 (34) 266 (42) 398 (39) 314 (36)
Three times a year 39 (6) 55 (9) 46 (7) 74 (7) 66 (8)
Four times a year 42 (7) 37 (6) 50 (8) 68 (7) 61 (7)
More often 10 (2) 8 (1) 11 (2) 13 (1) 16 (2)
Missing 154 (25) 156 (25) 169 (27) 261 (26) 218 (25)
TABLE 37 Participant dental characteristics at year 2
Participant dental characteristics
Randomised group, n (%)
PI OHA
No (N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 860)
Date of last visit to the dental practice (years ago)
< 1 400 (64) 408 (65) 400 (64) 645 (64) 563 (65)
1–2 22 (4) 20 (3) 3 (0) 23 (2) 22 (3)
> 2 5 (1) – 2 (0) 4 (0) 3 (0)
Missing 196 (31) 197 (32) 221 (35) 336 (33) 278 (32)
Do you think of yourself as
A regular attendee 411 (66) 403 (64) 399 (64) 642 (64) 571 (66)
Someone who sees a dentist when in
pain or trouble
17 (3) 25 (4) 5 (1) 28 (3) 19 (2)
Missing 195 (31) 197 (32) 222 (35) 338 (34) 276 (32)
In the last 12 months, did you receive OHA?
Yes 302 (48) 346 (55) 343 (55) 550 (55) 441 (51)
No 123 (20) 79 (13) 64 (10) 121 (12) 145 (17)
Missing 198 (32) 200 (32) 219 (35) 337 (33) 280 (32)
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TABLE 37 Participant dental characteristics at year 2 (continued )
Participant dental characteristics
Randomised group, n (%)
PI OHA
No (N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 860)
By whom?
Dentist 226 (36) 221 (35) 189 (30) 368 (37) 268 (31)
Hygienist 37 (6) 73 (12) 90 (14) 92 (9) 108 (12)
Both 32 (5) 48 (8) 61 (10) 87 (9) 54 (6)
Missing 328 (53) 283 (45) 286 (46) 461 (46) 436 (50)
In the last 12 months, did you receive a scale and polish?
Yes 219 (35) 342 (55) 370 (59) 494 (49) 437 (50)
No 204 (33) 83 (13) 37 (6) 172 (17) 152 (18)
Missing 200 (32) 200 (32) 219 (35) 342 (34) 277 (32)
By whom?
Dentist 153 (25) 213 (34) 216 (35) 317 (31) 265 (31)
Hygienist 51 (8) 119 (19) 139 (22) 155 (15) 154 (18)
Both 6 (1) 8 (1) 12 (2) 16 (2) 10 (1)
Missing 413 (66) 285 (46) 259 (41) 520 (52) 437 (50)
Smoked in the last 12 months?
Yes 56 (9) 47 (8) 50 (8) 78 (8) 75 (9)
No 370 (59) 380 (61) 355 (57) 592 (59) 513 (59)
Missing 197 (32) 198 (32) 221 (35) 338 (34) 278 (32)
What type of toothbrush do you normally use?
Manual 255 (41) 233 (37) 218 (35) 369 (37) 337 (39)
Electric 148 (24) 165 (26) 166 (27) 265 (26) 214 (25)
Do not use brush 24 (4) 29 (5) 22 (4) 36 (4) 39 (5)
Missing 196 (31) 198 (32) 220 (35) 338 (34) 276 (32)
How often do you prefer to have a scale and polish?
Never 14 (2) 12 (2) 10 (2) 20 (2) 16 (2)
Once every 2 years 24 (4) 7 (1) 7 (1) 22 (2) 16 (2)
Once a year 98 (16) 120 (19) 59 (9) 137 (14) 140 (16)
Twice a year 210 (34) 204 (33) 225 (36) 351 (35) 288 (33)
Three times a year 30 (5) 40 (6) 48 (8) 68 (7) 50 (6)
Four times a year 39 (6) 34 (5) 38 (6) 50 (5) 61 (7)
More often 6 (1) 5 (1) 13 (2) 14 (1) 10 (1)
Missing 202 (32) 203 (32) 226 (36) 346 (34) 285 (33)
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Section 3: clinical and patient-reported outcomes by year of follow-up
Section 3 shows descriptive data for the clinical (Tables 38 and 39) and patient-reported (Tables 40 and 41)
outcomes.
TABLE 38 Attendance rates by randomised allocation
Attended 3-year examination
Randomised group, n (%)
PI OHA
No (N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
444 (71) 447 (72) 436 (70) 712 (71) 615 (71)
TABLE 39 Clinical outcomes for participants who attended clinical follow-up only
Clinical outcomes
Time
point
Randomised group, mean (SD), n
PI OHA
No 12-monthly 6-monthly Personalised Routine
Present teeth Baseline 23.4 (4.7),
444
23.5 (4.5),
447
23.8 (4.4),
436
23.4 (4.7),
712
23.7 (4.3),
615
Year 3 23.6 (4.8),
444
23.6 (4.6),
447
23.9 (4.5),
436
23.5 (4.8),
712
23.8 (4.3),
615
% of sites bleeding Baseline 32.8 (22.8),
444
31.5 (23.7),
447
32.8 (22.9),
436
33.7 (23.1),
712
30.8 (23.1),
615
Year 3 39.3 (23.1),
444
38.2 (25.6),
447
39.3 (24.2),
436
39.2 (23.8),
712
38.7 (24.9),
615
% of teeth with calculus
present
Baseline 35.0 (26.0),
444
35.9 (27.4),
447
33.3 (25.3),
436
33.3 (25.1),
712
36.4 (27.4),
615
Year 3 40.5 (29.6),
444
34.4 (26.3),
445
31.3 (24.5),
435
35.7 (27.1),
711
35.1 (27.2),
613
Mean clinical pocket depth
(mm)
Baseline 1.8 (0.3),
444
1.8 (0.3),
447
1.8 (0.3),
436
1.8 (0.3), 712 1.8 (0.3),
615
Year 3 1.9 (0.3),
444
1.9 (0.3),
446
1.9 (0.3),
436
1.9 (0.3), 712 1.9 (0.3),
614
Mean clinical pocket depth
(four sites with clinical pocket
depth of ≥ 4mm), n (%)
Baseline 47 (11) 58 (13) 47 (11) 89 (13) 63 (10)
Year 3 63 (14) 62 (14) 59 (14) 98 (14) 86 (14)
TABLE 40 Questionnaire response rates by randomised group
Year
Randomised group, n (%)
PI OHA
No (N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
1 476 (76) 472 (76) 463 (74) 753 (75) 658 (76)
2 430 (69) 428 (68) 408 (65) 674 (67) 592 (68)
3 494 (79) 486 (78) 472 (75) 780 (77) 672 (78)
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TABLE 41 Patient-reported outcomes of those who replied to the follow-up questionnaire at 3 years
Outcomes
Time
point
Randomised group, mean (SD), n
PI OHA
No 12-monthly 6-monthly Personalised Routine
Self-efficacy Baseline 5.2 (1.1), 490 5.2 (1.2), 477 5.2 (1.2), 463 5.2 (1.2), 766 5.2 (1.2), 664
Year 1 5.2 (1.1), 418 5.1 (1.1), 417 5.2 (1.1), 407 5.2 (1.1), 665 5.2 (1.1), 577
Year 2 5.3 (1.1), 398 5.2 (1.2), 394 5.3 (1.1), 386 5.2 (1.1), 632 5.3 (1.2), 546
Year 3 5.3 (1.1), 493 5.2 (1.1), 485 5.3 (1.1), 472 5.3 (1.1), 780 5.2 (1.1), 670
PBC Baseline 4.4 (1.2), 486 4.4 (1.2), 474 4.5 (1.2), 462 4.5 (1.2), 764 4.4 (1.2), 658
Year 1 4.4 (1.2), 418 4.3 (1.2), 417 4.4 (1.2), 409 4.4 (1.2), 666 4.3 (1.2), 578
Year 2 4.4 (1.2), 395 4.5 (1.3), 394 4.3 (1.3), 386 4.4 (1.3), 630 4.4 (1.2), 545
Year 3 4.4 (1.3), 412 4.4 (1.2), 411 4.4 (1.2), 397 4.4 (1.3), 660 4.4 (1.2), 560
Attitude Baseline 5.8 (1.2), 489 5.9 (1.1), 475 5.7 (1.3), 463 5.8 (1.2), 767 5.8 (1.2), 660
Year 1 5.4 (1.6), 418 5.5 (1.5), 417 5.7 (1.4), 409 5.5 (1.5), 666 5.5 (1.5), 578
Year 2 5.6 (1.4), 397 5.6 (1.5), 394 5.6 (1.4), 386 5.5 (1.5), 632 5.6 (1.4), 545
Year 3 5.5 (1.6), 414 5.6 (1.4), 410 5.6 (1.5), 397 5.5 (1.5), 659 5.5 (1.5), 562
Subjective norm Baseline 5.3 (1.1), 479 5.3 (1.2), 469 5.3 (1.1), 453 5.3 (1.1), 749 5.2 (1.1), 652
Year 1 4.9 (1.2), 412 4.9 (1.2), 416 5.0 (1.2), 408 4.9 (1.2), 663 4.9 (1.2), 573
Year 2 4.9 (1.1), 392 4.9 (1.1), 390 4.9 (1.1), 384 4.9 (1.1), 624 4.9 (1.1), 542
Year 3 4.9 (1.2), 409 4.9 (1.2), 409 4.9 (1.1), 396 4.9 (1.2), 654 4.9 (1.1), 560
Behaviour score Baseline 4.7 (1.7), 485 4.7 (1.8), 476 4.8 (1.7), 463 4.6 (1.7), 762 4.9 (1.8), 662
Year 1 5.0 (1.7), 418 5.1 (1.7), 416 5.2 (1.7), 406 5.0 (1.7), 665 5.2 (1.7), 575
Year 2 5.1 (1.6), 398 5.1 (1.7), 396 5.3 (1.6), 383 5.1 (1.6), 632 5.2 (1.6), 545
Year 3 5.1 (1.7), 412 5.1 (1.7), 411 5.4 (1.6), 395 5.1 (1.7), 658 5.2 (1.6), 560
Intention score Baseline 5.5 (1.8), 445 5.4 (1.8), 451 5.5 (1.8), 418 5.3 (1.8), 707 5.6 (1.7), 607
Year 1 5.7 (1.7), 400 5.6 (1.7), 401 5.7 (1.7), 393 5.7 (1.7), 642 5.6 (1.7), 552
Year 2 5.6 (1.7), 387 5.6 (1.7), 377 5.7 (1.7), 373 5.6 (1.7), 614 5.7 (1.7), 523
Year 3 5.6 (1.7), 403 5.6 (1.7), 390 5.8 (1.7), 384 5.7 (1.7), 636 5.7 (1.7), 541
OHIP Baseline 5.6 (7.0), 476 6.0 (7.3), 466 6.1 (7.5), 456 5.8 (7.4), 752 6.1 (7.2), 646
Year 1 4.9 (6.5), 415 5.6 (7.0), 407 5.0 (6.6), 395 4.9 (6.5), 652 5.4 (7.0), 565
Year 2 4.7 (6.5), 389 5.4 (7.0), 387 4.4 (6.0), 381 4.8 (6.5), 619 5.0 (6.6), 538
Year 3 5.2 (6.8), 408 5.3 (6.7), 399 4.9 (6.7), 387 4.8 (6.5), 641 5.5 (6.9), 553
Has a plan to either
brush or floss better
Baseline 0.3 (0.4), 494 0.2 (0.4), 486 0.3 (0.4), 472 0.3 (0.4), 780 0.2 (0.4), 672
Year 1 0.2 (0.4), 494 0.2 (0.4), 486 0.2 (0.4), 472 0.2 (0.4), 780 0.2 (0.4), 672
Year 2 0.2 (0.4), 494 0.2 (0.4), 486 0.2 (0.4), 472 0.2 (0.4), 780 0.2 (0.4), 672
Year 3 0.2 (0.4), 494 0.2 (0.4), 486 0.2 (0.4), 472 0.2 (0.4), 780 0.2 (0.4), 672
Have you had
bleeding from your
gums when brushing
your teeth?
Year 3 2.2 (1.0), 484 2.2 (1.0), 473 2.2 (1.0), 459 2.2 (1.0), 777 2.2 (1.0), 639
Received private PI,
n (%)
Year 3 75 (15) 103 (21) 106 (22) 149 (19) 135 (20)
Missing, n (%) 228 (46) 221 (45) 227 (48) 372 (48) 304 (45)
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Section 4: tertiary outcomes (at baseline and 3 years)
Section 4 describes the tertiary measures at baseline (Table 42) and 3-year follow-up (Table 43).
TABLE 42 Tertiary outcomes at baseline
Tertiary outcomes at
baseline
Randomised group
PI OHA
No (N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
How clean do your teeth feel, mean (SD), n
After you brush 5.8 (0.9), 605 5.8 (0.9), 608 5.9 (0.9), 605 5.8 (0.9), 975 5.8 (0.9), 843
After a scale and polish 6.6 (0.8), 574 6.5 (0.9), 589 6.6 (0.8), 574 6.6 (0.9), 927 6.6 (0.8), 810
How clean do your teeth look, mean (SD), n
After you brush 5.3 (1.2), 608 5.3 (1.3), 603 5.3 (1.2), 601 5.3 (1.2), 970 5.2 (1.2), 842
After a scale and polish 6.2 (1.1), 575 6.1 (1.2), 585 6.1 (1.1), 567 6.2 (1.1), 928 6.1 (1.1), 799
How pleasant do your teeth feel, mean (SD), n
After you brush 5.8 (1.1), 607 5.7 (1.1), 604 5.8 (1.1), 600 5.8 (1.1), 971 5.7 (1.1), 840
After a scale and polish 6.3 (1.0), 574 6.3 (1.0), 581 6.3 (1.0), 565 6.3 (1.0), 924 6.3 (1.1), 796
How pleasant do your teeth look, mean (SD), n
After you brush 5.0 (1.4), 608 5.0 (1.4), 603 5.1 (1.4), 598 5.1 (1.4), 968 5.0 (1.4), 841
After a scale and polish 5.8 (1.4), 579 5.7 (1.3), 580 5.7 (1.4), 566 5.7 (1.4), 923 5.7 (1.4), 802
Do you experience sensitivity in your teeth? n (%)
Yes 304 (49) 293 (47) 282 (45) 445 (44) 434 (50)
No 304 (49) 309 (49) 323 (52) 527 (52) 409 (47)
Missing 15 (2) 23 (4) 21 (3) 36 (4) 23 (3)
How sensitive are your teeth? n (%)
Rarely sensitive 59 (9) 44 (7) 41 (7) 82 (8) 62 (7)
Sometimes sensitive,
rarely interfering with
what I eat or drink
166 (27) 152 (24) 135 (22) 221 (22) 232 (27)
Sometimes sensitive,
occasionally interfering
with what I eat or drink
79 (13) 90 (14) 98 (16) 135 (13) 132 (15)
Always sensitive 13 (2) 17 (3) 10 (2) 21 (2) 19 (2)
Missing 306 (49) 322 (52) 342 (55) 549 (54) 421 (49)
How sensitive are your
teeth?
2.1 (0.8), 317 2.3 (0.8), 303 2.3 (0.7), 284 2.2 (0.8), 459 2.2 (0.7), 445
On contact with hot
and cold, how often do
you get pain?
3.1 (1.4), 321 3.1 (1.4), 321 3.0 (1.4), 295 3.1 (1.4), 480 3.1 (1.3), 457
On contact with hot
and cold, how severe is
the pain?
2.9 (1.3), 319 2.8 (1.3), 321 2.9 (1.2), 292 2.8 (1.3), 477 2.9 (1.2), 455
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TABLE 43 Tertiary outcomes at 3 years
Tertiary outcomes at
3 years
Randomised group
PI OHA
No (N= 623)
12-monthly
(N= 625)
6-monthly
(N= 626)
Personalised
(N= 1008)
Routine
(N= 866)
How clean do your teeth feel, mean (SD), n
After you brush 6.0 (0.8), 408 6.0 (0.8), 408 6.1 (0.8), 395 6.0 (0.8), 656 6.0 (0.8), 555
After a scale and polish 6.6 (0.6), 397 6.6 (0.8), 407 6.7 (0.7), 386 6.7 (0.7), 643 6.6 (0.7), 547
How clean do your teeth look, mean (SD), n
After you brush 5.5 (1.2), 406 5.4 (1.2), 405 5.6 (1.2), 394 5.5 (1.2), 652 5.5 (1.2), 553
After a scale and polish 6.3 (1.0), 391 6.1 (1.1), 404 6.2 (1.1), 383 6.2 (1.1), 639 6.2 (1.1), 539
How pleasant do your teeth feel, mean (SD), n
After you brush 5.9 (1.0), 408 5.9 (1.0), 408 6.0 (1.0), 392 6.0 (1.0), 652 5.9 (1.0), 556
After a scale and polish 6.5 (0.9), 393 6.4 (1.0), 404 6.5 (0.9), 385 6.5 (0.9), 640 6.4 (1.0), 542
How pleasant do your teeth look, mean (SD), n
After you brush 5.3 (1.3), 406 5.2 (1.3), 407 5.4 (1.3), 391 5.3 (1.3), 650 5.2 (1.4), 554
After a scale and polish 5.9 (1.3), 396 5.8 (1.4), 404 5.9 (1.3), 382 5.9 (1.3), 638 5.9 (1.4), 544
Do you experience sensitivity in your teeth?, n (%)
Yes 161 (26) 165 (26) 157 (25) 241 (24) 242 (28)
No 235 (38) 224 (36) 224 (36) 385 (38) 298 (34)
Missing 227 (36) 236 (38) 245 (39) 382 (38) 326 (38)
How sensitive are your teeth? n (%)
Rarely sensitive 47 (8) 46 (7) 38 (6) 69 (7) 62 (7)
Sometimes sensitive,
rarely interfering with
what I eat or drink
73 (12) 87 (14) 85 (14) 131 (13) 114 (13)
Sometimes sensitive,
occasionally interfere
50 (8) 51 (8) 48 (8) 73 (7) 76 (9)
Always sensitive 9 (1) 3 (0) 1 (0) 4 (0) 9 (1)
Missing 444 (71) 438 (70) 454 (73) 731 (73) 605 (70)
How sensitive are your
teeth?, mean (SD), n
2.1 (0.9), 179 2.1 (0.8), 187 2.1 (0.7), 172 2.0 (0.8), 277 2.1 (0.8), 261
On contact with hot and
cold, how often do you get
pain?, mean (SD), n
2.8 (1.5), 199 2.8 (1.2), 196 2.8 (1.3), 183 2.7 (1.2), 299 3.0 (1.4), 279
On contact with hot and
cold, how severe is the
pain?, mean (SD), n
2.5 (1.2), 199 2.7 (1.2), 195 2.7 (1.2), 183 2.6 (1.2), 298 2.6 (1.2), 279
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Appendix 2 Health economics
Section 1: additional detailed methods for costing, the discrete choice
experiment and mapping discrete choice experiment valuations to the
trial outcomes
Calculations of unit costs
The cost of consumer products was based on a sample of commonly available products in the marketplace.
Given that data on the expense of replacing products (e.g. toothbrushes, interdental brushes) were not
collected, we have taken a sample of products to represent the variability and the range available. This is not
intended to be an exhaustive list of products.
TABLE 44 Cost of consumer dental care products
Item Type Unit cost (£) Reference
Interdental
brushes
Superdrug Totalcare interdental
brushes (6 pack)
2.49 Superdrug (www.superdrug.com; accessed
1 February 2017)
TePe interdental brushes 0.4 mm
(6 pack)
3.05 Superdrug (www.superdrug.com; accessed
1 February 2017)
Boots Expert TePe interdental
brushes 0.4 mm (6 pack)
3.25 Boots (www.boots.com; accessed 1 February 2017)
TePe interdental brush blue
0.6 mm (6 pack)
5.70 British Corner Shop (www.britishcornershop.co.uk;
accessed 1 February 2017)
Average 3.62
(0.60 each)
Electric
toothbrush
Oral-B® (Proctor & Gamble Co.,
Cincinatti, OH, USA) Genius 9000
Black
140.00 Boots (www.boots.com; accessed 1 February 2017)
Oral-B® Pro 600 49.99 Superdrug (www.superdrug.com; accessed
1 February 2017)
Philips (Amsterdam, the
Netherlands) Sonicare
DiamondClean
249.99 Boots (www.boots.com; accessed 1 February 2017)
Colgate® (Colgate-Palmolive, New
York, NY, USA) ProClinical® C350
59.99 Boots (www.boots.com; accessed 1 February 2017)
Oral-B® Vitality Precision 18.99 Tesco (www.tesco.com; accessed 1 February 2017)
Average 103.79
Manual
toothbrush
Sensodyne® (GlaxoSmithKline plc,
GSK House, Middlesex, UK)
Precision Toothbrush
3.00 Tesco (www.tesco.com; accessed 1 February 2017)
Aquafresh® (GSK) Complete Care
Medium
2.50 Tesco (www.tesco.com; accessed 1 February 2017)
Colgate® 360 Max White 4.00 Asda (www.asda.com; accessed 1 February 2017)
Colgate® Slim Soft 1.22 Sainsbury’s (www.sainsburys.co.uk; accessed
1 February 2017)
Average 2.68
continued
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Discrete choice experiment attributes and levels by segment of design
TABLE 44 Cost of consumer dental care products (continued )
Item Type Unit cost (£) Reference
Heads for
electric
toothbrush
Oral-B® Precision Clean brush
heads (4 pack)
18.75
(4.69 each)
Superdrug (www.superdrug.com; accessed
1 February 2017)
Philips Sonicare Pro Results
Standard Sonic toothbrush heads
(4 pack)
25.00
(6.25 each)
Philips (www.philips.co.uk; accessed
1 February 2017)
Colgate® ProClinical Sensitive
refill brush heads (4 pack)
18.99
(4.75 each)
Boots (www.boots.com; accessed
1 February 2017)
Oral-B® Sensitive Clean brush
heads (4 pack)
16.00
(4.00 each)
Sainsbury’s (www.sainsburys.co.uk; accessed
1 February 2017)
Average 19.69
(4.92 each)
TABLE 45 Experimental design, by segmented group
Attribute
Dental Health
Good Moderate Poor
Levels
considered for
choice sets Opt-out
Levels considered
for choice sets Opt-out
Levels considered
for choice sets Opt-out
Detailed and
personalised
OHA
All None All None All None
Frequency of PI All None All None All None
Bleeding gums Never Occasional Hardly ever Fairly
often
Occasional Very
often
Hardly ever Occasional Fairly often
Occasional Fairly often Very often
Look and feel Very clean Moderately
clean
Clean Unclean Moderately clean Very
unclean
Clean Moderately clean Unclean
Moderately clean Unclean Very unclean
Cost (£) All 0 All 0 All 0
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Mapping discrete choice experiment valuations to trial outcomes
TABLE 46 Mapping DCE WTP values to trial outcomes
DCE outcome Trial outcome/variable Mapping method/notes/assumptions
WTP value for routine or
personalised OHA provided by
dentist/hygienist
Type of OHA by randomisation l Mean WTP value applied to individuals based on
randomised group, according to provider of
treatment to each individual trial participant – full
compliance with type of OHA
l Total value assigned to year 1 as OHA given
at baseline
Provider of initial intervention
WTP value for different
annual frequency of PI,
provided by hygienist/dentist
Frequency of PI (routine data) l WTP value assigned to number of PIs
actually received
l Number of PIs based on routine data sources for
Scotland (PI item) and England (clinical data set
from FP17 routine data forms75), excluding
assumed baseline and final study visits
l Assumed stepwise linear function between 0, 3, 6
and more PIs over trial follow-up
l Provider of PI (dentist/hygienist) sourced from
baseline clinical examination forms and assumed
consistent for duration of follow-up
l Value assigned to the year in which PI was given
Provider (participant
questionnaire)
WTP value for frequency of
bleeding gums
Frequency of bleeding gums at
the 3-year follow-up time point
l Direct map from DCE question onto clinical trial
outcome, at an individual trial participant level at
3 years’ follow-up (i.e. how frequently do your
gums bleed when you brush your teeth?)
l WTP values attached to trial outcomes for
complete cases. Values imputed for participants
with missing trial outcomes using multiple
imputation methods
l Total value assigned to year 3
WTP value for aesthetic
outcome (teeth look and feel
clean and healthy)
How clean do your teeth look
and feel ‘right now’?
l Mapping for the base case based on an aggregate
outcome from four different measures in the trial
asking respondents how clean and healthy their
teeth look and feel ‘right now’
l Average score on a 7-point scale in the trial
(rounded to nearest whole number) reduced to a
5-point scale collapsing extreme ends of the values
and assigning WTP values from the DCE directly to
each trial participant aggregate score
l Sensitivity analysis to explore a scenario in which
all WTP values are mapped to a similar question
asking respondents how clean teeth look and feel
‘after brushing’, making the alternative assumption
that respondents to the DCE may relate how clean
their teeth look and feel to when they brush
l WTP value attached to trial outcomes for complete
cases. Values imputed for participants with missing
trial outcomes using multiple imputation methods
l Value assigned to each year
The annual cost to you N/A l Cost attribute used to calculate annual WTP for
the outcomes measured above
N/A, not applicable.
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Section 2: research conducted for questionnaire development
Literature review
The initial set of draft attributes and levels presented to our advisory group for feedback was informed by
a structured review of the literature regarding patient preferences for the processes and outcomes of
dental care. The review searched for qualitative studies and surveys from 2000 to 2014 of preferences,
experiences, attitudes, beliefs or opinions of adult patients or the general population. Studies were
included if they related to routine or preventative dental care. The literature review focused on studies
which could inform the selection of attributes for the DCEs. In brief, 15 articles were included and
assessed. There was clear qualitative evidence on processes and organisational aspects of care that patients
value. Continuity of care, and being treated ‘as a person, not as a patient’ were viewed positively.76–78
Dental anxiety and fear were significant barriers to attending the dentist.79,80 The review reaffirmed the
importance of costs,76,81,82 and provider of care.76,83
There was less information on preferences for dental health outcomes, such as bleeding gums (the primary
clinical end point for the trial). Therefore, it was crucial to include this as an attribute and to ensure that it
was framed correctly within the DCE. There was no information from the literature about the trade-offs
between aesthetic and clinical outcomes, particularly for people having PI. The lack of relevant literature
motivated the decision to undertake primary FG research.
Focus groups
After development of an initial set of attributes and levels important for the trial, and based on the
literature available, we ran FG discussions to see if these issues were important to the general population
(potential preventative dental care patients) and to determine if we omitted anything relevant and
important for our research questions.
Eighteen respondents from the general population in Aberdeen were recruited into four FG sessions.
Each group consisted of four or five respondents. FG discussions were recorded, transcribed and analysed
following a qualitative thematic framework. The FG protocol was approved by the University of Aberdeen
College Ethics Review Board. The FGs provided a rich data set with varied demographic characteristics.
Saturation was achieved after the second group.
Focus group results are discussed in the context of developing attributes and levels for the DCEs. The
goods to be valued within the DCE were all found to be important to participants, namely frequency of
visits, PI and OHA. Participants preferred to avoid dental pain, tooth loss and bad breath. Bleeding gums
were important, but only after the facilitator encouraged discussion of this issue. Bleeding was associated
with brushing. A description of how bleeding from a clinical point of view might translate into brushing
is presented in the DCE to ground the attribute in reality. Dental pain was not directly included as an
attribute as it would dominate all of the other attributes in the choice sets, limiting the ability to value any
potential differences between groups in trial outcomes. As aesthetic improvement was a prominent reason
in the FGs for having a PI, we included an attribute asking respondents to value how clean their teeth look
and feel. This aesthetic attribute was intended to value wider, non-health, benefits of PI or OHA.
Focus group data were further used to frame the questions and explain the attributes in the DCEs. For
example, many respondents were unaware of who a dental hygienist was, and their knowledge was
clearly dependent on experience. A comprehensive description of the roles and responsibilities of a dental
hygienist was thus included. There was a preference for personalised care; however, the meaning of
‘personalised’ is specific to each individual. The survey therefore included a detailed description of what we
meant by ‘personalised’ OHA, in line with the intervention delivered in the trial. Furthermore, many FG
participants tended to merge their preferences for PI with a routine visit to the dentist as the two often
happen at the same visit. In order to obtain preferences for PI, as opposed to a regular check-up, we
tailored the explanation of the PI attribute, emphasising the difference between PI and routine check-ups.
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Focus group data identified important contextual information. For example, respondents who had frequent
bleeding tended to be less bothered by it. Respondents with experience of a dental hygienist had a more
positive view of their role. Fear, anxiety, continuity of care and trust were important drivers of preferences.
These findings shaped the selection of a number of contextual questions for inclusion at the end of the
DCE surveys.
Think-aloud interviews
Once the final design was decided, we recruited five members of the general population and five
colleagues to work through the survey, providing comments on the content and framing of the questions.
We asked respondents to focus on areas of the questionnaire that were difficult to understand or any
problems that they experienced as they went along. Particular attention was paid to how the choice tasks
were interpreted and if there was any evidence of decision heuristics or attribute non-attendance. In
general, respondents reacted well to the questionnaire. A number of minor bugs in the process were
identified and corrected and some minor changes were made to clarify the instructions for the choice
tasks, in particular explaining what should and should not be considered when making the choices. No
changes were made to the DCE design at this stage as all attributes and levels were found to be
acceptable to respondents.
Pilot survey
We conducted a comprehensive pilot study with an online representative sample of the general
population. A major concern with the external validity of DCE responses relates to the issue of hypothetical
bias, in which the respondent’s stated preferences are not as they would act in reality. A particularly
problematic issue is that, in the presence of hypothetical bias, respondents often overstate the value they
place on a good or service. The implication is biased estimates of WTP and, hence, an overvaluation of
services in a CBA. Hypothetical bias may therefore contribute to incorrect policy recommendations.
There are many potential causes of hypothetical bias and much literature on how best to address it.
We compared a number of suggested approaches, including a cheap talk script, a consequentiality script
and asking respondents to sign an honesty oath. All approaches were compared with a standard practice
approach of reminding respondents about the availability of close substitutes and asking them to consider
their budget constraints when answering the choice tasks. The pilot questionnaire was administered to a
nationally representative sample of the general population, with oversampling (n = 100) in Scotland.
The Qualtrics survey platform was used to deliver the survey online.
To determine the presence or otherwise of hypothetical bias, we estimated marginal WTP and predicted
uptake from the DCE. We compared results across groups. We found no clear evidence of differences
across groups. While our sample was small, we were reasonably confident that the base-case approach
was sufficient for the main study.
The pilot study was also used to assess the direction of effect of the included attributes and levels. The
pilot data were analysed using both simple conditional logit model and mixed logit models, finding that all
attributes and levels had good face validity, with the expected coefficient signs and we found that WTP
estimates were within the extremes of the levels of the cost attribute presented (i.e. no attribute level
was valued at a WTP value of > £200 per year). Therefore, we concluded that the pilot version without
correction for hypothetical bias was appropriate for the main phase of data collection.
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Section 3: detailed claims for Scottish routine data
TABLE 47 Details of dental claims (Scotland)
Routine data claim
OHA, number of claims
Overall total,
n (n= 1337)
Routine Personalised
No PI
(n= 192)
12-monthly
PI (n= 193)
6-monthly PI
(n= 195)
Total
(n= 580)
No PI
(n= 250)
12-monthly
PI (n= 255)
6-monthly PI
(n= 252)
Total
(n= 757)
Clinical 498 495 522 1515 608 629 673 1910 3425
Simple scaling and polishing 253 333 519 1105 238 447 644 1329 2434
Small film 160 149 162 471 232 229 208 669 1140
Composite or synthetic resin 95 112 94 301 117 134 122 373 674
Amalgam 103 102 106 311 129 109 122 360 671
Additional fee for each visit 28 39 27 94 35 43 31 109 203
Fee per course of treatment 28 39 27 94 35 43 31 109 203
Incisal acid etch 26 33 30 89 44 42 27 113 202
Glass ionomer, silicate or silico-phosphate 28 27 33 88 23 39 30 92 180
Additional fee for first inlay or crown in the
same arch
17 11 18 46 29 33 31 93 139
Stoning and smoothing surface of a tooth 5 9 8 22 21 38 31 90 112
Treatment of sensitive cementum or dentine 6 13 19 38 14 25 15 54 92
Extensive clinical 13 11 11 35 23 14 18 55 90
Refixing or recementing a crown 15 13 12 40 15 18 14 47 87
Bonded full or jacket crown – non-precious
metal
11 8 10 29 17 18 20 55 84
Treatment urgently required for acute
conditions
14 16 11 41 10 16 12 38 79
Other treatment claims 158 131 133 422 192 253 216 661 1083
Total claims 1458 1541 1742 4741 1782 2130 2245 6157 10,898
If a code is not claimed, zero resource use is assumed.
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Section 4: participant-reported contact with non-dental health services
TABLE 48 Descriptive statistics for participant-reported contact with non-dental health services
NHS resource use item
OHA, n/N (%)
Routine Personalised
No PI
(n= 289)
12-monthly PI
(n= 287)
6-monthly PI
(n= 290)
Total
(n= 866)
No PI
(n= 334)
12-monthly PI
(n= 338)
6-monthly PI
(n= 335)
Total
(n= 1007)
NHS 24 Year 1 9/204 (4) 7/203 (3) 4/200 (2) 20/607 (3) 4/242 (2) 6/233 (3) 6/240 (3) 16/715 (2)
Year 2 5/196 (3) 5/186 (3) 6/179 (3) 16/561 (3) 6/207 (3) 3/214 (1) 2/209 (1) 11/630 (2)
Year 3 1/186 (1) 2/177 (1) 3/170 (2) 6/533 (1) 4/207 (2) 2/215 (1) 1/209 (0) 7/631 (1)
GP Year 1 26/204 (13) 24/205 (12) 20/200 (10) 70/609 (11) 25/244 (10) 28/237 (12) 17/240 (7) 70/721 (10)
Year 2 21/196 (11) 20/188 (11) 18/179 (10) 59/563 (10) 24/208 (12) 19/213 (9) 19/209 (9) 62/630 (10)
Year 3 23/187 (12) 9/179 (5) 7/168 (4) 39/534 (7) 20/207 (10) 17/217 (8) 13/209 (6) 50/633 (8)
A&E Year 1 10/202 (5) 9/204 (4) 4/198 (2) 23/604 (4) 3/242 (1) 10/236 (4) 7/239 (3) 20/717 (3)
Year 2 9/196 (5) 6/186 (3) 9/178 (5) 24/560 (4) 7/207 (3) 8/214 (4) 4/210 (2) 19/631 (3)
Year 3 1/188 (1) 1/176 (1) 3/169 (2) 5/533 (1) 3/207 (1) 4/215 (2) 3/208 (1) 10/630 (2)
Outpatients Year 1 13/204 (6) 12/203 (6) 18/202 (9) 43/609 (7) 14/243 (6) 12/237 (5) 10/239 (4) 36/719 (5)
Year 2 13/196 (7) 12/188 (6) 12/178 (7) 37/562 (7) 16/209 (8) 8/214 (4) 10/210 (5) 34/633 (5)
Year 3 13/188 (7) 7/179 (4) 8/171 (5) 28/538 (5) 9/207 (4) 9/216 (4) 8/209 (4) 26/632 (4)
Inpatients Year 1 10/203 (5) 5/202 (2) 5/199 (3) 20/604 (3) 3/243 (1) 7/236 (3) 3/239 (1) 13/718 (2)
Year 2 7/194 (4) 5/185 (3) 6/176 (3) 18/555 (3) 5/208 (2) 4/212 (2) 1/208 (0) 10/628 (2)
Year 3 3/188 (2) 1/177 (1) 1/167 (1) 5/532 (1) 1/207 (0) 1/212 (0) 2/209 (1) 4/628 (1)
A&E, accident and emergency; GP, general practitioner.
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Section 5: unit opportunity cost of time and travel to dental appointments
TABLE 49 Calculation of unit opportunity cost of time and travel to dental appointments
Time and travel costs
OHA, n, mean cost (SD)
Routine Personalised
No PI
(N= 289)
12-monthly
PI (N= 287)
6-monthly
PI (N= 290)
Total
(N= 866)
No PI
(N= 334)
12-monthly
PI (N= 338)
6-monthly
PI (N= 335)
Total
(N= 1007)
Participant time and travel costs
Participant mode of transport, n (%)
Data completeness 284 (98) 281 (98) 283 (98) 848 (98) 326 (98) 329 (97) 324 (97) 979 (97)
Walked 57 (20) 64 (22) 66 (23) 187 (22) 77 (23) 76 (22) 72 (21) 225 (22)
Cycled 7 (2) 5 (2) 5 (2) 17 (2) 8 (2) 8 (2) 4 (1) 20 (2)
Private car 186 (64) 173 (60) 177 (61) 536 (62) 209 (63) 213 (63) 212 (63) 634 (63)
Bus 27 (9) 35 (12) 32 (11) 94 (11) 25 (7) 24 (7) 31 (9) 80 (8)
Taxi 1 (0) 3 (1) 0 (0) 4 (0) 5 (1) 2 (1) 2 (1) 9 (1)
Other, non-specified 3 (1) 0 (0) 1 (0) 4 (0) 1 (0) 2 (1) 1 (0) 4 (0)
Metro 1 (0) 0 (0) 1 (0) 2 (0) 0 (0) 2 (1) 1 (0) 3 (0)
Boat 0 (0) 0 (0) 0 (0) 0 (0) 1 (0) 2 (1) 0 (0) 3 (0)
Train 2 (1) 1 (0) 1 (0) 4 (0) 0 (0) 0 (0) 1 (0) 1 (0)
Missing 5 (2) 6 (2) 7 (2) 18 (2) 8 (2) 9 (3) 11 (3) 28 (3)
Transportation costs, n, mean (£) (SD, £) 227, 3.46
(4.70)
238, 3.62
(6.32)
238, 3.47
(5.54)
267, 3.46
(6.35)
274, 3.60
(5.11)
703, 3.52
(5.56)
274, 3.63
(8.40)
815, 3.56
(6.75)
Minutes travelling/waiting, n, mean (SD) 281, 31 (25.56) 276, 31.2
(27.81)
279, 31.36
(25.29)
318, 28.72
(23.66)
322, 29.88
(27.4)
836, 31.19
(26.21)
326, 29.91
(28.11)
966, 29.51
(26.46)
Participant alternative activity, n (%)
Data completeness 281 (97) 276 (96) 276 (95) 833 (96) 324 (97) 328 (97) 323 (96) 975 (97)
Housework 59 (20) 57 (20) 55 (19) 171 (20) 58 (17) 60 (18) 75 (22) 193 (19)
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Time and travel costs
OHA, n, mean cost (SD)
Routine Personalised
No PI
(N= 289)
12-monthly
PI (N= 287)
6-monthly
PI (N= 290)
Total
(N= 866)
No PI
(N= 334)
12-monthly
PI (N= 338)
6-monthly
PI (N= 335)
Total
(N= 1007)
Child care 24 (8) 17 (6) 17 (6) 58 (7) 19 (6) 31 (9) 20 (6) 70 (7)
Caring for a friend/relative 6 (2) 6 (2) 3 (1) 15 (2) 7 (2) 6 (2) 5 (1) 18 (2)
Unemployed 14 (5) 11 (4) 15 (5) 40 (5) 9 (3) 18 (5) 14 (4) 41 (4)
Paid work 114 (39) 118 (41) 114 (39) 346 (40) 138 (41) 140 (41) 138 (41) 416 (41)
Voluntary work 3 (1) 5 (2) 5 (2) 13 (2) 6 (2) 2 (1) 4 (1) 12 (1)
Leisure activities 35 (12) 47 (16) 46 (16) 128 (15) 66 (20) 47 (14) 48 (14) 161 (16)
Other non-specified 5 (2) 8 (3) 8 (3) 21 (2) 8 (2) 13 (4) 10 (3) 31 (3)
Studying 12 (4) 3 (1) 5 (2) 20 (2) 5 (1) 6 (2) 4 (1) 15 (1)
Retired 5 (2) 3 (1) 5 (2) 13 (2) 7 (2) 3 (1) 4 (1) 14 (1)
Self-employed 2 (1) 1 (0) 1 (0) 4 (0) 1 (0) 2 (1) 1 (0) 4 (0)
Long-term sick/disabled 2 (1) 0 (0) 2 (1) 4 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Missing 8 (3) 11 (4) 14 (5) 33 (4) 10 (3) 10 (3) 12 (4) 32 (3)
Opportunity cost, alternative activities, n, mean
(£) (SD, £)
280, 7.16
(5.10)
274, 7.20
(5.80)
274, 7.23
(5.36)
320, 6.42
(4.54)
323, 6.99
(5.77)
828, 7.20
(5.42)
325, 6.90
(6.12)
968, 6.77
(5.52)
Participant unit cost for time and travel, n, mean
(£) (SD, £)
222, 10.53
(8.42)
234, 11.07
(10.70)
230, 10.83
(9.71)
261, 9.85
(9.59)
272, 10.74
(9.87)
686, 10.81
(9.66)
270, 10.61
(13.26)
803, 10.41
(11.04)
Companion time and travel costs
Participant accompanied, n (%)
Yes 52 (18) 36 (13) 38 (13) 126 (15) 55 (16) 50 (15) 41 (12) 146 (14)
No 220 (76) 231 (80) 233 (80) 684 (79) 265 (79) 268 (79) 274 (82) 807 (80)
Missing 17 (6) 20 (7) 19 (7) 56 (6) 14 (4) 20 (6) 20 (6) 54 (5)
Relationship of companiona
Partner 21 (36) 16 (41) 15 (35) 52 (37) 29 (51) 25 (45) 14 (33) 68 (44)
Other relative 16 (28) 14 (36) 19 (44) 49 (35) 15 (26) 16 (29) 13 (30) 44 (28)
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TABLE 49 Calculation of unit opportunity cost of time and travel to dental appointments (continued )
Time and travel costs
OHA, n, mean cost (SD)
Routine Personalised
No PI
(N= 289)
12-monthly
PI (N= 287)
6-monthly
PI (N= 290)
Total
(N= 866)
No PI
(N= 334)
12-monthly
PI (N= 338)
6-monthly
PI (N= 335)
Total
(N= 1007)
Paid companion 0 (0) 0 (0) 1 (2) 1 (1) 0 (0) 0 (0) 0 (0) 0 (0)
Friend 2 (3) 1 (3) 0 (0) 3 (2) 0 (0) 1 (2) 0 (0) 1 (1)
Other 19 (33) 8 (21) 8 (19) 35 (25) 13 (23) 13 (24) 16 (37) 42 (27)
Companion travel costs
Bus fare, n, mean (£) (SD, £) 34, 0.16 (0.75) 28, 0.08
(0.30)
30, 0.34
(0.84)
92, 0.19 (0.68) 29, 0.21
(0.53)
27, 0.26
(0.77)
24, 0.12
(0.42)
80, 0.20
(0.59)
Total costs, n, mean (£) (SD, £)b 263, 0.38
(2.55)
263, 0.09
(0.59)
265, 0.22
(1.60)
791, 0.23
(1.77)
309, 0.15
(0.85)
311, 0.20
(1.00)
308, 0.23
(1.34)
928, 0.19
(1.08)
Companion alternative activity, n (%)
Housework 5 (9) 3 (8) 6 (15) 14 (11) 12 (23) 11 (21) 3 (8) 26 (18)
Child care 3 (5) 1 (3) 3 (8) 7 (5) 1 (2) 4 (8) 4 (11) 9 (6)
Caring for a relative/friend 3 (5) 1 (3) 3 (8) 7 (5) 1 (2) 3 (6) 1 (3) 5 (4)
Unemployed 0 (0) 1 (3) 3 (8) 4 (3) 1 (2) 0 (0) 0 (0) 1 (1)
Paid work 12 (21) 7 (19) 6 (15) 25 (19) 11 (21) 11 (21) 9 (24) 31 (22)
Voluntary work 0 (0) 1 (3) 1 (3) 2 (2) 2 (4) 0 (0) 0 (0) 2 (1)
Leisure activities 18 (32) 15 (42) 10 (25) 43 (33) 14 (27) 13 (25) 14 (37) 41 (29)
Other non-specified 4 (7) 3 (8) 7 (18) 14 (11) 7 (13) 5 (10) 1 (3) 13 (9)
Studying 9 (16) 3 (8) 1 (3) 13 (10) 1 (2) 3 (6) 4 (11) 8 (6)
Retired 2 (4) 1 (3) 0 (0) 3 (2) 1 (2) 2 (4) 2 (5) 5 (4)
Disabled 0 (0) 0 (0) 0 (0) 0 (0) 1 (2) 0 (0) 0 (0) 1 (1)
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Time and travel costs
OHA, n, mean cost (SD)
Routine Personalised
No PI
(N= 289)
12-monthly
PI (N= 287)
6-monthly
PI (N= 290)
Total
(N= 866)
No PI
(N= 334)
12-monthly
PI (N= 338)
6-monthly
PI (N= 335)
Total
(N= 1007)
Companion unit cost (£) for time and travel 260, 1.35
(4.57)
260, 0.85
(2.94)
260, 1.03
(4.07)
780, 1.08
(3.92)
301, 0.89
(3.28)
306, 0.98
(3.16)
304; 0.96
(3.72)
911, 0.94
(3.40)
Average number of visits to dentist 271, 3.57
(1.99)
273, 3.75
(2.17)
283, 3.9
(2.37)
827, 3.74
(2.19)
327, 3.21
(1.87)
331, 3.61
(1.96)
328, 3.74
(1.87)
986, 3.52
(1.91)
Total cost (£) of time and travel:complete case 186, 44.08
(51.69)
201, 47.53
(57.18)
195, 47.16
(48.61)
582, 46.30
(52.61)
234, 35.16
(36.66)
249, 43.67
(58.72)
243, 44.38
(50.50)
726, 41.17
(49.72)
Total cost (£) of time and travel: imputation of
missing data
289, 43.55
(51.33)
287, 47.31
(57.12)
290, 46.44
(48.35)
866, 45.77
(52.36)
334, 34.57
(36.17)
338, 42.75
(56.46)
335, 44.36
(50.95)
1007, 0.57
(48.81)
a Respondents were able to tick more than one box to indicate who accompanied them (e.g. partner and child ‘other relative’).
b Companion total travel costs based on 2 × one-way bus fare, if reported. Otherwise, companion travel costs assumed equal to individual participant costs; includes £0 for those who
were not accompanied and, hence, paid nothing.
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Section 6: detailed results of further health economic analyses
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FIGURE 19 Confidence ellipses for base-case health economic results. NHS dental costs: (a) routine OHA, no PI vs.
routine OHA, 6-monthly PI; (b) routine OHA, 12-monthly PI vs. routine OHA, 6-monthly PI; (c) personalised OHA,
no PI vs. routine OHA, 6-monthly PI; (d) personalised OHA, 6-monthly PI vs. routine OHA, 6-monthly PI; and
(e) personalised OHA, 12-monthly PI vs. routine OHA, 6-monthly PI. (continued )
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FIGURE 19 Confidence ellipses for base-case health economic results. NHS dental costs: (a) routine OHA, no PI vs.
routine OHA, 6-monthly PI; (b) routine OHA, 12-monthly PI vs. routine OHA, 6-monthly PI; (c) personalised OHA,
no PI vs. routine OHA, 6-monthly PI; (d) personalised OHA, 6-monthly PI vs. routine OHA, 6-monthly PI; and
(e) personalised OHA, 12-monthly PI vs. routine OHA, 6-monthly PI.
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TABLE 50 Sensitivity analysis: including baseline and final clinical visits
Region
Mean (SD)
costs, £
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI), £
Mean (SD)
benefits, £
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
UK
Routine OHA
6-monthly PI
(n= 289)
97 (123) – 231 (139) – –
No PI
(n= 288)
97 (134) 2 (–22 to 25) 164 (134) –67 (–92 to –42) –68 (–103 to –33)
12-monthly PI
(n= 285)
105 (160) 10 (–13 to 33) 205 (133) –23 (–48 to 1) –33 (–67 to 1)
Personalised OHA
No PI
(n= 333)
87 (132) –3 (–31 to 25) 236 (145) 6 (–23 to 35) 9 (–24 to 42)
12-monthly PI
(n= 338)
110 (150) 21 (–8 to 49) 277 (134) 45 (17 to 74) 25 (–8 to 57)
6-monthly PI
(n= 335)
109 (164) 19 (–9 to 47) 317 (150) 88 (59 to 117) 69 (36 to 102)
Scotland
Routine OHA
6-monthly PI
(n= 195)
101 (118) – 251 (136) – –
No PI
(n= 195)
88 (102) –12 (–36 to 12) 192 (130) –59 (–89 to –29) –47 (–85 to –9)
12-monthly PI
(n= 195)
97 (116) –2 (–26 to 22) 226 (133) –24 (–54 to 5) –22 (–60 to 15)
Personalised OHA
No PI
(n= 252)
87 (114) –5 (–34 to 23) 260 (141) 7 (–26 to 41) 13 (–23 to 49)
12-monthly PI
(n= 255)
107 (142) 13 (–16 to 41) 302 (123) 45 (12 to 77) 32 (–3 to 67)
6-monthly PI
(n= 252)
108 (152) 14 (–14 to 43) 345 (138) 92 (58 to 125) 77 (42 to 113)
England
Routine OHA
6-monthly PI
(n= 94)
89 (133) – 189 (137) – –
No PI (n= 93) 115 (183) 32 (–23 to 86) 105 (122) –83 (–124 to –43) –115 (–185 to –45)
12-monthly PI
(n= 92)
122 (227) 33 (–20 to 87) 161 (123) –24 (–65 to 17) –58 (–126 to 11)
Personalised OHA
No PI (n= 81) 85 (175) –2 (–66 to 63) 161 (133) –15 (–69 to 38) –14 (–84 to 56)
12-monthly PI
(n= 83)
119 (173) 35 (–30 to 101) 199 (138) 30 (–24 to 84) –5 (–76 to 65)
6-monthly PI
(n= 83)
111 (197) 27 (–38 to 92) 233 (157) 60 (5 to 116) 34 (–38 to 105)
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TABLE 51 Sensitivity analysis: discounting 0% for costs and benefits
Region
Mean (SD)
costs, £
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI), £
Mean (SD)
benefits, £
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
UK
Routine OHA
6-monthly PI
(n= 289)
77 (109) – 150 (110) – –
No PI
(n= 288)
78 (126) 2 (–20 to 23) 81 (102) –69 (–88 to –49) –70 (–99 to –42)
12-monthly PI
(n= 285)
85 (147) 9 (–12 to 30) 117 (99) –31 (–50 to –12) –40 (–68 to –12)
Personalised OHA
No PI
(n= 333)
65 (120) –6 (–29 to 17) 130 (110) –18 (–41 to 4) –13 (–40 to 15)
12-monthly PI
(n= 338)
90 (139) 19 (–4 to 43) 170 (100) 20 (0 to 41) 1 (–26 to 28)
6-monthly PI
(n= 335)
86 (139) 15 (–8 to 38) 212 (120) 64 (42 to 86) 49 (21 to 76)
Scotland
Routine OHA
6-monthly PI
(n= 195)
75 (96) – 163 (112) – –
No PI
(n= 195)
66 (90) –9 (–29 to 12) 90 (106) –73 (–97 to –49) –64 (–95 to –34)
12-monthly PI
(n= 195)
70 (86) –4 (–24 to 17) 122 (103) –40 (–63 to –17) –36 (–66 to –6)
Personalised OHA
No PI
(n= 252)
63 (106) –5 (–29 to 19) 139 (112) –25 (–53 to 2) –20 (–50 to 9)
12-monthly PI
(n= 255)
83 (127) 13 (–11 to 37) 181 (97) 14 (–12 to 39) 1 (–27 to 29)
6-monthly PI
(n= 252)
82 (124) 13 (–11 to 36) 229 (117) 65 (38 to 92) 52 (23 to 81)
England
Routine OHA
6-monthly PI
(n= 94)
82 (132) – 123 (102) – –
No PI (n = 93) 102 (177) 25 (–27 to 76) 62 (89) –60 (–92 to –29) –85 (–146 to –24)
12-monthly PI
(n= 92)
116 (224) 35 (–16 to 86) 105 (89) –14 (–47 to 18) –50 (–111 to 12)
Personalised OHA
No PI (n = 81) 68 (156) –12 (–69 to 45) 103 (100) –11 (–52 to 30) 1 (–62 to 64)
12-monthly PI
(n= 83)
113 (171) 35 (–24 to 93) 136 (102) 26 (–14 to 67) –9 (–71 to 54)
6-monthly PI
(n= 83)
98 (175) 20 (–38 to 78) 162 (116) 50 (9 to 90) 30 (–32 to 91)
DOI: 10.3310/hta22380 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 38
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Ramsay et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
133
TABLE 52 Sensitivity analysis: discounting 6% for costs and benefits
Region
Mean (SD)
costs, £
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI), £
Mean (SD)
benefits, £
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
UK
Routine OHA
6-monthly PI
(n= 289)
72 (103) – 144 (102) – –
No PI (n= 288) 72 (117) 1 (–19 to 21) 79 (95) –65 (–84 to –47) –67 (–93 to –40)
12-monthly PI
(n= 285)
79 (139) 8 (–11 to 28) 113 (91) –29 (–48 to –11) –38 (–65 to –11)
Personalised OHA
No PI (n= 333) 60 (112) –6 (–27 to 16) 127 (102) –16 (–36 to 5) –10 (–36 to 15)
12-monthly PI
(n= 338)
84 (129) 18 (–4 to 39) 166 (93) 21 (1 to 41) 4 (–22 to 29)
6-monthly PI
(n= 335)
81 (131) 15 (–7 to 36) 205 (112) 62 (41 to 83) 47 (22 to 73)
Scotland
Routine OHA
6-monthly PI
(n= 195)
71 (91) – 157 (103) – –
No PI (n= 195) 62 (84) –9 (–28 to 10) 87 (99) –70 (–93 to –47) –62 (–90 to –33)
12-monthly PI
(n= 195)
66 (80) –4 (–23 to 15) 119 (95) –38 (–62 to –15) –34 (–64 to –5)
Personalised OHA
No PI (n= 252) 60 (100) –5 (–27 to 17) 136 (103) –22 (–48 to 3) –18 (–45 to 10)
12-monthly PI
(n= 255)
78 (118) 12 (–11 to 34) 176 (91) 15 (–10 to 40) 3 (–24 to 30)
6-monthly PI
(n= 252)
77 (117) 12 (–11 to 34) 221 (108) 63 (37 to 88) 51 (24 to 78)
England
Routine OHA
6-monthly PI
(n= 94)
76 (125) – 118 (94) – –
No PI (n= 93) 95 (165) 23 (–26 to 72) 61 (84) –56 (–85 to –27) –79 (–136 to –22)
12-monthly PI
(n= 92)
109 (213) 33 (–15 to 82) 101 (82) –13 (–42 to 15) –47 (–103 to 10)
Personalised OHA
No PI (n= 81) 63 (144) –12 (–65 to 42) 101 (94) –8 (–46 to 30) 3 (–54 to 61)
12-monthly PI
(n= 83)
104 (157) 31 (–23 to 86) 133 (94) 27 (–10 to 65) –4 (–62 to 54)
6-monthly PI
(n= 83)
93 (166) 20 (–34 to 73) 155 (109) 48 (9 to 88) 28 (–30 to 87)
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TABLE 53 Sensitivity analysis: all PI and OHA delivered by a dentist
Region
Mean (SD)
costs, £
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI), £
Mean (SD)
benefits, £
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
UK
Routine OHA
6-monthly PI
(n= 289)
74 (106) – 153 (107) – –
No PI (n = 288) 74 (119) 1 (–20 to 21) 83 (99) –70 (–89 to –51) –70 (–98 to –43)
12-monthly PI
(n= 285)
81 (141) 9 (–12 to 29) 122 (96) –29 (–48 to –10) –37 (–65 to –10)
Personalised OHA
No PI (n = 333) 62 (115) –6 (–27 to 16) 137 (104) –13 (–35 to 8) –8 (–34 to 19)
12-monthly PI
(n= 338)
87 (134) 18 (–3 to 40) 178 (97) 27 (6 to 47) 8 (–18 to 35)
6-monthly PI
(n= 335)
83 (134) 15 (–7 to 37) 220 (113) 70 (48 to 91) 55 (28 to 82)
Scotland
Routine OHA
6-monthly PI
(n= 195)
72 (93) – 161 (107) – –
No PI (n = 195) 64 (86) –8 (–28 to 11) 89 (104) –72 (–95 to –49) –64 (–93 to –34)
12-monthly PI
(n= 195)
67 (82) –4 (–23 to 16) 122 (99) –39 (–62 to –17) –35 (–64 to –6)
Personalised OHA
No PI (n = 252) 61 (103) –5 (–27 to 18) 141 (106) –20 (–46 to 6) –15 (–44 to 13)
12-monthly PI
(n= 255)
80 (121) 12 (–11 to 35) 184 (95) 19 (–6 to 44) 7 (–20 to 35)
6-monthly PI
(n= 252)
79 (120) 12 (–10 to 35) 231 (110) 69 (43 to 95) 57 (29 to 85)
England
Routine OHA
6-monthly PI
(n= 94)
78 (128) – 135 (106) – –
No PI (n = 93) 95 (167) 21 (–28 to 71) 69 (87) –65 (–97 to –34) –86 (–145 to –28)
12-monthly PI
(n= 92)
112 (216) 33 (–16 to 83) 122 (90) –9 (–42 to 24) –43 (–103 to 17)
Personalised OHA
No PI (n = 81) 65 (148) –13 (–68 to 42) 123 (97) –3 (–43 to 36) 9 (–50 to 69)
12-monthly PI
(n= 83)
108 (165) 33 (–23 to 88) 160 (101) 38 (–3 to 79) 6 (–56 to 67)
6-monthly PI
(n= 83)
95 (170) 19 (–36 to 74) 185 (116) 62 (20 to 103) 43 (–19 to 104)
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TABLE 54 Sensitivity analysis: all PI and OHA delivered by a hygienist
Region
Mean (SD)
costs, £
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI), £
Mean (SD)
benefits, £
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
UK
Routine OHA
6-monthly PI
(n= 289)
74 (106) – 126 (100) – –
No PI (n= 288) 74 (119) 1 (–20 to 21) 65 (89) –60 (–78 to –43) –61 (–88 to –34)
12-monthly PI
(n= 285)
81 (141) 9 (–12 to 29) 95 (89) –29 (–46 to –11) –37 (–64 to –10)
Personalised OHA
No PI (n= 333) 62 (115) –6 (–27 to 15) 100 (94) –24 (–43 to –4) –18 (–44 to 8)
12-monthly PI
(n= 338)
87 (134) 18 (–3 to 39) 130 (88) 5 (–14 to 24) –13 (–39 to 13)
6-monthly PI
(n= 335)
83 (134) 15 (–7 to 36) 167 (105) 43 (23 to 63) 29 (2 to 55)
Scotland
Routine OHA
6-monthly PI
(n= 195)
72 (93) – 131 (102) – –
No PI (n= 195) 64 (86) –8 (–28 to 11) 68 (92) –63 (–84 to –41) –54 (–83 to –25)
12-monthly PI
(n= 195)
67 (82) –4 (–23 to 16) 94 (92) –37 (–58 to –16) –33 (–61 to –4)
Personalised OHA
No PI (n= 252) 61 (103) –5 (–27 to 17) 103 (96) –28 (–53 to –4) –24 (–51 to 4)
12-monthly PI
(n= 255)
80 (121) 12 (–10 to 34) 133 (87) –1 (–24 to 22) –13 (–40 to 14)
6-monthly PI
(n= 252)
79 (120) 12 (–10 to 34) 175 (103) 44 (19 to 68) 31 (4 to 59)
England
Routine OHA
6-monthly PI
(n= 94)
78 (128) – 115 (97) – –
No PI (n= 93) 95 (167) 21 (–28 to 71) 58 (82) –56 (–86 to –27) –78 (–135 to –20)
12-monthly PI
(n= 92)
112 (216) 33 (–16 to 83) 98 (81) –13 (–45 to 18) –47 (–106 to 13)
Personalised OHA
No PI (n= 81) 65 (148) –14 (–67 to 39) 89 (88) –19 (–54 to 17) –5 (–64 to 54)
12-monthly PI
(n= 83)
108 (165) 32 (–22 to 85) 118 (91) 15 (–22 to 51) –17 (–78 to 43)
6-monthly PI
(n= 83)
95 (170) 18 (–35 to 71) 141 (106) 35 (–2 to 72) 17 (–43 to 77)
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TABLE 55 Sensitivity analysis: adding an additional cost for personalised OHA to all respondents in this cluster
Region
Mean (SD)
costs, £a
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI), £
Mean (SD)
benefits, £
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
UK
Routine OHA
6-monthly PI
(n= 289)
74 (106) – 147 (104) – –
No PI (n = 288) 75 (121) 1 (–26 to 28) 79 (98) –67 (–85 to –49) –68 (–101 to –36)
12-monthly PI
(n= 285)
81 (140) 8 (–18 to 35) 115 (95) –30 (–48 to –12) –39 (–70 to –7)
Personalised OHA
No PI (n = 333) 109 (215) 37 (–13 to 87) 129 (104) –17 (–37 to 3) –54 (–104 to –4)
12-monthly PI
(n= 338)
135 (190) 66 (16 to 116) 166 (96) 19 (–2 to 39) –48 (–100 to 5)
6-monthly PI
(n= 335)
105 (177) 34 (–5 to 72) 207 (117) 61 (40 to 82) 28 (–15 to 70)
Scotland
Routine OHA
6-monthly PI
(n= 195)
72 (93) – 159 (105) – –
No PI (n = 195) 64 (86) –9 (–40 to 23) 88 (102) –72 (–94 to –50) –64 (–102 to –26)
12-monthly PI
(n= 195)
67 (82) –4 (–36 to 27) 120 (98) –39 (–62 to –17) –35 (–74 to 3)
Personalised OHA
No PI (n = 252) 122 (231) 52 (–12 to 116) 138 (105) –23 (–46 to 0) –75 (–141 to –10)
12-monthly PI
(n= 255)
143 (196) 75 (11 to 140) 177 (93) 12 (–11 to 35) –63 (–130 to 4)
6-monthly PI
(n= 252)
106 (177) 36 (–12 to 84) 223 (113) 62 (39 to 86) 26 (–27 to 80)
England
Routine OHA
6-monthly PI
(n= 94)
79 (130) – 120 (96) – –
No PI (n = 93) 98 (170) 23 (–28 to 73) 62 (86) –57 (–87 to –27) –80 (–140 to –21)
12-monthly PI
(n= 92)
112 (214) 33 (–17 to 83) 103 (85) –13 (–43 to 17) –46 (–104 to 12)
Personalised OHA
No PI (n = 81) 69 (152) –9 (–65 to 47) 103 (97) –8 (–47 to 31) 1 (–59 to 61)
12-monthly PI
(n= 83)
111 (164) 35 (–22 to 91) 132 (98) 26 (–13 to 65) –9 (–70 to 52)
6-monthly PI
(n= 83)
102 (177) 25 (–32 to 82) 158 (113) 49 (11 to 87) 24 (–37 to 85)
a Note that this analysis also accounts for individual-level exemption status.
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TABLE 56 Sensitivity analysis: decreasing value of UDA (–20%)
Region
Mean (SD)
costs, £
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI), £
Mean (SD)
benefits, £
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
UK
Routine OHA
6-monthly PI
(n= 289)
69 (96) – 146 (105) – –
No PI (n= 288) 68 (104) 0 (–19 to 18) 79 (98) –66 (–85 to –48) –66 (–91 to –40)
12-monthly PI
(n= 285)
74 (119) 7 (–12 to 25) 115 (95) –29 (–48 to –11) –36 (–61 to –10)
Personalised OHA
No PI (n= 333) 59 (107) –5 (–25 to 16) 128 (105) –17 (–38 to 5) –12 (–37 to 13)
12-monthly PI
(n= 338)
81 (124) 18 (–3 to 38) 166 (97) 21 (0 to 42) 3 (–21 to 28)
6-monthly PI
(n= 335)
78 (124) 15 (–6 to 35) 207 (115) 63 (41 to 85) 49 (23 to 74)
Scotland
Routine OHA
6-monthly PI
(n= 195)
72 (93) – 159 (107) – –
No PI (n= 195) 64 (86) –8 (–28 to 11) 88 (102) –71 (–94 to –49) –63 (–92 to –34)
12-monthly PI
(n= 195)
67 (82) –4 (–23 to 16) 120 (99) –39 (–61 to –17) –35 (–64 to –6)
Personalised OHA
No PI (n= 252) 61 (103) –5 (–28 to 18) 137 (106) –23 (–49 to 3) –18 (–47 to 10)
12-monthly PI
(n= 255)
80 (121) 12 (–11 to 35) 178 (94) 14 (–11 to 39) 2 (–25 to 29)
6-monthly PI
(n= 252)
79 (120) 12 (–11 to 35) 225 (110) 64 (38 to 90) 52 (24 to 80)
England
Routine OHA
6-monthly PI
(n= 94)
63 (103) – 118 (97) – –
No PI (n= 93) 76 (133) 17 (–22 to 57) 61 (85) –56 (–87 to –26) –73 (–123 to –24)
12-monthly PI
(n= 92)
89 (173) 27 (–13 to 67) 104 (85) –10 (–42 to 22) –37 (–89 to 14)
Personalised OHA
No PI (n= 81) 52 (119) –9 (–55 to 36) 101 (97) –8 (–47 to 30) 1 (–50 to 52)
12-monthly PI
(n= 83)
86 (132) 27 (–19 to 73) 132 (98) 28 (–12 to 67) 0 (–53 to 53)
6-monthly PI
(n= 83)
76 (136) 16 (–30 to 62) 154 (113) 48 (8 to 88) 32 (–21 to 84)
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TABLE 57 Sensitivity analysis: increasing value of UDA (+ 20%)
Region
Mean (SD)
costs, £
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI), £
Mean (SD)
benefits, £
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
UK
Routine OHA
6-monthly PI
(n= 289)
79 (117) – 146 (105) – –
No PI (n = 288) 80 (136) 2 (–21 to 25) 79 (98) –66 (–85 to –48) –68 (–97 to –39)
12-monthly PI
(n= 285)
89 (164) 11 (–12 to 34) 115 (95) –29 (–48 to –11) –40 (–69 to –10)
Personalised OHA
No PI (n = 333) 65 (125) –7 (–31 to 17) 128 (105) –16 (–38 to 5) –9 (–38 to 19)
12-monthly PI
(n= 338)
92 (145) 19 (–5 to 43) 166 (97) 21 (0 to 41) 2 (–27 to 30)
6-monthly PI
(n= 335)
87 (146) 15 (–9 to 39) 207 (115) 63 (42 to 85) 48 (20 to 77)
Scotland
Routine OHA
6-monthly PI
(n= 195)
72 (93) – 159 (107) – –
No PI (n = 195) 64 (86) –8 (–28 to 11) 88 (102) –71 (–94 to –49) –63 (–92 to –34)
12-monthly PI
(n= 195)
67 (82) –4 (–23 to 16) 120 (99) –39 (–61 to –17) –35 (–64 to –6)
Personalised OHA
No PI (n = 252) 61 (103) –5 (–28 to 18) 137 (106) –23 (–49 to 3) –18 (–47 to 10)
12-monthly PI
(n= 255)
80 (121) 12 (–11 to 35) 178 (94) 14 (–11 to 39) 2 (–25 to 29)
6-monthly PI
(n= 252)
79 (120) 12 (–11 to 35) 225 (110) 64 (38 to 90) 52 (24 to 80)
England
Routine OHA
6-monthly PI
(n= 94)
94 (154) – 118 (97) – –
No PI (n = 93) 114 (200) 26 (–34 to 85) 61 (85) –57 (–87 to –26) –82 (–148 to –16)
12-monthly PI
(n= 92)
134 (259) 40 (–19 to 100) 104 (85) –10 (–42 to 22) –51 (–119 to 17)
Personalised OHA
No PI (n = 81) 78 (178) –16 (–80 to 49) 101 (97) –9 (–49 to 31) 7 (–61 to 74)
12-monthly PI
(n= 83)
130 (198) 39 (–27 to 105) 132 (98) 27 (–14 to 69) –12 (–81 to 58)
6-monthly PI
(n= 83)
114 (204) 22 (–43 to 88) 154 (113) 47 (6 to 89) 25 (–44 to 94)
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TABLE 58 Alternative method to map from DCE to trial for aesthetic outcome (mapping to ‘after brushing’)
Region
Mean (SD)
costs, £
Mean difference
in costs (95% CI)
vs. routine OHA
(6-monthly PI), £
Mean (SD)
benefits, £
Mean difference in
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
Incremental net
benefits (95% CI)
vs. routine OHA
(6-monthly PI), £
UK
Routine OHA
6-monthly PI
(n= 289)
74 (105) – 177 (92) – –
No PI (n= 288) 74 (118) 1 (–20 to 21) 113 (85) –64 (–79 to –49) –64 (–89 to –39)
12-monthly PI
(n= 285)
81 (141) 9 (–12 to 29) 148 (78) –28 (–43 to –13) –37 (–61 to –12)
Personalised OHA
No PI (n= 333) 62 (116) –6 (–28 to 17) 166 (84) –11 (–29 to 7) –5 (–29 to 18)
12-monthly PI
(n= 338)
86 (133) 18 (–4 to 40) 203 (78) 26 (8 to 44) 7 (–16 to 31)
6-monthly PI
(n= 335)
83 (134) 15 (–8 to 37) 235 (100) 59 (40 to 77) 44 (20 to 68)
Scotland
Routine OHA
6-monthly PI
(n= 195)
72 (93) – 190 (92) – –
No PI (n= 195) 63 (86) –9 (–28 to 11) 123 (89) –67 (–86 to –49) –59 (–85 to –33)
12-monthly PI
(n= 195)
67 (82) –4 (–23 to 16) 153 (82) –38 (–56 to –20) –34 (–59 to –8)
Personalised OHA
No PI (n= 252) 61 (103) –5 (–27 to 17) 173 (86) –18 (–39 to 3) –13 (–37 to 11)
12-monthly PI
(n= 255)
79 (121) 12 (–11 to 34) 212 (75) 18 (–3 to 40) 7 (–18 to 31)
6-monthly PI
(n= 252)
79 (120) 12 (–10 to 34) 253 (95) 62 (41 to 84) 50 (26 to 75)
England
Routine OHA
6-monthly PI
(n= 94)
78 (127) – 150 (88) – –
No PI (n= 93) 95 (165) 21 (–28 to 70) 93 (72) –57 (–81 to –33) –79 (–134 to –23)
12-monthly PI
(n= 92)
112 (215) 34 (–15 to 83) 137 (68) –10 (–34 to 13) –45 (–99 to 10)
Personalised OHA
No PI (n= 81) 66 (150) –12 (–68 to 44) 142 (73) –1 (–36 to 35) 11 (–45 to 68)
12-monthly PI
(n= 83)
108 (162) 32 (–24 to 89) 176 (81) 36 (0 to 71) 3 (–53 to 60)
6-monthly PI
(n= 83)
95 (170) 19 (–37 to 75) 180 (94) 38 (3 to 74) 19 (–37 to 76)
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Appendix 3 Recruitment
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FIGURE 20 Target vs. actual practice accrual.
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FIGURE 21 Target vs. actual participant accrual. Note: a delay to staff appointments (research hygienists and dental
research nurses) resulted in a delay to the start of recruitment of dental practices and participants against the
initial projected target accrual.
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TABLE 59 Recruitment by centre
Centre
OHA Randomisation date
Personalised Routine First participant Last participant
Scotland
Dental Care Glenrothes – 31 2 March 2012 18 May 2012
Discovery Dental Care 33 – 17 July 2012 28 September 2012
Mullins Dental Practice 35 – 11 June 2012 15 June 2012
Laurencekirk Dental Practice – 13 17 May 2012 30 May 2012
Woodside Dental Practice – 32 19 July 2012 16 August 2012
Baillieston Dental Care 31 – 19 June 2012 24 October 2012
P A Penney Dental Practice – 14 26 July 2012 20 September 2012
Wishaw Cross Dental Care 31 – 6 August 2012 18 October 2012
Clyde Dental – 23 18 July 2012 23 October 2012
S. Rankin 31 – 1 October 2012 5 December 2012
Barrhead Dental practice 29 – 13 August 2012 10 September 2012
The Hollies Dental Practice – 39 29 October 2012 1 November 2012
Chong Kwan and Associates 32 – 5 November 2012 9 November 2012
Duns Dental Practice – 35 9 October 2012 2 November 2012
Clark and Watson – 33 26 September 2012 14 November 2012
Dental Care Perth – 18 23 October 2012 25 February 2013
Dental Plus 31 – 3 October 2012 20 December 2012
Stirling Dental Care 31 – 5 November 2012 25 March 2013
West End Dental Practice 32 – 15 November 2012 13 December 2012
JL Barrack Dental Practice – 31 31 October 2012 24 January 2013
Selkirk 34 – 22 October 2012 9 November 2012
Bridge of Don Dental Practice – 38 19 November 2012 10 December 2012
Ardmillan Dental Practice – 34 11 December 2012 22 January 2013
Drumbrae Dental Surgery 16 – 13 November 2012 11 January 2013
Pickering Dental Care Ltd – 25 5 December 2012 6 May 2013
Karolak and Iwanowicz – 22 14 January 2013 15 April 2013
City Health Clinic – 34 25 January 2013 23 May 2013
Care Dental (Crieff) 31 – 7 January 2013 3 June 2013
Dunbar Dental Practice 43 – 4 February 2013 8 February 2013
Long and Gilmour Dental Care 22 – 11 March 2013 25 June 2013
Riverview Dental Practice – 30 10 April 2013 25 June 2013
Montgomery Street Dental 32 – 29 March 2013 22 May 2013
Invergowrie Dental 32 – 17 January 2013 15 March 2013
East Neuk Dental – 30 25 January 2013 12 April 2013
Mastrick Dental 32 – 12 February 2013 3 April 2013
Birch Valley Dental Clinic 34 – 19 February 2013 21 February 2013
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TABLE 59 Recruitment by centre (continued )
Centre
OHA Randomisation date
Personalised Routine First participant Last participant
Whitburn Dental Practice – 34 27 March 2013 19 June 2013
K H Stirling 29 – 21 March 2013 16 May 2013
Bute Dental Practice – 34 27 May 2013 31 May 2013
Peacocks Dental Surgery 22 – 20 May 2013 24 May 2013
St Leonards 32 – 1 May 2013 3 May 2013
Lochboisdale, South Uist 41 – 1 July 2013 5 July 2013
King Street, Orkney 46 – 10 June 2013 14 June 2013
D A Gilchrist – 36 26 June 2013 3 July 2013
England
Mr A I Robson and Associates 31 – 6 September 2012 18 October 2012
Mr S B Pabary and Associates 31 – 13 November 2012 30 April 2013
Sunderland Road Dental Practice – 31 12 September 2012 6 November 2012
Framwellgate Dental Practice 24 – 18 September 2012 5 February 2013
Osborne Dental Practice 26 – 12 June 2012 3 December 2012
Hetton Dental – 24 15 November 2012 24 April 2013
Shotley Bridge 31 – 29 November 2012 11 December 2012
Number One – 14 18 February 2013 4 July 2013
Stuart Eaborn Dentist 31 – 5 February 2013 23 April 2013
Dean Road Dental Surgery 33 – 10 January 2013 11 March 2013
Smith and Smith – 33 28 February 2013 14 March 2013
Kenton Lane – 31 15 April 2013 28 May 2013
Whickham Village 34 – 13 February 2013 28 March 2013
Blaydon Dental – 32 5 March 2013 27 March 2013
Gosforth Dental – 31 15 May 2013 5 June 2013
Nepali Dental – 30 15 May 2013 4 July 2013
Princes Street – 32 28 May 2013 27 June 2013
Front Street, Consett 7 – 5 June 2013 5 June 2013
Silver Dental Practice – 23 20 June 2013 4 July 2013
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